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Introduction
Preterm birth, defined as a delivery before the completion of 37 weeks of gesta-
tion, is a leading cause of neonatal morbidity and the second leading cause of
neonatal mortality.1,2 Preterm birth includes preterm labor with intact membranes
(PTL; ± 40%), preterm premature rupture of membranes (PPROM; ± 40%),
and indicated delivery because of deteriorating maternal or fetal health (± 20%).3
Preterm delivery occurs in approximately 7 to 11% of all births in western coun-
tries.4,5 Its incidence has increased during the last decade. Main reasons are (1) a
higher incidence of multiple births due to fertility-enhancing drugs and proce-
dures; (2) a tendency toward early (including preterm) induction or Cesarean sec-
tion for pathological pregnancies; (3) an increase in registration of births near the
borderline of viability; and (4) a more accurate estimated gestational age by the
increasing use of early ultrasound.6 Neonatal intensive care has improved the sur-
vival rate for babies, including those born at the very threshold of viability, but the
proportion of survivors with disabilities is still high.6
In this thesis we will focus on spontaneous preterm birth (SPB), which includes
PTL and PPROM. The strategies to prevent or reduce SPB have not been effec-
tive until now. SPB is a syndrome produced by a wide variety of disease conditions
operating through different pathogenic pathways and mechanisms.7 With the
recent advances in understanding the pathogenesis of SPB, a number of tech-
niques have been proposed to predict SPB.
It is of clinical relevance to be able to predict SPB, if an intervention is available
that is likely to improve outcome. Such an intervention should preferably prevent
preterm birth at all. Unfortunately this can presently not yet been achieved in
most cases. However, there are interventions improving outcome. The use of
tocolytic agents reduces uterine contractions, which prolongs pregnancy with an
average of several days. In this time period corticosteroids can be administered to
improve the fetal lung maturity.8-10 The opportunity to administer corticosteroids
to the mother is an important intervention recommended by the National
Institute of Health as it strongly reduces neonatal morbidity and mortality.9,10
Since tocolytic and steroid therapy may result in maternal and/or fetal side effects,
use of these therapies should be limited to women with true preterm labor at high
risk for SPB. Another reason to identify women at risk for a preterm birth is to
allow appropriate maternal transport to a tertiary care center. Optimal care can be
2
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provided for the newborn from birth onwards in a neonatal intensive care center
for neonates born before 32 gestational weeks. It is also important to identify the
women at low risk for SPB, to prevent the use of unnecessary interventions.
Past (and current) approaches to predict those women who will deliver preterm,
have relied on (1) demographic information (such as ethnicity, age, marital
status,2 (2) previous pregnancy history (e.g. prior spontaneous or induced abor-
tion, preterm birth in prior pregnancies11 and (3) clinical indicators in the current
pregnancy such as cervical change, increasing uterine contraction frequency and
vaginal bleeding.12 Multiple gestations also have a high risk of preterm birth, 50%
of all twin pregnancies and practically all of the higher-order multiple pregnan-
cies are born preterm.13 (4) Other risk factors associated with spontaneous SPB
are occupational,14 environmental,15 psychosocial,2,16-18 behavioral, and nutrition-
al factors.19 Previous SPB, African-American race, and second-or third trimester
bleeding have been associated most consistently with SPB. Among women with
singleton pregnancies, a previous preterm birth is the strongest historic predictor,
with relative risks reported in the range of 2 to 6.20-22 Moreover, until now preterm
birth risk scoring systems based on arbitrarily selected or weighted epidemiologi-
cal, historical, and clinical risk factors have insufficient predictive value.20,21,23,24
One of the main reasons that treatment to reduce preterm birth is so ineffective is
that the individual cause is rarely determined during prenatal care. It will remain
difficult to reduce preterm births if we cannot act on their causes. The failure of
traditional approaches to predict SPB is likely to be an inadequate understanding
of the underlying heterogeneous pathogeneses of SPB. It is important to get more
insight in the pathophysiology in order to be able to discover new predictive/diag-
nostic tests and new therapeutic modalities in the future. The understanding of
the pathogenesis has substantially improved recently and different pathways have
been described in the literature.7 New biochemical fluid markers (cytokines, hor-
mones and enzymes) might be relevant in the etiological model of SPB.
Aims of the thesis
The obstetric problem SPB is the basis for the studies described in the present the-
sis. As outlined above it is of clinical relevance to discover early etiologic markers.
This would allow us to identify subgroups of patients at high risk of preterm birth
to improve the efficacy of our management. Therefore it is our goal to present the
Introduction
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latest ideas regarding the pathogenesis and to describe the efficacy of (new) bio-
chemical and biophysical markers for predicting preterm birth based on a review of
the literature. We will focus on a variety of hormones, cytokines and enzymes and
will describe whether these markers can be useful in routine obstetrical practice.
Aim 1: to provide a systemic review of the literature regarding the
pathogenesis and methods to predict spontaneous preterm birth
Secondly, we would like to discover novel early etiologic markers. From the litera-
ture we know that matrix metalloproteinase-1 and -9 (MMP-1 and MMP-9) are
important in the maintenance and breakdown of the extracellular matrix of the
amniochorion and cervix.25 They play an important role during cervical dilatation
in human parturition. The presence of the biochemical marker MMP-1 has been
studied in human cervical tissue,26 the placenta,27 amniotic fluid28 and serum.29-32
The involvement of MMP-9 in parturition has been demonstrated in the amnion
of rat33 and humans,34 in amniotic fluid,35,36 urine37 and plasma.38 The purpose of
our study is to evaluate whether MMP-1 and -9 are detectable in a new medium,
cervicovaginal secretions. This will be studied in women during pregnancy and in
preterm and term labor. If cervicovaginal MMP-1 and/or MMP-9 are detectable,
we aim to evaluate the usefulness of these  markers in the prediction of SPB.
Aim 2: to assess the usefulness of matrix metalloproteinase-1 and -9 in
predicting spontaneous preterm birth
To date, the cervical length as measured by transvaginal ultrasonography (TVS)
and fetal fibronectin (FFN) levels in cervical or vaginal secretions have been most
strongly and consistently associated with subsequent SPB.7,20,21 A decade ago,
TVS was introduced as a non-invasive technique for the assessment of cervical
length. Currently, it is widely used in clinical obstetric care. However considerable
variability in cervical length measurements have been described in the literature.
Therefore the two studies regarding cervical length presented in this thesis aim to
asses the methodological and sociodemographic influences on the test, which
have not been addressed yet. Purposes of the studies are to further characterize
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how cervical length varies between various racial groups and other sociodemo-
graphic factors by gestational age intervals. Besides we aim to establish basic pop-
ulation norms of central length (nomograms) over time and clarify their relation-
ship both at term and preterm birth.
Aim 3: to assess normal cervical length across gestation and the influence
of sociodemographic factors on cervical length at term and preterm birth
One of the causes of SPB is cervical incompetence. Cervical incompetence is usu-
ally treated by bed rest and/or transvaginal cervical cerclage.39 A cerclage can be
inserted prophylacticly, prior to pregnancy or in the first trimester, or therapeuti-
cally after detection of cervical changes during pregnancy. TVS is used to identify
cervical changes such as funneling and shortening. Recent studies have shown
that a cerclage results in measurable cervical lengthening. It is not known
whether this relative restoration of cervical anatomy after prophylactic or urgent
cerclage predicts pregnancy outcome.40 Our purpose is to determine whether the
degree of cervical lengthening after cerclage predicts term delivery. The second
aim is to evaluate the usefulness of serial cervical length measurements after cer-
clage to predict pregnancy outcome.
Aim 4: to determine the usefulness of cervical length measurements after
cerclage and their predictive value of spontaneous preterm birth
Aims 2, 3 and 4 of the thesis are covered by means of patient studies performed in
New York. The last aim is completed in the Netherlands and includes the health-
care providers. It is our purpose to evaluate the usefulness of the above-mentioned
methods to predict SPB in the ‘unique’ Dutch obstetric care system.41,42 The first
line obstetrical care providers (midwives and general practitioners practicing
obstetrics) have to make a reliable assessment to refer a patient with symptoms of
threatened preterm delivery to the gynecologist. The Obstetric Indication List
(=‘Verloskundige Indicatie Lijst’ (VIL))43 is a good resource for risk selection in
the Dutch obstetric care. However, the guidelines in the VIL regarding preterm
birth are only briefly described. The impression exists that there are different
Introduction
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views regarding diagnosing and treating threatened preterm birth among and
within the three professional groups active in the Dutch obstetric care. A ques-
tionnaire was conducted to get insight in the consultation between the first and
second line regarding SPB, to be able to create new guidelines in the future. The
objective of our study is to describe the management and views regarding threat-
ened preterm birth, views about mutual cooperation and the acceptation of the
VIL among midwives, general practitioners and gynecologists. The second aim is
to provide insight in the use of (new) predictors of SPB and treatment modalities
by the Dutch gynecologists.
Aim 5: to study the management and views regarding spontaneous
preterm birth in Dutch obstetric care
6
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Reader’s companion
This thesis consists of two parts. In the first part the pathogenesis and (new)
methods for prediction of spontaneous preterm birth are described. An overview
will be given of the possible mechanisms resulting in uterine contractions, cervi-
cal change, rupture of the membranes and finally to spontaneous preterm birth. A
review is provided of the most important biophysical and biochemical markers to
predict SPB (chapter 2). Furthermore a new etiologic marker for SPB will be
assessed. In a case-control study we sought to determine whether matrix metallo-
proteinase-1 and -9 levels in cervicovaginal fluid differ in women during preg-
nancy compared to women at term or in preterm labor (chapter 3).
Chapters 4-6 focus on the assessment of the length of the cervix by TVS. This is a
diagnostic method already used often in clinical practice, but where standardization
is lacking. In chapter 4 we aim to create nomograms with an observational cohort
study of sonographically determined cervical length measured at 3 to 4-week inter-
vals. This will be studied in 125 women with uncomplicated, singleton pregnancies
that resulted in term deliveries. The association of sociodemographic factors with
changes in the length of the cervix across gestation will be described. In chapter 5
nomograms will be provided for 4 different race-groups in 777 women with uncom-
plicated, singleton pregnancies that resulted in term deliveries and 79 women who
delivered preterm. The racial variation in cervical length and its relation with
preterm delivery will be described. In chapter 6 the results of cervical length meas-
urements after cerclage are described to determine whether this relative restoration of
cervical anatomy after cerclage predicts pregnancy outcome. Fifty women with a
prophylactic cerclage and 30 with an urgent cerclage had sonographic examinations
before and after cerclage and thereafter three measurements until 32 weeks gestation.
The second part outline the views and management regarding the diagnosis and
treatment of preterm birth in the obstetrical care in the Netherlands. In chapter 7
the views on risk selection, management and mutual cooperation regarding SPB
under Dutch first line obstetrical care providers (midwives and general practition-
ers) and obstetrician/gynecologists are evaluated. In chapter 8 the use of (new)
diagnostic tests and treatment modalities for SPB under 85 Dutch
obstetrician/gynecologists are presented. Chapter 9 contains the summary and
discussion. Clinical guidelines will be provided for the general population and for
women at risk for SPB or with symptoms of threatened SPB.
Introduction
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2
Pathogenesis and methods for the prediction of
spontaneous preterm birth
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Introduction
In the last decade a lot of theories have been described regarding the cause of
spontaneous preterm birth (SPB). In this chapter we will describe a model of the
pathogenesis of SPB. Furthermore a systematic review will be provided regarding
various methods to predict SPB.
Method
The Pubmed (formerly Medline) database and the Cochrane library were used to
conduct a literature search to locate relevant articles regarding various methods to
predict SPB, published between January 1995 and January 2002. The search was
restricted to articles published in the English language. The words we used to
search were: ‘preterm birth’ or ‘premature labor’ and ‘CRH’, ‘ estrogen/estriol’,
‘MSAFP’, ‘HCG’, ‘doppler’, ‘relaxin’, ‘Interleukine-1/6/8’, ‘G-CSF’, ‘bacterial
vaginosis’, ‘thrombin/TAT’, ‘fetal fibronectin’, ‘cervical length’, ‘MMP-1/9’, ‘fetal
breathing movement’. Articles reporting results of original research and meta-
analyses were primarily consulted. Studies were reviewed and evaluated for quali-
ty per predictor. The selection was based on methodological qualities and applica-
bility. The following study designs were included in our review: randomized con-
trolled trials, well designed controlled trials without randomization, cohort or
case-control analytic studies, multiple time series with or without the interven-
tion. Review articles, opinions of respected authorities based on clinical experi-
ence, descriptive studies, or reports of expert committees were also employed for
this overview of biophysical and biochemical predictors of SPB. Studies with
other designs, or small sample sizes were excluded. Guidelines published by insti-
tutions such as the National Institute of Health (NIH) and the American College
of Obstetricians and Gynecologists (ACOG) were also reviewed. Additional stud-
ies were located by reviewing bibliographies of identified articles.
Pathogenesis of spontaneous preterm birth
Since the last decade there is growing clinical and experimental evidence that
most cases of SPB result from four primary pathogenic processes that may occur
either in isolation or in combination.1 While each process follows a unique bio-
chemical cascade, they share a common final biological pathway, involving the
release of prostaglandins which generate uterine contractions and an increased
12
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expression of genital tract proteases which promote cervical change and rupture
of membranes (Figure 1). To ascertain patients at risk, given these heterogeneous
biochemical and biophysical pathways, a combination of pathogenic-specific
markers will be needed.
A. Activation of the maternal and/or fetal hypothalamic pituitary adrenal
(HPA) axis
There is evidence that premature activation of the maternal and/or fetal HPA axis
due to maternal or fetal stress plays an important role in the genesis of 30% of
SPB. Hormonal mediators of HPA activation as well as markers of abnormal pla-
centation are indicators of the risk of SPB. Maternal and fetal stress lead to
increased expression of placental and amniochorion-decidual corticotrop in-
releasing hormone (CRH) (Figure 2).1 Both maturation and activation of the fetal
HPA axis lead to rising fetal cortisol and dehydroepiandrosterone sulfate
(DHEAS) levels. Rising fetal cortisol levels stimulate production of CRH in pla-
centa, membranes and decidua, which in turn, stimulates prostaglandin produc-
Pathogenesis & Predictors of SPB
13
Figure 1 Pathways of Preterm Birth (PTB) due to preterm Premature Rupture of the
Membranes (PPROM) and/or Preterm Labor (PTL) (reprinted with permis-
sion from: Lockwood and Kuczynski, markers of risk for preterm delivery;
J.Perinat. Med 1999; 27, 5-20)
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tion in the decidua and fetal membranes. CRH directly and indirectly, augments
androgen expression (DHEAS), through pituitary adrenocorticotropin (ACTH)
release.
These androgens are converted in the placenta to estrogens (E1-3) which enhance
the myometrial oxytocin receptors and facilitate contractions. Elevated maternal
serum alpha-fetoprotein (MSAFP) and human chorionic gonadotropin (hCG)
are markers of vascular abnormalities and IUGR and among patients delivering
preterm without infections or pre-eclampsia it can also be predictive of SPB.2,3
The epidemiological profile of risk for these conditions is mainly in nulliparous
patients, unmarried and poor mothers, patients reporting stress and anxiety.
B. Decidual-amniochorionic and systemic inflammation
Today, between 30% and 40% of SPB are thought to be attributable to maternal
infections and are considered preventable4,5 Ascending genital tract infections or
systemic bacterial and viral infections may lead to activation of systemic and/or
14
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Figure 2. The role of estrogens and CRH resulting from activation of the fetal HPA axis,
leading to uterine contractions, cervical changes, and/or rupture of the fetal
membranes. (reprinted with permission from: Lockwood and Kuczynski,
markers of risk for preterm delivery; J.Perinat. Med 1999; 27, 5-20).
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local cytokine network, which appears to be the principal mechanism for SPB in
such patients.6 This generates interleukin-1 beta (IL-1β) and tumor necrosis fac-
tor-alpha (TNF-α), which stimulate uterotonin (prostaglandins, endothelins,
leukotrienes) and proteases (collagenases, plasmin) production by the myometri-
al and cervical cells and also by decidua and membranes. These pro-parturition
effects are amplified by IL-1/TNF-mediated induction of: a) IL-6 and CRH
expression which further enhance prostaglandin production; and b) IL-8, a gran-
ulocyte chemotactant and activator, which causes the release of elastases and col-
lagenases. Granulocyte stimulating factor (G-CSF) is another cytokine that plays
a role modulating an inflammatory response. Particular striking is the association
between bacterial vaginosis (BV) and SPB.4 Systemic infections are also associat-
ed with PTL and/or SPB1 and despite controversial results from studies regarding
asymptomatic bacteriuria, Romero et al. showed in a meta-analysis that untreated
asymptomatic bacteruria during pregnancy significantly increased rate of low
birth weight and preterm birth.7 These findings suggest that an infection even
remote from the uterus can activate an inflammatory process that triggers an
uteroplacental response, leading to SPB. 
The epidemiological profile of risk for infections are women at risk for acquiring
sexually transmitted diseases (e.g. young, poor, minority, unmarried, inner city
women) harboring vaginal pathogens including bacterial vaginosis.
C. Decidual hemorrhage
Recurrent decidual hemorrhage presenting as vaginal bleeding occurring in the
first and subsequent trimesters is associated with a 3-fold increase in adjusted rel-
ative risk for SPB due to preterm contractions.8 This pathway of decidual hemor-
rhage causes SPB in about 20%. Harger et al. observed that vaginal bleeding in
more than one trimester carried the highest identifiable risk of preterm premature
rupture of membranes (PPROM), with an odds ratio of 7.4.9 Ekwo et al. found a
high positive predictive value for recurrent vaginal bleeding and SPB when their
previous pregnancy had been complicated by PPROM. Less than a quarter of
patients delivering preterm have recurrent vaginal bleeding.10 Hemorrhage leads
to local thrombin generation, which binds to cellular receptors in the decidua to
enhance protease production. Thrombin is a component of the coagulation cas-
cade and is a potent uterotonic agent. In vitro studies demonstrated a mechanistic
explanation for increased myometrial acitivity, observed with clinically apparent
Pathogenesis & Predictors of SPB
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intrauterine bleeding, such as placental abruption.11,12 An indicator of thrombin
activation would need to be used for minimal or occult intrauterine bleeding. One
such test, thrombin-antithrombin III (TAT) complex levels, measures the amount
of activated thrombin bound to antithrombin III, an endogenous thrombin antag-
onist. Several investigators observed that TAT levels progressively rise throughout
gestation, increase further with labor, and reach a peak with the delivery of the
placenta.11
The epidemiologic profile of risk for decidual hemorrhage-associated SPB
includes older, parous, married, college-educated women,13 distinct from the pro-
file for both infection - and stress - associated SPB.
D. Pathological uterine distension.
Conditions associated with pathologic uterine “stretch” include those which pro-
mote an abnormal increase in intrauterine volume (multifetal gestations, polyhy-
dramnios), or conditions limiting uterine expansile capacity, such as a T-shaped
uterus due to in utero DES exposure or to Müllerian duct anomalies. Both clinical
settings are strongly associated with the occurrence of preterm labor and/or
PPROM (20% of all SPB causes). The mechanism accounting for this association
appears to involve the transduction of a signal initiated by mechanical stretch of
uterine myometrial (via increases in gap junctions), cervical, and fetal membrane
cells through the cellular cytoskeleton to activate cellular protein kinases.14
The epidemiologic profile of risk for this condition is women with multifetal ges-
tations, polyhydramnios and uterine anomalies. The only available diagnostic
method playing a role in this cascade is sonographic detection of the above-men-
tioned conditions.
Regarding the pathogenesis we conclude that each of these biochemical processes
share a final common pathway characterized by increased uterotonins (e.g., oxy-
tocin, endothelin, and leukotriene) and proteases (e.g., matrix metalloproteinases
or collagenases, plasminogen activators, plasmin, and elastase) expression causing
uterine contractions, cervical change and fetal membrane rupture. Mediators of
these diverse biochemical pathways (e.g., CRH, estriol, IL-6, thrombin) and by-
products of fetal membrane extra cellular matrix (ECM) degradation (e.g., FFN)
present unique biochemical signatures predicting the occurrence of a subsequent
16
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preterm labor with intact membranes and/or premature rupture of the fetal mem-
branes. Cervical incompetence is not mentioned in the model, but is considered
as an early manifestation of the usual preterm birth processes (i.e., hemorrhage,
infection, or overdistention but not stress). In this case the stimuli (thrombin,
cytokines and mechanical stretch) occur at a point when the uterus has no gap
junctions, oxytocin receptors or myosin light chain kinase and so there are no
contractions. However, proteases and IL-8 promote cervical change and thus
incompetence.
Methods for the prediction of spontaneous preterm birth (review)
Epidemiologic factors
Past and current approaches to predict those women who will deliver preterm, have
relied on demographic information, previous pregnancy history and current preg-
nancy findings as cervical change, increasing uterine contraction frequency and
vaginal bleeding. Other variables associated with SPB are occupational, environ-
mental, psychosocial, behavioral and nutritional factors. These above-mentioned
factors are also described in chapter 1. Previous preterm birth, black race, and sec-
ond-or third trimester bleeding have been associated most consistently with SPB.
Uterine monitoring
At least 13 randomized controlled trials have examined the efficacy of home uter-
ine activity monitoring (HUAM) for the prevention of SPB. These studies have
varied in design, inclusion criteria, and measurements of outcomes. Results have
also varied, with some trials reporting no difference and some reporting a differ-
ence in pregnancy outcome in monitored and unmonitored women. The largest
study involved 2422 women at risk and showed no improvement in outcome.15
Although HUAM is approved by the U.S. Food and Drug Administration (FDA)
for women with a prior SPB, data are insufficient to support a benefit from
HUAM for the prevention of SPB.16-18 Therefore this system of care can not be
recommended.
Pathogenesis & Predictors of SPB
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Pathway specific biochemical markers for the prediction of SPB
The following section reviews the pathway-specific and common-pathway bio-
chemical markers to predict the spontaneous onset of labor or rupture of the fetal
membranes prior to 37 weeks’ gestation.
Corticotropin-Releasing Hormone (CRH)
CRH is a 41-amino acid peptide first identified in 1980, and initially localized to
the hypothalamus where its release into the portal circulation stimulates pituitary
adrenocorticotropic hormone (ACTH) production which, in turn, enhances adre-
nal cortisol secretion.19 Moreover, CRH mediates the autonomic, immunological
and behavioral responses of mammals to stress.19,20 CRH is also synthesized in
the placenta, fetal membranes and decidua.21-23 Several studies have demonstrat-
ed that increased levels of CRH indicate a higher risk for preterm delivery.24,25
McLean et al. showed that among patients who delivered preterm, a rise in CRH
occurred six weeks earlier in the second trimester.26,27 This suggests that in some
patients, the timing of parturition is determined early in gestation. So it was
hoped that this marker might allow the identification early in pregnancy of
patients at risk for SPB. Maternal serum CRH concentrations are elevated as early
as 18 weeks gestation in women with subsequent SPB.24,25,28-32 In a large prospec-
tive study about 1047 low-risk women recruited at 15-20 weeks of gestation, mid-
trimester maternal CRH was significantly associated with preterm birth before 34
weeks.28 However, the authors concluded that when used alone the measurement
has a low predictive power because of the very low risk of the studied population
(positive predictive value of 3.6% with a SPB prevalence of 1.1%). Plasma CRH
levels rise during the second half of pregnancy, peak during labor, and rapidly
decline postpartum.26,29,32 The pre-parturition increase in CRH is accompanied
by a fall in CRH binding protein, leading to a rapid increase in circulating bioac-
tive CRH at term.26
The poor predictive efficacy of CRH elevations may be related to limitation of its
role to SPB due to maternal or fetal stress. Since this ‘stress’ pathway only account
for one-third of all SPBs, CRH elevation can only predict 30% of all patients
delivering prematurely.30,33 Furthermore, the significant variability of CRH
between different weeks of gestation and among different patients makes inter-
pretation of serum levels difficult.28 Other assessments in large prospective studies
18
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are required before this marker can be introduced in to clinical practice. Thus far
there is no commercial diagnostic test available for CRH.
Estrogen
Estriol begins to appear in maternal blood during the 9th week gestation and its
plasma concentration continues to increase throughout pregnancy.34 Circulating
maternal estriol is derived from fetal adrenal precursors. Premature and/or stress-
induced activation of the fetal hypothalamic-pituitary-adrenal (HPA) axis
enhances fetal adrenal dehydroepiandrosterone sulfate (DHEAS) production.
Upon transfer to the placenta DHEAS is converted to estradiol (E2) and estrone
(E1). In addition, DHEAS can be 16-hydroxylated in the fetal liver. In the placen-
ta this is converted to estriol (E3).35 For many years, the measurement of estriol,
urinary or plasma, was used as a marker of fetal-placental well-being. This diag-
nostic test has disappeared with the development of fetal heart rate monitoring
devices. The increase in estrogens directly affects myometrial contractility.36
Initial studies employing longitudinal sampling have demonstrate a rise in both
plasma and salivary E3 two to five weeks before the onset of labor whether occur-
ring at term deliveries or preterm. This increase in E3 may be a used to diagnose
threatened preterm labor in women at high-risk for SPB.36,37 Germain et al.
observed a 20% surge in maternal E2 nine days before the onset of both preterm
and term labor.38 McGregor et al. conducted a multi-site, triple blinded prospec-
tive study in which they measured salivary estriol every week from 22 weeks
onward in 241 pregnant women.36 The advantages of salivary determinations are
the ease and non-invasiveness of its collection, the stability of the concentration
during transport, and a reliable and reproducible assay technique. A salivary E3
level greater than or equal to 2.3 ng/ml was found to have a sensitivity of 71%, a
specificity of 77% (Likelihood ratio 3.1).36 The test has reduced effectiveness in
women who were treated with glucocorticoid therapy. Furthermore its utility is
not known in patients with placental abruption, premature rupture of mem-
branes, incompetent cervix, intrauterine fetal growth restriction and twin preg-
nancy, because these patients were excluded from the study. The test has a nega-
tive predictive value of 98%, but has poor specificity, and a very poor positive pre-
dictive value (9%).36,39 An additional concern is the test’s greatly reduced effec-
tiveness at identifying patients at risk for SPB prior to 30 weeks gestation, precise-
ly the group at highest risk for perinatal morbidity and mortality.
Pathogenesis & Predictors of SPB
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Estrogens can be measured in saliva, serum, and cervicovaginal secretions.
Although the U.S. Food and Drug Administration (FDA) has recently approved a
commercially available salivary E3 test (SalestTM) which can target a select popu-
lation at risk for premature labor, its utility is limited to generally low-risk patients
with a gestational age greater than 30 weeks who were not treated with glucocorti-
coid therapy. The tests low positive predictive value is likely to lead to unnecessary
interventions. Based on above-mentioned concerns and the limited evidence
available, the test cannot be recommended at this time for screening patients for
PTL. Before any conclusion can be reached, other studies are needed. Currently,
this marker should be used only as part of a research protocol.
Relaxin
Relaxin is a protein produced by the corpus luteum and secreted into the periph-
eral circulation. Levels of relaxin during pregnancy are increased in the first
trimester, slightly decrease thereafter, but remain elevated in the second and third
trimester above that found in the non-pregnant state. Relaxin is thought to syner-
gize with progesterone to suppress myometrial contractions but more importantly
it may be one of the major components involved in cervical ripening. Both the
cervix and the human fetal membranes have relaxin receptors and relaxin stimu-
lates collagenase in the cervix and the human fetal membrane.40 In two small
studies it was observed that relaxin was increased at 30 weeks in most patients
who experienced subsequent preterm labor.41,42 The demonstration of increased
relaxin mRNA in the decidua of patients in preterm labor, even in the absence of
infection, is a strong indication of the role relaxin plays in preterm labor.43 Vogel
et al. reported that serum relaxin collected at 18 gestational weeks was an inde-
pendent predictor for SPB < 34 weeks (odds ratio, 11.3; 95% CI 2.1-59.1).44
Relaxin can be measured in the maternal serum and may serve as a major con-
tributor of cervical ripening. Relaxin levels correlate with cervical change. Some
small studies reported that an increase of relaxin was associated with subsequent
preterm labor. Further studies are required to determine the specific role of relax-
in as a useful covariate to identify women at risk for SPB. The test is not available
for clinical use, yet.
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Maternal serum α-fetoprotein (MSAFP) and human chorionic gonadotropin (hCG)
Studies have repeatedly found that women with a single, anomaly-free fetus, and
high MSAFP levels in their second trimester, are at increased risk of delivering
preterm.3,45,46 However, the reason for this association is presently unknown.
Unexplained high levels of MSAFP have been associated with both ultrasono-
graphic placental abnormalities and vascular and inflammatory placental lesions
observed at delivery.47 Weiner et al. measured MSAFP and umbilical artery
Doppler waveforms in 144 consecutive women referred for amniocentesis, and
observed a 50% preterm birth rate in women in the high MSAFP group.48 They
also observed that Doppler indices tended to be more often abnormal (indicating
increased downstream resistance) in women referred for an elevated MSAFP.
Employing a stepwise multiple linear regression, they noted that gestational age
at delivery could be predicted during the mid-second trimester using a combina-
tion of the umbilical artery Doppler velocimetry and MSAFP.
Gonen and colleagues observed that women with human chorionic gonadotropin
(hCG) levels greater than 4 MOM had an increased risk of SPB (odds ratio 3.3;
95% CI 1.3-8.2).49 Van Rijn et al. showed an increased risk of SPB (relative risk
7.8; 95% CI 3.2-19.0) when MSAFP ≥ 2.5 MOM and hCG ≥ 2.5 MOM.3 Given
that elevated MSAFP and hCG values are also linked to uteroplacental vascular
abnormalities and fetal growth restriction, these findings provide further support
for the association between fetal stress and SPB.1
Both MSAFP and hCG are measured in maternal serum. In the absence of fetal
malformations or multiple gestations, MSAFP and/or maternal serum hCG ele-
vations in the second trimester are associated with an increased risk of SPB. The
positive predictive value of 41% may justify intensified obstetric surveillance in
women with unexplained elevated (or very low) MSAFP and/or maternal serum
hCG values for an increased risk of PTL and/or fetal IUGR. Commercial diag-
nostic tests are available. However, because of low sensitivity, negative and posi-
tive predictive values, MSAFP and hCG testing are not recommended for clinical
use as predictors of SPB. The negative predictive value of maternal serum screen-
ing is too low for it to be useful as a screening instrument for adverse pregnancy
outcome.
Pathogenesis & Predictors of SPB
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Interleukine (IL)-1β, 6, 8
The inflammatory cytokines IL-1β and TNFα are indirect uterotonins since they
increase local prostanoid production.33 IL-6 is secreted by decidual and chorionic
cells in response to IL-1β and TNFα stimulation. The quantity of IL-6 that is
produced exceeds that of IL-1β by approximately 1000-fold.33,50 Furthermore, ele-
vated amniotic IL-6 levels as early as 16 weeks’ gestation and increased placental
IL-6 expression have been associated with SPB, particularly in the presence of
intra-amniotic infections (IAIs).51-54 A cohort study from Lockwood et al. evaluat-
ed the role of cervical IL-6 elevation in the prediction of SPB of 161 asymptomatic
women.55 Levels of IL-6 were measured by immunoassay. A receiver-operator
characteristics (ROC) curve analysis indicated that a single cervical IL-6 value >
250 pg/ml, present between 24 and 36 weeks gestation, optimally identified
patients with a subsequent preterm delivery. There was a 4.2-fold increase in
maximal cervical IL-6 concentrations among patients with preterm versus term
deliveries (sensitivity 50.0%, specificity 85.0%, positive predictive value (PPV)
47.2% and negative predictive value (NPV) 86.4%). Goepfert et al. confirmed the
above-mentioned findings that cervical IL-6 at 24 weeks is higher in women who
subsequently had a SPB at < 35 weeks than in women who delivered at term.
However, elevated cervical IL-6 concentrations were not independently associated
with SPB. A positive fetal fibronectin (FFN) test result was strongly associated
with elevated cervical interleukin 6, but bacterial vaginosis (BV) was not.56
Elevated cervical and serum IL-6, and amniotic fluid IL-8 levels are strongly
associated with the presence of intra-amniotic infections.57-59 IL-8 recruits and
activates granulocytes, which release an extremely potent extracellular matrix
(ECM)-degrading elastase.60 Cervical granulocyte elastase activity is also associat-
ed with cervical change and SPB.61
The cytokines IL-1β,-6, -8 can be measured in maternal serum and cervical secre-
tions. They play a role in inflammation-based SPB. Lower genital tract IL-6 and
IL-8 concentrations appear to be related to subsequent SPB. However, presently
there are no consistent results regarding the usefulness in predicting spontaneous
preterm birth. IL-1β, IL-6, IL-8 are not commercially available for clinical use.
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Granulocyte colony-stimulating factor (G-CSF)
Granulocyte colony-stimulating factor (G-CSF) is a cytokine produced by mono-
cytes, which, among other characteristics, attracts circulating leukocytes into tis-
sue. G-CSF has been found in placental macrophages and in decidual cells.
Goldenberg et al. showed that elevated plasma G-CSF levels collected at 24 and
28 weeks’ gestation in low risk pregnant women, were associated with subsequent
early (<32 weeks) SPB, especially within the next 4 weeks, but not with late SPB.
Elevated plasma G-CSF levels at 24 weeks have been associated with SPB at 24 to
28 weeks’ gestation (sensitivity 54%; specificity 79%; PPV 2% and NPV 99%).62 At
28 weeks’ gestation an elevated plasma G-CSF value is associated with SPB at 28
to 31 weeks’ gestation (sensitivity 37%; specificity 95%; PPV 7% and NPV 99%).
The adjusted odds ratios are ranging from 6 to 25 measured in plasma at 24 to 28
weeks’ gestation. Early SPB seems to be associated with an inflammatory process
that is identifiable by the presence of a cytokine in maternal plasma several weeks
before the early SPB. However, later SPB does not seem to be associated with
such a process.
G-CSF is present in plasma and amniotic fluid and concentrations can be meas-
ured with enzyme-linked immunosorbent assay (ELISA). G-CSF is a marker for
inflammation and appears to be a powerful predictor of early preterm birth. The
test is not available yet for clinical use. Whether the test itself will be useful in pre-
dicting SPBs will depend on a number of factors, including sensitivity and posi-
tive predictive values in various populations.
Bacterial Vaginosis
The syndrome bacterial vaginosis (BV) was defined by Gardner and Dukes in
1955 as a nonspecific vaginitis caused by haemophilus vaginalis.63 Since 1977,
studies have shown the importance of anaerobes in this clinical syndrome. To
date, BV is seen as a common condition in which the normal vaginal microflora,
lactobacilli and a small numbers of anaerobes, are replaced by a polymicrobial
overgrowth of anaerobes, gardnerella vaginalis and mycoplasma hominis. BV is
fairly common, with a prevalence ranging from 10% to 25% in a general obstetric
population to 64% of patients in clinics for sexually transmitted diseases.63-65 Fifty
percent of women with BV are asymptomatic.66 The condition is found more fre-
quently in African-American (22%) than in Caucasian (8%) women.67 The pres-
Pathogenesis & Predictors of SPB
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ence of BV has been associated with SPB independent of other known risk factors
and is suggested as a potentially treatable risk factor for SPB.63,68
Bacterial vaginosis is associated with an increased risk of preterm rupture of
membranes (odds ratio: 7.3),68 low birthweight69 and SPB (odds ratios ranging
from 1.8 to 2.8).63,70 BV is probably a marker for a subclinical infection of the
upper genital tract, which may lead to SPB. Trials on screening and treating BV in
pregnant women to reduce the incidence of SPB have been conducted in mixed
pregnant populations with varying results. In some small randomized controlled
trials treatment with oral antibiotics (metronidazole with or without erythromy-
cin) in women with BV who are at risk for SPB (history of previous preterm deliv-
ery or low prepregnancy weight) has resulted in a reduction of the SPB rate.71
However, other studies have not confirmed a reduction of the SPB rate after BV
treatment.72,73 A recent meta-analysis reviewed five trials involving 1504 women.74
Analysis of women with low risk for SPB included trials with the following treat-
ments, amoxicillin, clindamycin and metronidazole (with or without erythromy-
cin). Although investigators found antibiotic therapy was effective at eradicating
BV, no difference in the rate of SPB between the two groups was observed.
However, analyzing the subgroup of women with a previous preterm birth, the
difference in SPB was significant, with an odds ratio of 0.37 (95 % confidence
interval, 0.23-0.60). This meta-analysis did not include results from the most
recent and largest double-blinded, randomized controlled trial. Carey et al. found
no difference in the rates of SPB between the treatment and placebo group in a
trial of 1953 women who had aymptomatic BV in a general obstetrical population.
While Brocklehurst et al. showed a reduction in SPB after BV treatment in
women with SPB in history, Carey et al. did not demonstrate a significant differ-
ence in preterm birth rates in the subgroup with a history of SPB.73,74 A recent
review from Berg et al. reported that there are insufficient data to suggest that
screening and treating women in either low or high risk will reduce the overall
rate of preterm birth.75 Prophylactic treatment of low-risk women or in high-risk
women without BV is not indicated, because it may change the normal vaginal
flora to an intermediate type or to BV which may increase the risk of SPB.76
Future studies must include data on the neonatal and postpartum sequelae to
understand the risks of antibiotic treatment.
The diagnosis of BV requires a wet-mount or gram stain of vaginal secretions
obtained from the posterior vaginal fornix using a sterile cotton swab. Amsel’s cri-
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teria for BV are characterized by the presence of typical discharge, clue-cells,
increased pH, a positive amine test and lack of lactobacilli.77 Another method to
diagnose bacterial vaginosis is described by Nugent.78
Thus, although some trials have shown an association with the presence of BV
and preterm birth, most large trials have failed to demonstrate that treatment of
BV can prevent SPB. The presence of anaerobic flora in the upper genital tract
may be the link between BV and SPB. BV may not be the cause of SPB but a
downstream marker of some other underlying pathology. There remains discus-
sion whether treatment of BV in women with a history of SPB lowers the risk of
SPB. Until larger, better-randomized studies of antibiotic treatment for BV during
pregnancy become available, we conclude that BV treatment is indicated only in
patients with a history of SPB. There is no indication for screening to identify or
prevent preterm birth in a general population.79
Lactoferrin
Lactoferrin is an iron-binding glycoprotein originally described as present in milk
and to a lesser extent in exocrine fluids, such as bile and tears. Lactoferrin may be
important in iron uptake by the intestinal mucosa and probably acts as a bacterio-
static agent by rendering iron unavailable as a nutrient to bacteria. Its presence in
neutrophils and its release during inflammation indicate that lactoferrin may also
be involved in the immune response to infection.80 Lactoferrin is present in low
concentrations in amniotic fluid during early pregnancy, with levels increasing as
pregnancy progresses. One study has shown that lactoferrin levels in amniotic
fluid were higher in women in preterm labor with an amniotic fluid infection
than in women in preterm labor without infection. Cervical lactoferrin correlated
well with other markers (e.g. IL-6, sialidase activity and BV) of lower genital tract
infection. Only very high levels in the cervix are associated with SPB but with low
sensitivity. Currently, lactoferrin testing does not seem to be helpful in the predic-
tion of SPB and it is not available for clinical use.
Thrombin, thrombin-antithrombin (TAT)-complexes
Thrombin subserves a number of hemostatic functions, such as generation of fib-
rin and activation of the clotting co-factors (factor V and VIII) and platelet activa-
tion.1 In addition to its pro-coagualant properties, thrombin also enhances expres-
Pathogenesis & Predictors of SPB
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sion of tissue-type and urokinase-type plasminogen activator (PA). The PA’s gen-
erate plasmin from plasminogen, which can directly degrade the crucial compo-
nents of the extracellular matrix (ECM) laminin, fibronectin, collagen III.
Plasmin activates the matrix metalloproteinases (MMP)1,11,12 Thrombin also trig-
gers the release of MMPs from the decidua. Finally, thrombin binds to myometrial
receptors to trigger contractions.81 Decidual hemorrhage and consequent throm-
bin generation, thus leads to a proteolytic cascade of damaging the ECM of the
fetal membranes, promoting premature rupture of the membranes and cervical
change and stimulating contrcations. Thrombin-antithrombin (TAT) complex
levels are elevated in patients with preterm labor who are destined to deliver
before term and in patients destined to rupture their fetal membranes.11,81 This
suggests that preterm labor resulting in preterm birth is associated with the activa-
tion of thrombin.11 Further and larger studies are required to determine the role
of TAT-complexes in the prediction of SPB. The test is not available yet in clinical
practice.
Final common pathway biochemical and biophysical predictors of
preterm birth
Although each of the pathogenic mechanisms described above has a distinct bio-
chemical and epidemiological profile, each converges on a common pathway
involving increased genital tract uterotonin (e.g. prostaglandin) and protease
expression. These proteolytic processes at the decidua and membranes lead to a
breakdown of the ECM of the fetal membranes and cervix. Approaches to the
detection of these pathological processes are the identification of fetal fibronectin
(FFN) in cervico-vaginal secretions, the transvaginal sonographic determination
of cervical length, the previously described uterine contraction monitoring, and
the identification of MMP in various media.
Fetal Fibronectin (FFN)
Fibronectins are large-molecular-weight glycoproteins found in extracellular
matrix (ECM) and plasma.82 FFN is produced during fetal life by amniocytes and
cytotrophoblasts of the chorion and placenta.83 In the latter site it is localized in
the extravillous cytotrophoblast of the anchoring villi and cytotrophoblastic shell.
In the fetal membranes, FFN is concentrated at the junction of the decidua and
chorion. Its presence in the cervicovaginal secretions is normal prior to the 20th
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week.82 By 22 weeks, the amnion, chorion and decidua basalis fuse with the
decidua parietalis and FFN is not normally released in vaginal mucus.
Numerous trials have shown both an association between the presence of cervico-
vaginal FFN and SPB.82,84 They show a decrease in the risk of SPB in the absence
of cervicovaginal FFN. The mechanisms responsible for the presence of FFN in
cervicovaginal secretions in cases of threatened SPB are unknown, however, sepa-
ration of the chorion from the deciduous membrane of the lower uterine segment
may allow its release. FFN secretion in the cervical canal may also occur in
response to a chorionic inflammation (with accompanying proteolysis).82 The cell
attachment properties of fibronectin disrupt preceding PPROM and preterm
labor, allowing fibronectin to leak into cervicovaginal secretions. In initial studies,
the presence of cervicovaginal FFN after 21 weeks was found to be predictive of
SPB. It is difficult to compare the results because of differences in study popula-
tions, protocols, and methodological quality. Recent meta-analyses among 29 and
27 relevant studies regarding FFN have confirmed this association in populations
at both low and high risk for SPB.85-87 The inclusion period was generally 24 to 34
weeks; a quantitative test was used, with 50 ng/ml the cut-off for a positive deter-
mination. Two principal types of populations have been studied: the asympto-
matic general population and populations at risk for SPB.
Table 1 reports the prevalence of SPB in symptomatic women and provides the
predictive efficiency of FFN. The review of published studies confirms a clear
association between FFN and SPB, with excellent sensitivity, specificity and nega-
tive predictive values. The likelihood ratios are also high, but rarely greater than 5.
Pathogenesis & Predictors of SPB
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Lockwood82 Cervix/vag. 117 82 82 83 81
Bittar90 Cervix 102 79 86 77 87
Iams88 Vagina 192 44 76 60 76
Peaceman91 Vagina 763 41 86 45 85
Rozenberg92 Vagina 76 70 70 45 87
Bartnicki93 Vagina 112 68 90 79 83
Table 1. Cervico vaginal FFN and the prediction of SPB in symptomatic patients
Authors FFN Site n Sensit. Spec. PPV NPV
(%) (%) (%) (%)
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A negative FFN was associated with a greater than 95% likelihood of not deliver-
ing within 14 days of a negative test result.88,91
The use of the FFN test in women with suspected preterm labor appears to have
significant utility in reducing unnecessary interventions and admission. In a
before-and-after study (1800 women in each period), Joffe et al. reported the effect
of using FFN for women with threatened preterm birth. Knowledge of the FFN
test result reduced the number and duration of admissions for preterm labor as
well as the number of tocolytic prescriptions without a negative impact on neona-
tal outcome.89 There was a 50% cost-reduction ($ 486,000/year) based on a reduc-
tion in admissions and charges per admission in women with threatened SPB.
Fetal fibronectin is also predictive of SPB in asymptomatic patients (Table 2).
Lockwood et al. showed that among asymptomatic patients and patients at mod-
erate risk for SPB, FFN appeared equally predictive of SPB. Its presence in cervi-
covaginal secretions preceded SPB by > 3 weeks.84 Goldenberg et al. found that a
positive FFN at 24 weeks was associated with a > 60-fold increased risk of SPB.97
Thus, the presence of FFN in vaginal or cervical secretions before 35 weeks is a
moderately good predictor of SPB but appears to be most useful as an indicator of
women at low risk for preterm birth. 
The predictive power of FFN is stronger at earlier gestational age (24-28 weeks)
than later in pregnancy and is stronger for short-term prediction (7-14 days) than
for SPB overall.97 Nonetheless, reviewing all of these studies, Khan et al. showed
that only 26% of the authors’ conclusions about the diagnostic value of FFN met
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Lockwood84 Vagina 326 24-36 68 80 30 95
Hellemans95 Cervix 133 26-36 60 85 25 96
Greenhagen96 Cervix 108 24-34 62 84 24 97
Goldenberg97 Cervix 2929 22-30 63 98 15 100
1SPBs < 28 weeks
Table 2. Cervical-vaginal FFN and the prediction of SPB in asymptomatic patients.  
Authors FFN Site N Sampling Sensit. Spec. PPV NPV
weeks (%) (%) (%) (%)
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the ‘golden standard’ and that 66% of the authors overestimated the diagnostic
values of their test.98 In view of the lack of an effective management to offer after a
positive test, it does not seem reasonable to recommend this test for all pregnant
women at this time, without a further assessment of such strategy except as mark-
er of women not in need of intervention.
FFN determinations are conducted on specimens collected from the vaginal pool
or cervical mucus at the external os using a speculum examination. The sampling
should be performed between 24 weeks and 35 weeks of gestation.91 To prevent
false-positives, the following criteria should be met for the use of FFN-testing:
intact amniotic membranes, minimal cervical dilatation (< 3 cm); no cerclage; no
vaginal bleeding; no intercourse within 24 hours; no digital examination within
past 24 hours; no use of vaginal lubricants or disinfectants.83 The U.S. Food and
Drug Administration (FDA) approved the FFN test in 1995. The current test is a
rapid immunoassay with results available within 30 minutes.99
Thus, the presence of FFN in cervical and vaginal fluid is an important marker
for impending SPB83 in both high-risk asymptomatic and symptomatic women
with both single and multiple test strategies. Fetal fibronectin testing is available
for clinical use to identify patient subgroups. Those testing positive need addi-
tional observation and/or intervention. Patients with a negative test and nonspe-
cific clinical signs and symptoms may safely be observed in the outpatient setting
for at least 14 days. The test should not be routinely used to screen low-risk,
asymptomatic women, because the incidence of SPB in this population is low.87
Cervical length shortening measured by transvaginal sonography (TVS)
The human cervix has been shown to be a dynamic organ throughout gestation,
varying markedly in both shape and length.100 As delivery approaches, the cervix
begins to shorten in association with effacement and dilatation. If a change in the
cervix were to be used for the prediction of SPB, a standardized method of cervi-
cal evaluation is needed. During the past 20 years, ultrasound assessment of the
cervix has moved from a research tool to a standard part of obstetric diagnostic
imaging. A number of investigators have observed that shortened cervical lengths
determined by TVS are predictive of SPB in both symptomatic and asymptomatic
patients with singleton gestations (Table 3). Iams et al. evaluated the cervical
length of 2915 pregnant women at 24 and 28 weeks with singleton gestations. The
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study confirmed that there is an inverse relationship between the transvaginal cer-
vical length and the frequency of SPB.101 The mean cervical length at 24 weeks
gestation was 34.0 ± 7.8 mm for nulliparous women and 36.1 ± 8.4 mm in
parous women, the mean cervical length at 28 weeks was 1.5 mm shorter. Iams
concluded that a cervical length less than 25 mm at 24 weeks gestation or the
presence of a funnel that accounts for 50% of the cervical length predict an
increased risk for SPB. Hassan et al. reported that nearly 50% of patients with a
cervical length ≤ 15 mm on a second-trimester sonogram had an early SPB.102
Cook et al. reported in a small study that 95% of women ‘at risk’ for SPB with
closed endocervical canal with a length of < 21 mm before 20 weeks were associ-
ated with delivery < 34 weeks.103 As is the case for FFN, it seems more valuable
to use the NPV of the test. In a patient with preterm contractions, the absence of a
funnel at the internal cervical os and a cervical length of 30 mm or greater indi-
cates that the patient is not at increased-risk for SPB. These observations could
prevent unnecessary tocolysis and intervention.101
There have only been a few studies on cervical length as a predictor of outcome in
twin gestations. The role of the cervical length is less clear than in the singleton
population. Crane et al. noted that a cervical length of < 3 cm was a poorer pre-
dictor of SPB in symptomatic patients with twin gestations, achieving a sensitivity
of 75%, specificity of 30%, and positive and negative predictive values of 63% and
43%, respectively.107 Imseis et al. found that cervical length measurement of > 3.5
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Gomez106 < 1.9 Sympt. 59 73 78 67 83
Gomez106 29 < 1.9 Sympt. 59 73 78 67 83
Crane107 24 < 3 Sympt. 136 81 65 46 90
Hassan102 14-24 ≤ 2.5 Sympt. 6877 15 98 31 96
≤ 1.5 8 99 47 96
Iams101 24 < 3 Asympt. 2915 54 76 9 97
28 < 3 2531 70 68 7 98
Table 3. Cervical length and the prediction of SPB in singleton gestations.
Authors Gestational Cervical Study n Sens. Spec. PPV NPV
age length Population. (%) (%) (%) (%)
(weeks) cut off (cm)
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cm between 24-26 weeks’ gestation was a marker for twin gestations at low risk for
delivery at < 34 weeks’ gestation.108 Goldenberg et al. found that a cervical length
of < 2.5 cm at 24 weeks’ gestation and Guzman et al. that a cervical length < 2.0
cm between 15-28 weeks’ gestation were good predictors of SPB in twin gesta-
tions.104 The primary finding in triplets is that the average cervical length com-
pared with gestational age-matched controls was shorter.105 The mean cervical
length in triplets was 25.0 ± 8.0 mm at 24 weeks gestation, compared with 35.2 ±
8.3 mm in singletons.110
The length of the cervix is the distance between the internal os and external os
measured by TVS.101 Measurements can be affected by numerous confounding
factors such as different operators and techniques (e.g., placing the electronic
calipers or recording the best image), variable machine quality, differing cut-off
values or varying degrees of bladder filling. Thus, standardization of measure-
ments is important. In summary, many studies agree on an inverse relationship
between the transvaginal cervical length and the frequency of SPB. The high neg-
ative predictive value of a cervical length of greater than 30mm could prevent
unnecessary tocolysis and intervention.101 Transvaginal ultrasonography is avail-
able for use in daily clinical practice.
Combining cervical ultrasound and fetal fibronectin
In a multicenter trial, Iams et al found a short cervix (defined as < 25 mm), par-
ticularly if associated with a posititve FFN test result, to be a strong predictor of
SPB.111 Rozenberg et al. studied a population of women hospitalized with symp-
toms of preterm labor.92 Although the two tests had similar diagnostic values, they
did not identify all of the same patients who subsequently delivered prematurely.
The authors concluded that neither test was to be preferred over the other. Rizzo
et al. have conducted a comparable study, in which they concluded that FFN was
superior to ultrasound. In fact, the difference was moderate: for FFN and ultra-
sound, respectively, the sensitivity was 80.9 and 70.2 %, and the specificity 83.6
and 80.3%.112 A more recent trial by the National Institute of Child Health and
Human Development Maternal Fetal Medicine Network examined the sequen-
tial use of both methods to try to stratify risk groups as well as determine etiolo-
gies of SPB.109 The presence of either a cervix less than 25 mm in length at less
than 35 weeks of gestation or a positive FFN test was strongly associated with
SPB, especially in women with a history of SPB. These data are particularly use-
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ful in decreasing the assessed risk of SPB in women with classic risk factors and
negative results of one or both tests. The tests do not identify precisely the same
cases, which suggests that the etiology may be different. Further studies are need-
ed to explain these mechanisms and to be able to propose management that is
appropriate and efficacious for each of the groups that one or the other marker
may identify. The success of interventions once a short cervix is identified or posi-
tive FFN test result is obtained remains uncertain.
Proteases / Matrix metalloproteinases (MMP-1 -2 and -9)
The MMPs are a family zinc-dependent ECM degrading enzymes. Interstitial
collagenase (MMP-1) cleaves collagen types I, II and III113 while the gelatinases
(MMP-2 and -9) further degrade denatured collagen fragments generated by
interstitial collagenase. The MMPs and their natural inhibitors, the Tissue
Inhibitors of Metalloproteinases (TIMPs) are produced by amnion, chorion, and
decidua and are important in the maintenance and breakdown of the ECM of the
amniochorion and cervix.113 Rajabi et al. observed an 8-fold increase in serum
MMP-1 activity in patients with SPB compared with patients having uncompli-
cated pregnancies delivering at term.1,114 Interpolation of these raw data suggest a
sensitivity of 94%, a specificity of 92%, positive predictive value of 89% and nega-
tive predictive value of 96%. Furthermore increased MMP-9 expression has also
been associated with the onset of term labor. It results in the degradation of the
ECM of the fetal membranes and facilitates their rupture under both physiologi-
cal and pathological conditions. It remains to be seen whether similar elevations
are present in SPB. Large increases in MMP-2 have also been described in
preterm prematurely ruptured membranes.115 It has been suggested that MMP-2
is the activator of proMMP-9 and cleaves it into active forms.116
The presence of MMP-1 has been studied in human cervical tissue114, the placen-
ta117, amniotic fluid118 and serum.119-122 Those studies provide evidence that
MMP-1 plays an important role during cervical dilatation in human parturition.
The involvement of MMP-9 in parturition has been demonstrated in rat
amnion,116 human amniochorion,123 amniotic fluid,124,125 fetal membranes,
urine126 and plasma.127 Increased expression of MMP-9 protein and activity has
been demonstrated as a marker for preterm as well as term labor in fetal mem-
branes, as well as amniotic fluid.118 These tests are not yet available for clinical use.
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Nitrite and nitrate concentration
Nitrite and nitrate concentration are active metabolites of nitric oxide and are ele-
vated in patients with chorioamnionitis.128 Elevation of nitrite and nitrate concen-
tration in vaginal secretions is accompanied by premature rupture of membranes
and precedes premature delivery.129 Because nitric oxide has been known to acti-
vate MMPs and induce apoptotic cell death in various cells, overproduction of
nitric oxide may not only be a predictive marker but may also be involved in cervi-
cal ripening, fragility of membranes and subsequent premature delivery.
Suppressors of nitric oxide synthesis may be candidate therapeutic agents. There
is no clinical test available.
Fetal breathing movements (FBM)
Breathing movements occur for the first time at about ten weeks of gestation. The
incidence of FBM increases till 30 weeks of gestation, when breathing movements
are present for about 30% of the time. Breathing may occur in short or longer last-
ing spells, with regular or irregular breathing. The breath-to-breath intervals
decrease till about 30 weeks and increase thereafter.130 Fetal breathing movements
are affected by many variables, such as maternal glucose intake (increase) and
diurnal variations. FBM are reduced in active labor, presumably due to a rise in
prostaglandins, which has a direct inhibiting effect on the fetal respiratory cen-
ter.131 The incidence of fetal breathing movements is reduced about three days
before the onset of spontaneous labor at term and during the latent phases of
labor.132 In patients with induced labor, breathing movements remain essentially
unchanged until the active phase of labor and then diminish significantly, such
that only few episodes of short duration of fetal breathing are seen up to deliv-
ery.133 Cessation of FBM appears to be a normal physiologic event during labor at
term and during elective oxytocin induction of labor that results in delivery.134
Investigators have documented this phenomenon during preterm labor,135,136
while others have been unsuccessful in replicating this observation.137-139 Women
with preterm labor, intact membranes and presence of FBM have a very high
chance of not being delivered within a week (sensitivity 92%; PPV 93%).135,136
This does not hold for situation with ruptured membranes.
Real-time ultrasound observation of FBM is considered to be present when it is
sustained for 30 seconds or more and is considered to be absent when no sus-
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tained breathing movements can be detected in 45 minutes.140 It is unclear how
much time exactly is required to diagnose the absence or presence of fetal breath-
ing movements, because long periods of apnea are a normal phenomena, so a
long examination period can be necessary to come to a diagnosis. This makes the
method less appealing for use in clinical practice.When a fetus of a woman with
preterm labor without rupture of the membranes shows fetal breathing move-
ments, it is likely that the pregnancy will last. In all other cases of pregnancy com-
plications the absence or presence of FBM has no clinical relevance. This method
would be available for use in clinical practice, however to date it is seldomly used.
Summary review predictors of SPB
Recent clinical and experimental evidence supports the concept that most SPBs
result from one of four distinct but frequently overlapping primary pathogenic
mechanisms: activation of the maternal or fetal HPA axis due to stress; inflamma-
tion to pre-existing or ascending genital tract infections; decidual hemorrhage or
placental abruption; and pathologic distention of the uterus due to multiple ges-
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HUAM Abdomen 25-34 +
CRH Serum, plasma 17,22,25,28
E2/E3 Serum,saliva,CVS 17,22,25,28 +
MSAFP Serum 22
HCG Serum, CVS 17
Uterine Uterus 20,23
Art.Doppler (Ultrasound) 22
Relaxin CVS 18,30
IL-6, IL-8 Serum,cervix, AF 22,25,28
G-CSF Plasma, AF 24,28
BV Vagina 12,20,28 +
TAT Serum 22,25,28,31
FFN CVS 22,25,28,31 +
Cx Length Vagina (TVS) 22,25,28,31 +
MMP-1 Serum, 22,25,28
MMP-9 Serum, CVS,Urine 22,25,28
FBM Uterus (Ultrasound) 28,32 +
Table 4. Preferable site and gestational age (weeks) of sampling of SPB Markers.
Predictor Site sampled Gestational Diagnostic
age (weeks) test available
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tations or polyhydramnios. In the final biochemical pathway various uterotonins
and enhanced genital tract protease activity promote myometrial contractions,
rupture of membranes and cervical change. Given the fact that most patients with
maternal stress, uteroplacental vascular abnormalities, bacterial vaginosis, and
vaginal bleeding do not deliver preterm, variations in host susceptibility can play a
role in the occurrence of prematurity. Thus, SPB is a multifactorial process occur-
ring when the sum of the stimuli for labor exceed the ability of the maternal host
to resist that stimuli.Various risk factors (including obstetrical history and socio-
economic and epidemiological risk factors) and biochemical markers from the
model have been evaluated as potential predictors of SPB. In Table 4 the location
and gestational age of sampling for all the potential predicting variables of SPB
are summarized. All these factors have some relationship to SPB.
Conclusion
Only transvaginal cervical ultrasonography, FFN, salivary estriol, HUAM, FBM
and BV are used in clinical practice. To date, the best predictor of early preterm
birth is FFN, with consistently high odds ratios reported. For example, in the
overall population study, at 24 weeks’ gestation a positive FFN test result has an
odds ratio of 40 for predicting a SPB at < 32 weeks’ gestation.97 The next most
effective predictor is a short cervix determined by ultrasound with an odds ratio of
approximately 8.101 At present, ultrasonography to determine cervical length,
FFN testing, or a combination of both are likely to be useful in determining
women at high risk for preterm labor. However, their primary clinical usefulness
may rests with their negative predictive value given the lack of proven treatment
options to prevent SPB. FFN testing may be useful in women with symptoms of
preterm labor to identify those with negative values and, thus, a reduced risk of
SPB, thereby avoiding unnecessary intervention. We must, however, keep in
mind that no therapy has yet been proven to be efficacious, especially in a general
population.
Based on consistent scientific evidence there are no current data to support the
use of salivary estriol or HUAM. Granulocyte colony-stimulating factor (G-CSF)
in plasma at 24 and 28 weeks’ gestation has adjusted odd ratios ranging from 6 to
25 for early SPB.62 However larger studies are needed for G-CSF and other bio-
chemical markers (e.g. CRH, Il-6, relaxin, MMP-1, -9, MSAFP, hCG). Bacterial
vaginosis has an odds ratio of approximately 2.3 for SPB at < 32 weeks’ gestation,
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and most other predictors, if significant at all, has odds ratios of ≤ 2.68 There is
still controversial data regarding the role of BV screening and treatment as strate-
gy to identify and reduce SPB. Screening for risk of SPB by means other than his-
toric risk factors has not been shown to be efficacious in the general obstetric pop-
ulation.
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Abstract
Objective. We sought to determine whether cervicovaginal fluid matrix metallo-
proteinase-1 and -9 (MMP-1 and MMP-9) levels differed during pregnancy com-
pared with those at term or in preterm labor.
Study design. We used sensitive immunoassays to measure MMP-1 and -9 levels
in cervicovaginal secretions. Cases (n=32) included women who delivered pre-
term, and were sampled more than 3 week prior to delivery (n=19), within 1
week of delivery (n=7) and during spontaneous labor (n=6). Controls consisted
of 80 women matched for race, age and gestational age, delivering at term and
who were sampled at 20-32 weeks (n=47), within one week of delivery (n=14)
and during term labor (n=19).
Results. Among cases and controls, cervicovaginal MMP-1 levels were low and
unaffected by labor. Among non-laboring control patients the median and range
of MMP-9 concentrations were also low (0; 0-0.04 ng/ml), and these remained
unchanged with advancing gestational age. However, MMP-9 levels increased
significantly within 1 week of term labor (0.8; 0-22.8 ng/ml; p=0.001), and dur-
ing term labor (6.6; 0-30.6 ng/ml; p=0.04) with the highest values observed
among laboring patients with ruptured membranes (24.8; 19.2-30.6 ng/ml;
p=0.002). Among cases, MMP-9 concentrations were unaltered prior to preterm
labor, but increased among patients in preterm labor (0.3; 0-30 ng/ml; p=0.02).
Conclusion. Cervicovaginal MMP-1 levels were low and unchanged during
either preterm or term labor. In contrast, MMP-9 levels increased during term and
preterm labor but did not predict preterm delivery in asymptomatic patients.
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Introduction
The delivery of infants prior to 37 weeks of gestation complicates 10 % of births in
the USA1 and is a leading cause of neonatal morbidity and mortality.2 Traditional
methods of predicting women at risk that rely on obstetrical history, demographic
factors or premonitory symptoms are inaccurate.3 Biochemical and biophysical
techniques that have been employed for prediction of preterm delivery include
intermittent antenatal uterine contraction monitoring,4 transvaginal sonographic
measurement of cervical length,5-8 assays of biochemical markers such as salivary
estriol,9,10 corticotrophinreleasing hormone,11-13 cytokines and fetal fibronectin in
cervicovaginal secretions.14,15 With the exception of fetal fibronectin, none of
these endpoints alone, has proved sufficiently sensitive and specific to justify its
incorporation into routine antenatal care at low or even high risk.
We postulated that the release of chorionic fetal fibronectin and structural
changes in the cervix preceding labor reflect proteolytic degradation. The human
cervix is predominantly a fibrous organ with less than 15 % smooth muscle. It has
a highly organized arrangement of collagen fiber bundles in a proteoglycan
matrix, which gives it the structural rigidity it needs to retain the conceptus until
term.16 Matrix metalloproteinases (MMPs) are a family of zinc-dependent extra-
cellular matrix-degrading enzymes. Interstitial collagenase (MMP-1) cleaves col-
lagen types I, II and III.17 The gelatinases (MMP-2 and -9) further degrade dena-
tured collagen fragments generated by interstitial collagenase. MMPs and their
natural inhibitors are produced by the amnion, chorion and decidua and are
important in the maintenance and breakdown of the extracellular matrix of the
amniochorion and cervix.17 The presence of MMP-1 has been studied in human
cervical tissue,18 the placenta,19 amniotic fluid,20 and serum.21-24 Those studies
provide evidence that MMP-1 plays an important role during cervical dilatation in
human parturition. The involvement of MMP-9 in parturition has been demon-
strated in the rat amnion,25 human amniochorion,26 amniotic fluid,27,28 urine29
and plasma.30 The purpose of our study was to evaluate whether MMP-1 and -9
are detectable in the cervicovaginal secretions of women during pregnancy and in
preterm and term labor, and, if so, whether cervicovaginal MMP-1 and/or -9 may
be useful markers of preterm birth.
We hypothesized that, since the MMP’s act to regulate the fetal membrane and
extracellular matrix of the cervix, there should be a measurable elevation in their
Matrix Metalloproteinases-1 and -9.
49
hoofdstuk 03  07-05-2002  09:40  Pagina 49
concentrations in cervicovaginal fluid during the process of breakdown of fetal
membrane structure and the process of cervical ripening. Further, increased con-
centrations should be apparent whether these processes are occurring at term or
preterm.
Materials and Methods
Data reported in this study were acquired as part of an ongoing prospective cohort
study to evaluate sociodemographic, biochemical and clinical factors that may be
used for the prediction of preterm delivery. Study sites included the Women’s
Health Clinic at Bellevue Hospital Center, New York, USA and the Department
of Obstetrics and Gynecology of the University Medical Center Utrecht, the
Netherlands. The local institutional review boards approved the study and we
obtained informed consent from all patients. Term delivery was defined as deliv-
ery at or after 37 completed week’s gestation. All patients had an estimated date of
confinement determined by the date of last menstrual period (LMP) and con-
firmed by serial ultrasounds.
Cases (n=32) included women who delivered preterm, and where sampled more
than 3 weeks prior to delivery (n=19), within 1 week of delivery (n=7) and dur-
ing spontaneous labor (n=6). Controls consisted of 80 women matched for race,
age and gestational age, delivering at term and who were sampled at 20-32 weeks
(n=47), within 1 week of delivery (n=14) and during labor (n=19). All partici-
pants screened negatively for bacterial vaginosis and sexually transmitted diseases.
The collection of cervicovaginal secretions during pregnancy was performed
sequentially at 3-4 week intervals between 20 and 32 weeks’ gestation. For this
cross-sectional study, only one specimen for each gestational age (20-24, 25-28,
29-32 weeks) was used for analysis. All comparison groups contained one sample
only for each woman. In the event that we had more than one sample available
for analysis, we selected the sample from the earliest gestational age period.
Spontaneous preterm and term labor were defined as active labor resulting in
delivery with cervix dilatation. Vaginal and cervical samples were collected sepa-
rately from the posterior fornix of the vagina and from the endocervical canal dur-
ing a speculum exam using a Dacron swab. Since we detected no difference
between MMP-1 or MMP-9 concentrations collected from the vagina or the
cervix, we report values for vaginal specimens only, since these were collected
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more frequently. The swab was placed in an antiprotease solution, containing an
anti-protease buffer consisting of 750 µL of 1% bovine serum albumin in Tris
buffer (BSA-TBS) with 5 mmol/l EDTA, 5 mmol/l phenolmethylsulfonylfloride
(PMSF) and 0.5 trypsin inhibitory units of aprotinin. This buffer does not effect
the MMP-1 or MMP-9 immunoreactivity in the respective enzyme-linked
immunosorbent assays (ELISAs). The specimens were refrigerated after collec-
tion and centrifuged for 10 minutes at 2500 rpm at a temperature of 4° C.
Following centrifugation, 0.25 ml of the supernatant was aliquotted into
microfuge tubes and stored frozen at - 80° C until assayed.
Commercially available ELISAs for MMP-1 and -9 (Oncogene, Cambridge, MA,
USA) were used to measure the MMP-1 and-9 in the cervicovaginal secretion
supernatants. The intra-assay coefficient of variability (CV) was 6%, and the
interassay CV was 12% CV for both biochemical endpoints. The lower limit of
detection of MMP-1 and -9 was 0.055 ng/ml with values below this designated as
undetectable. For analysis, we used the value of 0 ng/ml for the undetectable sam-
ples. There was no significant difference between samples collected in the
Netherlands and in New York. For statistical analysis the χ2 test was used for eval-
uation of rates and proportions. Continuous variables were compared by the
Wilcoxon signed-rank sum tests, with two-tailed α < 0.05 considered significant.
Results
Table 1 illustrates the demographic and obstetric characteristics of the 32 women
who delivered preterm and in the study population 80 age, race and gestational
age matched controls that delivered at term. In the study population the total cer-
vicovaginal samples available for the assays were MMP-1 (n=190) and MMP-9
(n=107). Only 26% of all specimens had detectable levels of MMP-1. Among
cases and controls, cervicovaginal MMP-1 levels were unaffected by labor. Table 2
demonstrates that, among non-laboring control (term) patients (> 3 weeks prior
to delivery), MMP-9 concentrations were low. However, MMP-9 levels increased
significantly within 1 week of term labor and during term labor. The highest
MMP-9 values were observed among laboring patients with ruptured membranes. 
Table 3 demonstrates that, among cases, MMP-9 levels were unaltered prior to
preterm labor, but increased among patients in preterm labor. Figure 1 shows that
the median MMP-9 levels were barely detectable during pregnancy, were
Matrix Metalloproteinases-1 and -9.
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increased in preterm and term labor and displayed a more than ten-fold increase
in the presence of ruptured membranes. The significant correlation between
MMP-9 levels and cervical dilatation is shown in Figure 2 (r= 0.48; p< 0.02).
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Preterm (n=32) Term (n=80)
Race
Black 4 0 0 4 0 1
Asian 5 0 0 10 0 4
Hispanic 9 1 2 21 7 7
White 1 6 4 12 7 7
Parity
Nulliparous 5 5 3 23 6 7
Multiparous 14 2 3 24 8 12
Maternal age
< 20 yr. 2 0 1 2 2 3
20 < 35 yr. 14 5 4 39 9 12
≥ 35 yr. 3 2 1 6 3 4
Number of 
patients assayed 18 6 5 42 4 9
for MMP-1
Number of
patients assayed 3 6 6 14 14 18
for MMP-9
Table 1. Sociodemographic characteristics of the study population for matrix metal-
loproteinase (MMP)-1 and MMP-9.
>3 weeks <1 week In labor >3 weeks <1 week In labor
Characteristic prior to  prior to prior to  prior to 
delivery delivery delivery delivery
(n=19) (n=7) (n=6) (n=47) (n=14) (n=19)
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MMP-9 0 (0-0.04) 0.8 (0-22.8) 6.6 (0-30.6) * 1.3 (0-14.4) 26.5(15.5-30.6)†
Table 2. Median and range of matrix metalloproteinase (MMP)-9 values (ng/ml) in
detectable cervicovaginal secretions collected more than 3 weeks and less
than 1 week prior to delivery, and in term labor, with or without rupture of
the membranes (ROM).
>3 weeks prior <1 week prior In labor No ROM ROM
to delivery to delivery
(n=28) (n=14) (n=28) (n=20) (n=8)
MMP-9 0 (0-0.14) 0.3 (0-30) 0.02
Table 3. Median and range of matrix metalloproteinase (MMP)-9 values (ng/ml) in
detectable vaginal secretions collected during pregnancy (non-labor) and
in preterm labor.
Preterm Preterm
non-labor labor p-value*
(n=9) (n=5)
*p<.001 by the Kruskal-Wallis multiple group rank sum test for the comparison of the three time
period groups; 
† p<.001 by the Wilcoxon rank sum test for the comparison of the term ROM vs. no ROM groups.
* By the Wilcoxon rank sum test
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Figure 1. Association of median matrix metalloproteinase (MMP)-9 during pregnancy,
prior to delivery and in preterm and term labor with or without rupture of
membranes.
Figure 2. Correlation between matrix metalloproteinase (MMP)-9 concentration and cer-
vical dilatation in term labor with and without rupture of membranes (ROM)
and in preterm labor without ROM.
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Comments
Rajabi and colleagues18 found that MMP-1 levels were increased 13-fold in the
human lower uterine segment and cervix at parturition. In human placentas a
significant increase of total collagenase activity has been shown after the onset of
labor.19 After inactivation of tissue inhibitor of MMP-1, a 12- to 17-fold increase in
collagenase activity was found. Vadillo-Ortega and co-workers20 found increased
levels of MMP-9 in amniotic fluid of patients with normal term labor and preterm
rupture of membranes.
Elevated levels of collagenolytic activity, measured in cervical biopsies from preg-
nant women who delivered at term,18 indicate that collagenase may play an active
role in the cervical ripening process. As collagenase acts extracellularly in the
matrix, it might diffuse into the serum and provide a signal of incipient labor.
Rajabi and associates23 showed no change in serum MMP-1 activity throughout
pregnancy until the onset of term labor and an eight-fold increase during preterm
labor. They suggested that serum MMP-1 might be a valuable marker for detect-
ing preterm labor. Granström and colleagues21 reported that serum collagenase at
term was higher than in the non-pregnant state. MMP-1 levels were higher in
women with a ripe cervix than in those described as having stiff and inelastic cer-
vices. Contrary to these reports, Morrison and co-workers22 found no elevation in
serum collagenase at term labor. These inconsistent findings may be due to the
use of different assay methods.
Immediately prior to and during labor, we expected increases in the cervicovagi-
nal secretion of MMP-1. However, we now report that cervicovaginal MMP-1 was
not associated with the onset of preterm or term labor. It is possible that MMP-1
activity is restricted to the tissue and not released into cervicovaginal secretions.
Prior to accepting this conclusion, however, our cross-sectional sampling method-
ology should be compared with a longitudinal study, in which a group of women
have their MMP levels measured over time, through labor and delivery. An addi-
tional caveat relates to the nature of the ELISA assay. Whereas total immunologi-
cal levels of MMP generally correlate well with biological activity, it is possible
that tissue inhibitors of metalloproteinase activity could have influenced our
results. For example, MMP activity might be increased in the absence of elevated
concentrations if inhibitor levels are reduced. Given our findings, the ELISA
assay of vaginal MMP-1 does not seem useful for prediction of preterm delivery.
Matrix Metalloproteinases-1 and -9.
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In our study, among controls, cervicovaginal MMP-9 values were low more than 3
weeks prior to the onset of term labor, increased within 1 week of labor, reached
relatively high concentrations in labor and peaked with membrane rupture. In
contrast, among cases, MMP-9 levels remained unchanged until the onset of
spontaneous preterm labor.
The presence of MMP-9 has been studied in rat amnion,25 human
amniochorion,26 amniotic fluid,27,28 urine29 and plasma.30 Vadillo-Ortega and col-
leagues26 demonstrated with Western blot analyses that MMP-9 protein increased
in the human amniochorion with labor. MMP-9 is expressed by amnion epitheli-
um, macrophages, chorion laeve trophoblast and decidual cells. The increased
expression of MMP-9 will result in degradation of the extracellular matrix of the
fetal membranes and facilitate their rupture under both physiological and patho-
logical conditions. Athayde and co-workers27 showed that women with preterm
premature rupture of membranes had higher MMP-9 concentrations in amniotic
fluid than women in spontaneous preterm labor with intact membranes. Women
with an intra-amniotic infection had higher concentrations of MMP-9 than
women without infection.27 Locksmith and associates28 found MMP-9 levels in
the amniotic fluid to be reliable for diagnosing intra-amniotic infection. Recently,
a simple non-invasive assay was used to quantitate urinary MMP-9 activity
among a small group of patients (n=15) with threatened premature labor.29 This
study showed that both positive and negative predictive values for a risk of prema-
ture delivery were 80%. Tu and co-workers30 reported that plasma MMP-9 con-
centrations, assayed with an ELISA, remained unchanged throughout pregnancy,
but increased in women who presented with spontaneous labor.
The timing of MMP-9 expression in the cervicovaginal secretions in our study is
comparable with the findings of Tu and colleagues30 in plasma. We also showed
an association of cervicovaginal MMP-9 expression with rupture of the mem-
branes, as was previously described in plasma and amniotic fluid.26, 30 We antici-
pated that preterm labor would be preceded by a prolonged period of cervical
remodelling and ripening, causing earlier release of MMP-9 into cervicovaginal
secretions than was found preceding term labor. However, our results indicate
that term labor was preceded by earlier release of MMP-9. We did find a signifi-
cant correlation between MMP-9 expression and cervical dilatation.
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While, there might be an important role for MMP-9 in the mechanisms of labor
and membrane rupture, MMP-9 levels prior to preterm delivery are not signifi-
cantly increased in comparison to MMP-9 throughout pregnancy. MMP-9 there-
fore does not appear to be useful as a predictor of preterm birth. However, since
we measured MMP-9 in the same manner as MMP-1, i.e. with an ELISA, the
limitation discussed above applies to MMP-9 as well. Interestingly, MMP-9 might
be useful to confirm a suspicion of premature rupture of membranes if amniotic
fluid cannot be collected for a confirmatory fern or pH test. Future research is
necessary to study the usefulness of such a confirmatory test.
Matrix Metalloproteinases-1 and -9.
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Abstract
Objective. We conducted this study to evaluate sociodemographic factors to be
associated with changes in the length of the cervix across gestation in pregnancies
that resulted in term deliveries.
Study design. This study was an observational cohort design. In 125 women with
a singleton pregnancy cervical length was determined and measured at 3 to 4-
week intervals between 20 and 32 weeks gestation. We developed a structured
questionnaire to collect psychosocial and sociodemographic characteristics.
Bivariate analysis, analysis of variance, and regression analysis were used to study
variation in cervical length.
Results. Overall, cervical length decreased minimally as gestational age pro-
gressed. However, among African-American patients cervical length decreased
significantly with increasing gestational age (p = .006). In addition, high psy-
chosocial stress was associated with significantly shorter cervices later in gestation,
independent of race (p = .003). Finally, women whose occupations involved
skilled manual labor had shorter cervices (p = .02).
Conclusions. Women who are black, under stress, or working as skilled manual
laborers demonstrate significant shortening of the cervix during gestation. Given
that a shorter cervix predisposes to preterm delivery, our findings provide new
insights into the well-described association of these psychosocial and sociodemo-
graphic factors with an increased risk of preterm delivery.
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Introduction
The human cervix has been shown to be a dynamic organ throughout gestation,
varying markedly in both shape and length.1 As term approaches, the cervix
begins to shorten, in association with effacement and dilatation. Recently, reduc-
tion in cervical length determined sonographically during the second and third
trimesters has been correlated with increased risk of preterm delivery.2-4
Among women with uncomplicated pregnancies, there are minimal data on the
correlations of psychosocial and sociodemographic variables with cervical length
across gestation. Moreover, published studies aimed at developing reference
ranges for cervical length throughout uncomplicated pregnancy contain conflict-
ing information.2-7 We believe it is important to ascertain whether this observed
variability in cervical length reflects methodological differences in cervical length
measurements (ie, interobserver variation; different methods of reporting cervical
length, such as using mean versus minimal values, and variation in degree of
bladder distention) or biological variability that may be associated with differen-
tial exposure to risk factors.
Therefore, we undertook this study to test the hypothesis that, in uncomplicated
pregnancies that resulted in term deliveries, there is significant variability among
women in the length of the cervix, and that this variability correlates with psy-
chosocial and sociodemographic factors.
Material and methods
Data reported in this study were acquired as part of an ongoing prospective cohort
study to evaluate psychosocial, sociodemographic and clinical factors that may be
used for the prediction of preterm delivery. From July 1996 to June 1997 we serial-
ly evaluated cervical length using vaginal ultrasonography in 125 patients with
singleton pregnancies that progressed to term in the Women’s Health Clinic at
Bellevue Hospital Center. We obtained prior approval for the study from the insti-
tutional review board, and we obtained informed consent from all patients as part
of the enrollment process. We defined term delivery as delivery at or after 37 com-
pleted weeks’ gestation. All patients were < 23 weeks’ gestation at enrollment,
and all had a well-confirmed estimated date of confinement by date of last men-
strual period and ultrasound. Patients who had a first prenatal visit after 23 weeks
Sociodemographic predictors and cervical length
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of gestation, who had documented ruptured membranes, or who had chromoso-
mal or congenital anatomic abnormalities of the fetus were ineligible to partici-
pate. The study population consisted predominantly of publicly insured or unin-
sured patients. Key sociodemographic characteristics are listed in Table 1.
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Race
Black 29 23
Asian 24 19
Hispanic 52 42
White 20 16
Parity   
Nulliparous 57 46
Multiparous 68 54
Marital status  
Single (unsupported) 45 36
Married 61 49
Living together 19 15
Maternal age
< 20 y 12 10
20 < 35 y 102 81
≥ 35 y 11 9
Education
< 9 y 20 16
9 - 12 y 16 13
High school degree 69 55
College or graduate degree 20 16
Income
< $10,000/ y 55 44
$10,000 < $20,000/ y 57 36
> $20,000/ y 10 8
Not reported 3 2
Table 1. Sociodemographic characteristics of the study population (n = 125).
Characteristic No %
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A single ultrasonographic operator performed all cervical length measurements to
eliminate the possibility for interobserver variability in measurement technique.
The intraobserver variability was 3.0 mm, on the basis of a sample of 24 repeat
measurements. Cervical length was evaluated serially at 3- to 4- week intervals
that coincided with routine prenatal care visits. The range of gestational ages at
which we measured cervical length was 20-32 weeks. We attempted to obtain at
least 1 cervical length measurement at each of 3 gestational age periods of 20-24
weeks, 25-28 weeks and 29-32 weeks. When only 2 of these periods were repre-
sented (n=31), that period’s measurement was treated as missing data for the
analysis. In those instances in which we collected 2 measurements in a given ges-
tational age interval (n=22), we averaged the measures in subsequent analyses.
Ultrasonographic scans were performed with a Siemens Sonoline Prima ultra-
sound unit. After the patient emptied the bladder, she was placed in the lithotomy
position. A 6.5-MHz transvaginal transducer was covered with a sterile condom.
The endocervical canal was visualized in the sagittal plane, and the calipers were
placed at the furthest points between the internal and external os. When funnel-
ing was present, we measured the distance over which the endocervical walls were
juxtaposed. Because pressure against the cervix generated by insertion of the
transducer can influence the length of the endocervical canal, it was measured 3
times at each session. When different values were obtained, the minimum value
was used, consistent with previously described methods.3,4
Information regarding obstetrical history, complications during the current preg-
nancy, sociodemographic factors, and other clinical characteristics of the patient
were obtained from the medical record and by a self-administered questionnaire.
The questionnaire was distributed and explained during the first study visit,
between 20 and 24 weeks of gestation. The women completed the questionnaire
at home, and the responses were reviewed with the patient during the next study
visit. The questionnaire represents a significant modification of previously devel-
oped instruments8,9 and was tailored to the specific objectives of this study. We
pretested and then revised it on the basis of initial responses of volunteers who did
not participate in the study.
Stress was evaluated according to a weighted scale of 35 life events (Table 2) to
measure the level of psychosocial stress that occurred during the pregnancy and in
the year before conception. On the basis of relative stress scoring systems,9 each
Sociodemographic predictors and cervical length
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life event on the inventory was assigned a numeric score. Life events that occurred
in the year before the pregnancy were weighted by a factor of two thirds compared
with those that occurred during pregnancy, on the basis of subjective pretest
assessments of the relative difference in perceived stress during these times. The
sum of the weighted scores represents the overall psychosocial stress score.
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Trouble with your boss / co-workers
Family  troubles
Major arguments with husband / partner
Sexual difficulties
You experienced a major illness or injury
A loved one experienced a major illness or injury
Serious financial problems
Death of spouse /  close family member           
Addition of a new ‘family’ member 
Major change in behavior of family member
You moved to another neighborhood
You experienced a change in your self-esteem
You moved to another state        
You moved to another country
Death of close friend
You or your husband / partner were arrested
You were married
You were divorced
You were separated from your husband /partner
You achieved special successes
You were physically hurt by someone close to you.
You were laid off or fired from work
Your husband / partner was laid off or fired from work
You took on a new loan or mortgage
You experienced foreclosure on a mortgage or loan
You have become homeless
You were denied a Green Card
You or your partner are unable to find work
You are fearful that someone at home will hurt you
You started or graduated from school
A child has left home (on bad terms)
You were a victim of rape
A child was expelled from school
Table 2. Listing of major life events contributing to stress scale.
Life events used for stress-scale:
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Four categories of income and education (Table 1) were created from the respons-
es. These were based on the standard US Bureau of the Census classification.10
Similarly, occupation was stratified into 4 groups, according to the census classifi-
cation as follows: (1) unskilled (no usual employment, homemaker) and partly
skilled (protective service, private household, other service); (2) skilled (trans-
portation, construction trade, handlers, skilled crafts, repair, operators, fabricators,
and laborers); (3) intermediate (technical, administrative support and sales); and
(4) professional (managerial and professional specialty).10 To measure overall
socioeconomic status, we divided the sum of individual scores derived for mater-
nal and paternal education, occupation, and family income into 4 quartiles, low-
est, low, moderate, and high socio-economic status.
We developed an exercise score (0-12), computed by adding points assigned for
varying amounts of the following weekly activities: flights of stairs climbed; hours
of light, moderate, or heavy physical exercise; and hours of housework per week.
Questions regarding the women’s attitude toward the pregnancy included the
degree to which the respondents had planned the pregnancy and the degree of
anxiety associated with confirmation of the pregnancy. The women were also
queried concerning the convenience of the timing of the pregnancy and the reac-
tion of the husband or partner and children to the pregnancy. A single weighted
score (0-20) was used to categorize the woman’s attitude toward the pregnancy.
Body mass index was calculated with the formula (weight [kg] / height2 [m]).
The weight used in this calculation was the reported prepregnancy weight record-
ed during the woman’s first prenatal visit.
Data analysis was performed with the aid of the JMP statistical analysis software,
version 3.1.5 (SAS Institute Inc, Cary, North Carolina). Required sample sizes
were computed at the beginning of the study using a power analysis of the expect-
ed difference in mean cervical length for participants who possessed one of the
preselected sociodemographic characteristics of interest (e.g. marital status). We
enrolled sufficient participants for an α value of .05 and a β value of .20. For this
study, we considered it important to detect mean differences in cervical length of
≥ 4.0 mm. Probability values < .05 were considered to indicate a statistically sig-
nificant difference in this study. Analysis techniques included the χ2 test for bino-
mially distributed outcomes, student t-tests and analysis of variance for continu-
ous, normally distributed variables, and the Wilcoxon rank-sum test for non-nor-
mally distributed data. Multiple stepwise regression analysis was used to evaluate
Sociodemographic predictors and cervical length
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the association of cervical length with psychosocial and sociodemographic factors.
Finally, change in cervical length over time was evaluated by repeated-measures
analysis of variance.
Results
Demographic characteristics of the study population are shown in Table 1.
Cervical length data on the study population appear in Table 3. When the group
of women as a whole is considered, as gestation proceeded, cervical length did not
change significantly (Figure 1). The overall mean cervical length was 39.7 mm
(± 6.8 mm) at 20-24 weeks, 38.6 mm (± 7.5 mm) at 25-28 weeks, and 37.3 mm
(± 7.3 mm) at 29-32 weeks (Table 3). However, among African-American
patients, cervical length shortened significantly as gestation proceeded (Figure 2).
Moreover, this difference was statistically significant when compared with other
ethnic groups (p=.006, Table 3). Level of stress and length of the cervix were
inversely associated (Figure 3). Patients in the highest category of psychosocial
stress had a shorter cervix in the gestational period from 25-28 weeks (p=.004)
and from 29-32 weeks (p=.003), compared with patients with lower psychosocial
stress scores (Table 3).
68
Chapter 4
Figure 1. Overall mean cervical length change in 3 different gestational age groups (p not
significant). Open circles, mean cervical length.
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Parity, age, and a composite measure of socio-economic status (ie, paternal educa-
tion, maternal education, paternal occupation, maternal occupation, and family
income) showed no significant association with cervical length. When maternal
occupation was evaluated separately, women who worked as skilled manual labor-
ers demonstrated a significant shortening of cervical length at 25-28 weeks
(p=.006) and 29-32 weeks of gestation (p=.02, Table 3). Furthermore, in our
sample population, length of the cervix was not associated with certain other
sociodemographic factors such as marital status, education, height, prepregnancy
Sociodemographic predictors and cervical length
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Overall mean 
cervical length 100 39.7 ± 6.8 38.6 ± 7.5 37.3 ± 7.3
Race
Black 23 39.3 ± 7.7 36.9 ± 8.9 33.0 ± 5.5 * 36.5 ± 6.2
Asian 19 39.8 ± 6.5 39.5 ± 7.3 40.1 ± 7.3 39.7 ± 6.0
Hispanic 42 40.2 ± 6.4 39.7 ± 6.7 38.0 ± 6.7 39.3 ± 5.6
White 16 39.1 ± 7.1 37.3 ± 7.0 37.9 ± 8.8 37.7 ± 6.7
Stress score
Lowest 56 40.0 ± 6.0 39.2 ± 7.8 38.5 ± 7.1 39.3 ± 6.1
Low 17 39.7 ± 8.1 39.5 ± 5.2 36.5 ± 7.2 39.4 ± 5.0
Moderate 16 41.5 ± 6.6 40.4 ± 5.7 38.7 ± 7.0 40.3 ± 5.7
Severe 11 36.1 ± 7.9 30.6 ± 7.5 † 30.5 ± 5.9 ‡ 30.8 ± 5.2
Maternal occupation
Partly skilled 64 40.0 ± 6.7 39.3 ± 7.1 37.8 ± 7.6 39.0 ± 6.0
skilled 5 33.1 ± 5.5 26.0 ± 7.7 * 26.7 ± 4.7 § 30.0 ± 4.3
intermediate 30 39.9 ± 7.0 38.8 ± 7.3 37.2 ± 6.3 38.1 ± 5.9
professional 1 45.9 ± 0.8 37.6 ± 1.3 41.3 ± 2.1 41.6 ± 1.4
Table 3. Cervical length (in millimeters) in 3 gestational age periods, grouped by
various sociodemographic and psychosocial characteristics.
Characteristic % 20-24 wk 25-28 wk 29-32 wk mean
Analysis of variance was used to evaluate the data. For all values without symbols, differences were
not statistically significant.
*  p= .006
† p= .004
‡ p= .003
§ p= .02
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Figure 2. Mean cervical length in African-American versus non-African-American
women. The trend is significant by analysis of variance (p= .006). Open circles,
African-American women; x, non-African-American women.
Figure 3. Mean cervical length in women with severe stress compared with women with
lower stress levels. The trend is significant by analysis of variance (25-28 weeks,
p= .004; 29-32 weeks, p= .003). Open circles, severe stress; x, lowest to moder-
ate stress.
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body mass index, attitude toward pregnancy, exercise level, religion, and working
during pregnancy. Because short cervical length has been associated with an
increased risk of preterm birth, we also evaluated other reported risk factors for
preterm delivery in our sample, even though all of the women delivered at term.
Thus, no association was found between cervical length and prior preterm deliv-
ery, prior cervical surgery, and clinical factors such as oral contraceptive use, pres-
ence of a urinary tract infection, bacterial vaginosis, yeast infection, or anemia.
Similarly, we found no significant association between cervical length and current
smoking behavior, history of drug use, or current alcohol use. Multiple stepwise
regression analysis revealed no added predictive value of these traditional preterm
delivery risk factors on cervical length. These risk factors were rarely present in
our study population, however, so that we can make no definitive statement con-
cerning a possible association with cervical length at this time.
Comment
Data on cervical length during uncomplicated pregnancies have been inconsis-
tent.2,3,5 Values for mean cervical length described in the literature vary signifi-
cantly from 32 mm to 48 mm. Suggested cut off values for the prediction of
preterm delivery vary from 18 to 40 mm.2,3,7 In addition, there is controversy over
when cervical shortening occurs in uncomplicated pregnancies. Reported values
vary from 16 to 31 weeks.2,3,5,6 These studies were conducted among different
populations, which may account for some of the reported variation. Our data
show that mean cervical length does not decrease significantly across gestation in
our general study population (Figure 1).
At the initiation of this study, we hypothesized that the discrepant results regard-
ing cervical length reported in the literature can be attributed to differences in
psychosocial and sociodemographic factors among the various study populations.
Papiernik et al.11 proposed that preterm delivery could be predicted by the identi-
fication of multiple risk factors that either predated or accompanied pregnancy.
Historic and demographic factors that were found to be associated with preterm
delivery by univariate analysis included prior preterm delivery (12.5% increased
risk over baseline), maternal stature < 1.52 m (7.4% increased risk), maternal age
< 21 years or > 36 years (6.5% increased risk), and the lowest socio-economic
classification (13.3% increased risk).8,11 We found no association of cervical length
with these sociodemographic factors in our study population of women who
Sociodemographic predictors and cervical length
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delivered at term. Previous research indicates racial differences in risk for prema-
ture birth. African-American women are at a higher risk of preterm delivery, with
risks ranging from 10.8 % to 18.8%.12,13 Kleinman and Kessel14 found an overall
black/white ratio of 3.0 for very low birth weight infants (92 % of these infants
were born preterm), and among women at low risk the black/white ratio was even
higher, at 3.4.
Our data show that shorter cervices develop in black women with increasing ges-
tational age when compared with other groups. Although all of the women in our
study delivered at term, there are nonetheless differences between African-
American women and other women in the duration of gestation. Papiernik et al.15
reported that among French women the most common gestational week of deliv-
ery at term was 39 weeks for African-American patients, but 40 weeks for white
patients. Goldenberg et al.16 also report that African-American infants are born
earlier than white infants. In studies published to date, different theories have
been offered to explain these data, such as lower socio-economic status among
African-Americans; a higher prevalence of known risk factors such as hyperten-
sion, diabetes, and anemia; higher risk of maternal infection; differences in psy-
chosocial factors; and genetic predisposition. Goldenberg et al.16 suggest that
powerful yet unknown risk factors are more prevalent among black women are
responsible for their shorter gestations. Thus, African-American women may pos-
sess a characteristic, or be differentially exposed to a risk factor (e.g., ascending
infection leading to chorioamnionitis and subsequent preterm rupture of the
membranes)17 that predisposes them to shorter gestations. We suggest that black
women might react differently to an exposure based on a genetic component of
yet-unspecified origin. Our finding of a significant shortening of the cervix during
gestation among blacks may reflect this reaction.
Maternal stress has been associated with preterm delivery. The link between
maternal stress and preterm delivery is suggested by the increased preterm deliv-
ery rate among (1) unmarried and poor mothers,18 (2) patients who experience
major stressful events,8,19-21 and (3) those with objective and subjective evidence of
anxiety.8,20,21 In addition, our data show that women who experience severe stress
have a significantly shorter cervix between 25 and 32 weeks when compared with
women in lower psychosocial stress categories.
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The shorter cervical length in women with severe stress might be explained by the
fact that chronic stress leads to an increase in maternal plasma cortisol. As a result,
placental corticotropin-releasing hormone production will increase.22,23 This
might disturb the biochemical balance between corticotropin-releasing hormone
and corticotropin-releasing hormone-binding protein as gestation progresses, lead-
ing to a premature excess of unbound bioactive corticotropin-releasing hormone in
the maternal circulation. Bioactive corticotropin-releasing hormone has been
reported to stimulate oxytocin action and increase prostaglandin release, thereby
stimulating uterine smooth muscle contractions and proteolytic degradation of the
cervical connective tissue,24 which would be reflected in shortening of the cervix.
Mamelle et al.25 reported in a large French survey among pregnant women that
38.4 % of skilled workers experienced intense occupational fatigue during preg-
nancy. In addition, a weekly working time of more than 40 hours and shift work
were found to be risk factors. They also found that mental stress (doing routine
work and work requiring little attention) and environmental factors (noise, cold
temperature, very wet atmosphere and manipulation of chemical substances) sig-
nificantly increase the risk of preterm delivery to as high as 10.3%, compared with
5.8% among all working women. Albeit in only a small sample of women (n=5),
we found a significant association of skilled manual labor with shortened cervical
length. A larger sample size and more detailed data on the work environment
would be required, however, to support a conclusion that this type of work
impacts cervical length through its generation chronic physical and mental stress.
In conclusion, we have shown that 3 psychosocial and sociodemographic factors
(African-American race, stress and skilled manual labor) are associated with a short-
er cervical length with increasing gestational age in uncomplicated pregnancy. These
results suggest potential application in the management of patients who are at risk
for preterm delivery. The physiologic shortening of the cervix with increasing gesta-
tional age in African-American women, patients under severe stress, or skilled man-
ual laborers may prove important when evaluating cervical length. It is possible that
the observed cervical shortening that occurs in women who are African-American,
stressed, or skilled laborers may either reflect or promote pathological processes. As
has been shown in several studies,2-4,7 cervical shortening before development of
preterm labor has been associated with a significant risk of preterm delivery.
Therefore, our findings suggest areas for additional research concerning the biologic
mechanisms that promote preterm delivery in these 3 separate subgroups.
Sociodemographic predictors and cervical length
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Abstract
Objective. To assess variation in cervical length among African-American,
Hispanic, Asian, and Caucasian women by transvaginal sonography and to study
if associations between preterm birth and cervical length are related to ethnic ori-
gin.
Methods. A prospective cohort was undertaken of women seeking prenatal care
between 1996 and 2001. They were recruited to undergo serial transvaginal cervi-
cal sonography at 20-24, 25-28 and 29-32 weeks. Maternal race was determined by
patient’s self-report. Data from previous pregnancies and outcome of the index
pregnancy were abstracted from the medical record. Preterm delivery was defined
as delivery <37 weeks gestation. Data were analyzed by chi-square tests, t-tests,
analysis of variance (ANOVA) and by multiple linear regression. Nomograms and
percentiles of cervical length were generated for each ethnic group.
Results. A total of 856 pregnancies were included in the study, 65.5% Hispanic,
11.6% Asian, 9.5% Caucasian, and 13.4% African-American. Preterm rates did not
significantly differ by race or ethnicity, but African-Americans delivered on aver-
age earlier (38.4 weeks) than the other groups (ANOVA, P<0.05). Between 20
and 33 weeks all women displayed progressive cervical shortening except Asians.
African-American women had shorter cervices across all 3 gestational age inter-
vals than the other ethnic groups (ANOVA, p<0.001). Between 20 and 24 weeks,
significant differences in cervical length between women who delivered preterm
compared with those delivering at term were observed only amongst African-
Americans (31.4 mm vs. 37.7mm, t-test, p=0.006). Significant differences in cer-
vical length between patients delivering preterm compared with those delivering
at term were noted amongst both African-Americans and Hispanics at 25-28
weeks and amongst all groups in the 29-32 week interval.
Conclusions. This data suggests that the predictive value of cervical length varies
with gestational age among different racial and ethnic groups.
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Introduction
During the past decade, transvaginal ultrasonographic measurements of the
cervix have been described as a reliable predictor of preterm labor and delivery.
Iams et al. reported a mean cervical length at 24 weeks of 35.2mm in his predomi-
nantly (63%) African-American population of singleton gestations.1 They found
that women with transvaginal cervical lengths of less than 26mm (<10th per-
centile at 24 weeks gestation) had a relative risk of 9.5 for preterm delivery, but the
positive predictive value for preterm delivery was only 17.8%. Several authors
described cervical shortening throughout normal pregnancy and in relation to
spontaneous preterm birth (SPB) although the reported timing of these changes
was not consistent.2-5
In our previous study we ascertained whether this observed variability in cervical
length reflected methodological or sociodemographic factors.6 We found that
shorter cervical lengths were independently associated with African-American
race, psychological stress, and skilled manual labor in women who delivered at
term.6 Several reports which concluded that short cervical lengths between 19 and
24 weeks gestation were associated with an increased risk of preterm delivery were
conducted in populations predominantly composed of African-Americans.1,7-9
Thus, we questioned whether the ethnic origin of a patient plays a role in the pre-
dictive value of cervical length measurements for spontaneous preterm birth.
Given the variations in cervical length measurements at various gestational age
time points and in various ethnic groups, we sought to establish basic population
norms over time. We aim to assess if association between preterm birth and cervi-
cal length are related to ethnic origin.
Material and Methods
Women seeking prenatal care at Bellevue Hospital between July 1996 and
November 2001 were recruited to participate in an ongoing prospective cohort
study to evaluate psychosocial, demographic, and clinical risk factors that may pre-
dispose to preterm labor and delivery. Preterm delivery was defined as a delivery,
greater than 25 weeks and less than 37 weeks gestation. In our inner-city popula-
tion, the overall incidence of preterm delivery was about 10%. The Institutional
Review Board approved this study and all women with singleton pregnancies
signed informed consent at the time of enrollment. All women were less than 23
weeks gestation at enrollment and had an estimated date of delivery established by
Racial variation in cervical length
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last menstrual period and/or ultrasound. Patients who had a first prenatal visit
after 23 weeks of gestation, who had chromosomal or congenital anatomic abnor-
malities of the fetus or had a medically indicated ‘elective’ preterm delivery, were
ineligible to participate. Information regarding obstetric history, complications
during the current pregnancy, sociodemographic factors, other clinical characteris-
tics of the patient, pregnancy outcome and neonatal data was obtained from the
(prenatal) medical record, patient’s self-report and by a self-administered ques-
tionnaire. The questionnaire was distributed and explained during the first study
visit, between 20 and 24 weeks and the responses were reviewed with the patient
during the next study visit. The questionnaire represented a significant modifica-
tion of previously developed instruments and was previously validated to measure
stress, four categories of income and education, socio-economic status, occupation,
exercise during pregnancy and the women’s attitude toward the pregnancy.6
Transvaginal sonographic cervical length measurements were obtained during the
three gestational age intervals (20-24, 25-28 and 29-32 completed weeks). The
ultrasound exams were performed with a Siemens Sonoline Prima ultrasound
unit using a 6.5-MHz transvaginal probe in the manner as described previously
by us.6 Cervical length measurements were followed longitudinally over time.
The primary health care providers for the patients were blinded to all ultrasound
findings performed as a part of this research protocol in order to assess the natural
history of any potential cervical changes.
Data analysis was performed with the aid of the JMP statistical analysis software
(Version 4.0.3, Copyright 1989-2000, SAS Institute Inc.) and SPSS for Windows
(Version 6.1.4, Copyright 1989-1995, SPSS Inc.). Analysis techniques included
the chi-square test for binomially distributed outcomes, student t-test and analysis
of variance (ANOVA) for continuous, normally distributed variables. Multiple
linear regression analysis was used to determine the relationship of demographic
characteristics (age, marital status, socio-economic status, ethnicity), past obstetric
history (parity, prior preterm birth, prior spontaneous abortion < 20 weeks), body
mass index, stress, exercise, smoking, attitude towards pregnancy, and cervical
length at the three gestational age intervals with gestational age of delivery.
Separate regression analysis was done to explore an independent association of
the above-mentioned factors and cervical length at 20-24, 25-28 and 29-32 weeks.
Nomograms for the 5th, 25th, 50th, 75th, and 95th percentiles were generated longi-
tudinally over time for the 4 racial/ethnic groups.
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Results
During the study period, 910 women with singleton pregnancies underwent 2nd
trimester cervical ultrasound examinations at three predetermined gestational age
intervals. Fifty-four women contained exclusion criteria, which made them ineli-
gible for participation in the study. The final study population consisted of 856
women. African-American women were older, had higher rates of prior preterm
birth and were more often multiparous (Table 1). Although African-American
women had on average a shorter gestational age at delivery, there was no statisti-
cally significant difference in preterm birth rate (< 37 weeks) amongst the four
groups of women. However early preterm birth < 35 weeks gestation occurred
more often in the African-American population.
Cervical length was normally distributed with mean values of 39.2 mm between
20-24 weeks; 37.6 mm between 25-28 weeks; and 36.3 mm between 29-32 weeks’
Racial variation in cervical length
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Race
Number  (%) 561 (65.5) 99 (11.6) 81 (9.5) 115 (13.4)
Age in years (SD) 26.1 (5.5) * 27.5 (5.0) 27.4 (5.3) 28.6 (5.6)*
Parity (mean (SD)) 1.0 (1.2) 0.9 (1.1) 0.5 (0.8) 1.4 (1.7)*
Prior preterm birth (%) 49 (8.4) 6 (6.1) 4 (4.9) 18 (15.7)*
Weeks at delivery (SD) 39.2 (1.9) 38.9 (2.6) 39.3 (1.5) 38.4 (3.1)*
% preterm birth < 37 weeks 8.0 13.3 7.6 14.4
% preterm birth < 35 weeks  2.9 7.1 0 9.9*
Cervical Length in mm (SD) 38.3 (6.1) 38.4 (5.5) 37.0 (6.8) 34.7 (7.2)*
Table 1 .Data regarding demographics, obstetrical history and pregnancy outcome
by ethnic group. PTB = preterm birth, SD= standard deviation.
Hispanic Asian Caucasian African-
American
* P<0.05 by ANOVA
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gestation. All patients had progressive cervical shortening across the observation
period except Asians (Figure 1). The mean cervical length of African-American
women was shorter across all three gestational age intervals compared to the other
ethnic groups (ANOVA, p<0.001), also after controlling for possible confounding
factors (preterm birth, obstetrical history, sociodemographic factors). The 5th, 25th,
50th, 75th, and 95th percentiles for cervical lengths of the Hispanics (as largest
group of our study population) and the African-Americans are shown in Figure 2.
The 5th percentile of the African-Americans decreased from 20 weeks to 33 weeks
from 20 mm to 16 mm and the 5th percentile of the Hispanics from 26 to 25 mm.
African-American women who delivered preterm had shorter cervices at 20-24
weeks than African-American women delivering at term (31.4 mm vs. 37.7 mm, t-
test, p=0.006; Table 2). This difference was not found for the other ethnic groups.
At 25-28 weeks only African-American and Hispanic women showed a significant
difference of mean cervical length between women who delivered preterm and
those who delivered at term. At 29-32 weeks significant differences in cervical
length were noted between women delivering preterm compared to those deliver-
ing at term in all four racial/ethnic groups.
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Figure 1. Cervical Length Changes Across Gestational Age by Race (Mean ± SD).
ANOVA, p<0.001 for African-Americans at all time intervals
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Figure 2. Nomograms for Cervical Length Measurements by EGA in Hispanics and
African-Americans.
African-Americans
Hispanics
C
er
vi
ca
l L
en
gt
h
C
er
vi
ca
l L
en
gt
h
hoofdstuk 05  07-05-2002  09:57  Pagina 83
84
Chapter 5
R
ac
e
20
-2
4 
6/
7 
w
ee
k
Te
rm
39
.9
 (7
.3
)
46
9
39
.3
 (5
.9
)
79
39
.3
 (6
.6
)
68
 
37
.7
 (7
.9
)
88
PT
B
 <
 3
7 
w
ee
ks
39
.8
 (6
.9
)
40
37
.0
 (3
.3
)
12
35
.3
 (1
7.
1)
6 
31
.4
 (9
.9
)*
16
PT
B
 <
 3
5 
w
ee
ks
38
.1
 (6
.1
)
14
37
.5
 (3
.2
)
7
-
-
29
.0
 (1
0.
2)
*
11
25
-2
8 
6/
7 
w
ee
ks
Te
rm
38
.6
 (6
.9
)
44
3
38
.3
 (6
.2
)
75
37
.1
 (6
.9
)
67
35
.7
 (7
.7
)
81
PT
B
 <
 3
7 
w
ee
ks
35
.1
 (6
.9
)*
40
34
.6
 (6
.7
)
8
31
.9
 (1
1.
7)
5
25
.2
 (6
.9
)*
11
PT
B
 <
 3
5 
w
ee
ks
34
.3
 (8
.4
)*
16
32
.3
 (7
.7
)*
5
-
-
23
.8
 (9
.1
)*
6
29
-3
2 
6/
7 
w
ee
ks
Te
rm
37
.1
 (7
.2
)
46
3
39
.0
 (7
.3
)
68
36
.4
 (7
.1
)
66
33
.3
 (7
.3
)
88
PT
B
 <
 3
7 
w
ee
ks
34
.5
 (7
.0
)*
32
31
.5
 (6
.6
)*
12
30
.5
 (1
0)
6
27
.8
 (1
0.
9)
*
11
PT
B
 <
 3
5 
w
ee
ks
30
.1
 (8
.2
)*
9
28
.6
 (6
.1
)*
6
-
-
28
.0
 (9
.7
)*
8
Ta
bl
e 
2.
C
om
pa
ri
so
n 
of
 m
ea
n 
ce
rv
ic
al
 le
ng
th
 a
t t
hr
ee
 g
es
ta
tio
na
l a
ge
 g
ro
up
s 
w
ith
in
 fo
ur
 e
th
ni
c 
gr
ou
ps
 b
et
w
ee
n 
w
om
en
w
ho
 d
el
iv
er
ed
 a
t t
er
m
 a
nd
 w
om
en
 w
ho
 d
el
iv
er
ed
 p
re
te
rm
 (P
T
B
)(
<
 3
7 
an
d 
<
 3
5 
w
ee
ks
). 
H
is
pa
ni
c
A
si
an
C
au
ca
si
an
A
fr
ic
an
-A
m
er
ic
an
(n
=
52
3)
(n
=
98
)
(n
=
74
)
(n
=
11
5)
M
ea
n 
(S
D
) 
ce
rv
ic
al
 le
ng
th
n
n
n
n
* 
P
<
0.
05
 b
y 
t-
te
st
 o
f c
om
pa
ri
so
n 
of
 m
ea
n 
ce
rv
ic
al
 le
ng
th
 p
er
 e
th
ni
c 
gr
ou
p 
‘te
rm
’ w
it
h 
‘ P
T
B
 <
 3
7 
w
ee
ks
’ a
nd
 ‘t
er
m
’ w
it
h‘
 P
T
B
 <
 3
5
w
ee
ks
’.
hoofdstuk 05  07-05-2002  09:57  Pagina 84
When preterm birth was defined as a delivery before 35 weeks our findings were
similar, except for the Caucasians, who did not deliver before 35 weeks in our
study population. At 20-24 weeks gestation only the African-Americans showed a
significant difference in cervical length between women who delivered < 35
weeks compared to those who delivered thereafter. Cervical length measured at
25-28 and 29-32 weeks were significantly different between the women who deliv-
ered < 35 weeks compared to those delivering thereafter in all racial/ethnic
groups.
Multiple linear regression analysis of the total study population demonstrated sig-
nificant independent associations between gestational age at delivery and
racial/ethnic origin, prior preterm birth, and mean cervical length at 25-28 and
29-32 weeks. Regression analysis was also utilized to show any independent asso-
ciations with cervical length. Mean cervical length per gestational age interval
was also associated with racial/ethnic origin and with cervical length measure-
ments at the other gestational ages. When analyzed for each racial/ethnic group
we observed that mean cervical length at 20-24 weeks was associated with ‘mater-
nal age’ among Hispanics, with ‘parity’ among Asians and with ‘stress’ among
African-Americans. The mean cervical length at 25-28 weeks in Asian women
was related to ‘socio-economic status’ and in African-Americans cervical length at
29-32 weeks was associated with ‘prior preterm birth’.
Discussion
This study - in an ethnically diverse New York City population - demonstrated
progressive cervical shortening between 20 and 33 weeks gestation among
African-American, Caucasian and Hispanic but not Asian women. African-
American women had significantly shorter cervices across all 3 gestational age
intervals compared with the other groups. African-American women who deliv-
ered preterm had shorter cervices at 20-24 weeks gestation than African-American
women who delivered at term. This difference was not found among the other
racial/ethnic groups until 25-28 weeks among Hispanics and 29-32 weeks for
Caucasians and Asians. Thus, the earliest and strongest association between a
shortened cervical length and preterm birth was found among African-American
women, an ethnic group which consistently displays a shorter mean cervical
length across the 2nd and 3rd trimesters. One of the limitations of our study design
is that the size of ethnic groups was different. It gives low numbers in the group of
Racial variation in cervical length
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Asians and Caucasians who delivered preterm. Furthermore we did not find rele-
vant confounding factors in the total study population, but we can not preclude
that there are none. It might be that we could not detect it with our study design.
Racial differences in rates of preterm births and low birth weight infants have
been the topic of longstanding research and debate.10 Epidemiological studies of
ethnically diverse groups have shown that African-American women were more
likely to experience preterm birth, followed by Hispanic, Asian and Caucasian
women.11-13 It has been suggested that the increased rates of preterm birth in
African-American women in the United States have been attributed to differences
in socio-economic factors. Such as poor health care, poor nutrition, short preg-
nancy interval, increased exposure to infectious agents, and increased stress dur-
ing pregnancy. There is also data to suggest that shortened gestation and lower
birth weights infants persist in African-American American women after control-
ling for these risk factors.12-15
While not specifically addressed in prior studies, this racial/ethnic group variation
in cervical length and it preterm birth predictive value is supported by prior stud-
ies. Iams et al. described cervical shortening with increasing gestational age after
20 weeks’gestation, with median values falling from 35-40 mm at 24-28 weeks to
30-35 mm after 32 weeks.1 The likelihood of spontaneous preterm birth increased
as cervical length at 24-28 weeks decreased. This applied specifically to the sub-
jects whose cervices shortened by 6 mm or more, between 24 and 28 weeks.
Interestingly, the population studied by Iams and colleagues consisted of more
than 60% of African-Americans.1 Also studies by Hassan et al., Heath et al. and
Hibbard et al. linking shortened cervices to prematurity evaluated predominantly
African-American populations.7-9 The population studied by Heath and associ-
ates contained 50% African-Americans. They observed that the mean cervical
length of African-American women was significantly shorter than that of
Caucasians at 23 weeks gestation.8 They concluded that short cervical length at
23-24 weeks gestation was associated with increased risk of preterm delivery.
Hassan et al. evaluated a population containing 81% African-Americans and
noted that women with a cervical length of ≤ 15 mm at 20-24 weeks had a 48%
risk of early preterm birth.7 In contrast, Kushnir et al. studied a population com-
posed of only 2% African Americans and reported that shortening of cervical
length started from about 30 weeks.4
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Dijkstra et al. previously evaluated only women who delivered at term and
observed that African-American women had shorter cervices than women of
other ethnic groups.6 The current study evaluates a larger population including
preterm deliveries and confirms our previous findings at term.6 We now provide
strong evidence that cervical length measurements predict preterm birth at 20-24
weeks only among African-American women, who have shorter cervices at that
age than other racial/ethnic groups. For the other groups, shortening of the cervix
starts later and has a substantial relation to preterm birth when measured after 25
weeks in Hispanics and after 29 weeks in Caucasians and Asians. A short cervix
may provide a less effective barrier to ascending genital tract infections. This
observation may contribute to the far higher risk for infection-associated preterm
membrane rupture and preterm labor with intact membranes among African-
American women. In our study Hispanics for instance seem to have more reserve
capacity, because they start of with a longer cervix that shortens across gestation at
a slower rate. The Caucasian and Asian women in our study have the longest cer-
vices and the least gestational-age related shortening. This might give them a
lower risk of infection-associated prematurity. The reasons why African-American
women may have shorter cervices are unknown but could reflect biological (e.g.,
higher endogenous estradiol, polymorphisms in cytokine receptor genes) or envi-
ronmental factors. The latter may include increased stress, exposure to environ-
mental toxins, poor nutrition, and increased exposure to infectious agents. From a
practical perspective, our study suggests that the value of cervical length measure-
ments may be limited prior to 25 weeks in racial/ethnic groups other than
African-Americans and before 29 weeks among Caucasians and Asians. When
measuring cervical length by transvaginal sonography in order to assess risk for
preterm birth, consideration should be given to ethnic background when inter-
preting results.
Racial variation in cervical length
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Abstract
Objective. To determine whether the degree of cervical lengthening after cerclage
and whether serial follow-up measurements of cervical length after cerclage are
predictive of pregnancy outcome.
Methods. Eighty women whose primary physician determined that a prophylactic
(n = 50) or urgent cerclage (n = 30) was indicated had transvaginal ultrasono-
graphic evaluation before and after cerclage. Thereafter, most women had three
additional transvaginal ultrasound examinations until 32 weeks’ gestation. At
each examination, the mean of three measurements was calculated. Statistical
analyses were done by t-test, analysis of variance, and logistic regression, with sig-
nificance set at p < .05.
Results. The mean ± standard deviation precerclage cervical length was 27.2
(10.3 mm and after cerclage was 34.1 ± 9.9 mm (n = 80, p < .001, paired t test).
No significant association was found (r = -0.26) between the difference in cervi-
cal length (postcerclage - precerclage lengths) and pregnancy outcome. Patients
with a prophylactic cerclage had a mean cervical length that was consistently
longer in patients delivering at term compared with those who delivered preterm
at 20 to 32 weeks’ gestation. In the urgent cerclage group a significant difference
in cervical length between those who delivered at term compared with preterm
was evident only at 28 to 32 weeks.
Conclusion. The increase in cervical length after cerclage is not predictive of term
delivery. Serial cervical length measurements in the late second or early third
trimester predict preterm birth but could provide earlier warning in patients with
a prophylactic cerclage than in patients with urgent cerclage.
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Introduction
The measurement of cervical length by transvaginal ultrasonography has been
used to assess the risk of preterm delivery in women with poor obstetric histories,
potential preterm labor, cervical incompetence and multiple pregnancies. There
appears to be an inverse relationship between cervical length and risk of preterm
delivery.1-3 Women who have a cervical cerclage for suspected cervical incompe-
tence remain at increased risk for preterm labor and delivery. Historically, these
women were followed up after cerclage using digital or speculum examinations,
although some clinicians avoid vaginal examination.4
At present, the result of a cerclage procedure on cervical length can be viewed by
transvaginal ultrasonography. Studies of postelective cerclage have shown some
correlation with eventual pregnancy outcome.4,5 Andersen et al4 reported that a
short upper cervical segment before 30 weeks’ gestation was associated with a sig-
nificantly higher risk of preterm delivery before 36 weeks. Rana et al5 also report-
ed the importance of ultrasonographic follow up after cerclage. When early signs
of cerclage failure or funneling were detected, immediate intervention with hospi-
talization and tocolysis was undertaken which improved the final outcome of the
pregnancy.
Recent studies showed that prophylactic, urgent, and emergency cerclage proce-
dures resulted in measurable cervical lengthening.6-8 It is not known whether this
relative restoration of cervical anatomy after prophylactic or urgent cerclage pre-
dicts pregnancy outcome. Our purpose was to determine whether the degree of
cervical lengthening after cerclage predicts term delivery. The second aim of the
study was to evaluate the usefulness of serial measurements of cervical length
after cerclage, until 32 weeks’ gestation, to predict pregnancy outcome.
Materials and Methods
A prospective observational study was conducted using a protocol approved by
our institutional review board. All women treated with either a prophylactic or
urgent cerclage between January 1997 and July 1999 at the New York University
Medical Center, who had transvaginal ultrasonographic evaluation of the cervix
48 hours before cerclage and within 72 hours after cerclage were included in the
study (n = 80). Women who had an emergency cerclage were excluded. After cer-
Cervical shortening after cerclage
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clage, most women had three additional transvaginal ultrasound examinations
until 32 weeks’ gestation. Sonography was done at the New York University
Medical Center or Bellevue Hospital Perinatal Diagnostic Units. To minimize
interobserver variability, only one sonographer participated in the study at each
site, and each woman had cervical measurement at one site only. A maternal-fetal
medicine specialist reviewed all measurements.
Prophylactic cerclage (n = 50) was placed at 14.3 ± 2.8 weeks. The indication
was a history of cervical incompetence (based on one or more of the following
conditions: history of second-trimester pregnancy loss, history of diethylstilbestrol
(DES) exposure in utero, cervical conization, and uterine anomaly) or a history
of preterm birth with early cervical dilation without uterine contractions. An
urgent cerclage (n = 30) was placed at 19.7 ± 3.1 weeks in women with a cervical
length shorter than 25 mm confirmed by transvaginal ultrasound before 24 weeks’
gestation.
Cervical length, defined as the length of the closed endocervical canal, was meas-
ured by transvaginal sonography using a 7.0 MHz probe (Acuson EV7, Acuson
Corp., Mountain View, CA). In cases of cervical funneling, the apex of the funnel
was considered the beginning of the closed endocervical canal and the external os
was considered the distal end of the endocervical canal. In each case, after the
woman emptied her bladder, the probe was inserted into the vagina until it met
resistance. The probe was then withdrawn slightly to reduce compression, and
three measurements were taken. The mean of the three measurements was used
for analysis. None of the patients had contractions, bleeding, or discharge. None
received prophylactic tocolysis, but some received prophylactic antibiotics at the
discretion of the operator. In 65 patients, a modified Shirodkar procedure as
described by Frieden et al.9,10 was done. In 15 patients a McDonald cerclage11 was
placed, where the choice of suture material was left to the operator. Seventy sub-
jects were needed to achieve 80% power to detect a 30% difference in the rate of
preterm delivery, with α = .05. Cervical length measurements before and after
cerclage between 20-32 weeks were compared using paired t-test, analysis of vari-
ance, and logistic regression using JMP statistical software (SAS Institute, Cary,
NC).
94
Chapter 6
hoofdstuk 06  07-05-2002  09:58  Pagina 94
Results
Sociodemographic characteristics and obstetric histories of the study population
are shown in Table 1. No significant difference in baseline characteristics and in
precerclage and postcerclage measurements was noted between patients who had
Shirodkar compared with McDonald sutures. Mean gestational age at delivery
was 36 weeks and 4 days (95% confidence interval [CI], 35.4, 37.4), and mean
birth weight was 2760 g (95% CI, 2567, 2952 g). In total, 32 women (40%) had a
Cervical shortening after cerclage
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Race
Black 8 10
Asian 2 3
White 61 76
Hispanic 9 11
Parity
Nulliparous 48 60
Primiparous 17 21
Multiparous 15 19
History of cervical incompetence based on
one or more of following conditions: (n = 50)
Diethylstilbestrol exposure utero 6 8
Uterine anomaly 1 1
Cervical conization 2 3
Previous cerclage 11 14
Second trimester loss 47 59
Previous preterm birth 24 30
Type of pregnancy
Singleton 64 80
Twin 12 15
Triplet 4 5
Maternal age (year)
median 34 
(range) (22-46)
Table 1. Sociodemographic factors and obstetrical history of study population  
(n = 80).
Characteristic n %
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preterm birth (less than 37 completed weeks’ gestation), distributed in the same
proportion in women with a prophylactic and urgent cerclage. The reasons for
preterm birth were spontaneous preterm labor (ten women, 30%), preterm pre-
mature rupture of membranes (seven, 24%), induction for suspicion of intra
amniotic infection (three, 10%), indicated preterm birth (four, 12 %), planned
cesarean after determination of fetal lung maturity (four, 12%), and second-
trimester loss (four,12%).
The mean precerclage cervical length was 27.2 ± 10.3 mm, and the mean
postcerclage length was 34.1 ± 9.9 mm (n = 80, p < .001, paired t-test). There
was no significant association (r = -0.26) between the difference in cervical
length (postcerclage - precerclage length) and pregnancy outcome. A significant
relationship could be shown between gestational age at delivery and length of the
cervix between 28 and 32 weeks (r = 1.4, p = .002). Figure 1 shows a decrease in
96
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Figure 1. Comparison of the mean cervical length (in mm) before and after cerclage,
using 5 gestational age categories, in women who delivered preterm or at term.
Prophylactic and urgent cerclage groups were combined. Precerclage was meas-
ured between 15-20 weeks’ gestation; postcerclage was measured between 14
4/7 and 20 4/7; < 24 weeks was measured between the postcerclage measure-
ment and 24 weeks; 24-27 weeks; and 28-32 weeks. 
* p = .002
*
Delivery < 37 wks 
Delivery ≥ 37 wks
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cervical length over time in women who delivered before 37 weeks’ gestation. The
mean cervical length, measured between 28 and 32 weeks, was significantly dif-
ferent in women who delivered preterm compared with those who delivered at
term (21.0 ± 5.7 compared with 30.3 ± 9.5 mm, respectively; P = .002). The
mean standard deviation of all measurements shown in Figure 1 is ± 8.9 mm.
Table 2 shows the mean cervical length and standard deviation before and after
prophylactic and urgent cerclage. The association between cervical length before
and after cerclage with pregnancy outcome in the prophylactic cerclage group is
shown in Table 3. Cervical length before and after urgent cerclage related to preg-
Cervical shortening after cerclage
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Preoperative cervical length 31.4 (± 9.8) 20.1 (± 6.9) †
Postoperative cervical length 37.4 (± 9.5) 28.6 (± 8.3) ‡
Cervical difference (post-pre) 6.0 (± 7.5) 8.5 (± 5.9)
Mean cervical length (20 - 23 wk) 34.3 (± 9.1) 29.6 (± 8.3)
(n = 37) (n = 18)
Mean cervical length (24 - 27 wk) 31.4 (± 11) 26.2 (± 6.9)
(n = 28) (n = 25)
Mean cervical length (28 - 32 wk) 30.4 (± 10.9) 25.2 (± 7.4)
(n = 22) (n = 24)
Mean cervical length (> 32 wk) 33.5 (± 11.4) 24.0 (± 3.9) *
(n = 12) (n = 11)
Table 2. Comparison of cervical length measurements between prophylactic and
urgent cerclage (by t-test).
Prophylactic cerclage  Urgent cerclage
(n = 50) (n = 30)
Values are reported as mean and standard deviation in millimeters.
† p = .001
‡ p = .001
* p = .01
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nancy outcome is shown in Table 4. In the prophylactic cerclage group, the mean
cervical length was consistently longer in women who delivered at term compared
with those who delivered preterm at 20-23, 24-27, and 28-32 weeks’ gestation
(Table 3). However, in the urgent cerclage group a statistically significant differ-
ence in cervical length between those who delivered at term comparing to those
who delivered preterm was evident only at 28-32 weeks (Table 4).
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Preoperative cervical length 28.6 (± 9.9) 33.1 (± 9.9)
Postoperative cervical length 36.3 (± 9.0) 38.1 (± 9.9)
Cervical difference (post-pre) 7.6 (± 6.9) 5.0 (± 7.8)
Mean cervical length, (20 - 23 wk) 28.8 (± 5.8)§ 37.3 (± 9.2) †
(n = 13) (n = 24)
Mean cervical length, (24 - 27 wk) 23.3 (± 7.7) 34.7 (± 10.8) ‡
(n = 8) (n = 20)
Mean cervical length, (28 - 32 wk) 20.5 (± 5.6) 32.6 (±10.7) §
(n = 4) (n = 18)
Table 3. Comparison of cervical length measurements with pregnancy outcome in
women after a prophylactic cerclage (by t-test).
Preterm Term
< 37 wk  ≥ 37 wk
(n = 19) (n = 31)
Values are reported as mean and standard deviation in millimeters.
† p = .005
‡ p = .01
§ p = .04
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Preoperative cervical length 19.2 (± 6.1) 20.8 (± 7.6)
Postoperative cervical length 29.3 (± 7.4) 28.0 (± 9.1)
Cervical difference (post-pre) 10.1 (± 4.7) 7.2 (± 6.6)
Mean cervical length, (20 - 23 wk) 31.6 (± 6.8) 28.0 (± 9.3)
(n = 8) (n = 10)
Mean cervical length, (24 - 27 wk) 27.0 (± 6.1) 25.7 (± 10.8)
(n = 10) (n = 15)
Mean cervical length, (28 > 32 wk) 21.2 (± 6.1) 27.5 (± 7.3) *
(n = 9) (n = 15)
Table 4. Comparison of cervical length measurements with pregnancy outcome in
women after an urgent cerclage (by t test).
Preterm Term
< 37 wk  ≥ 37 wk
(n = 19) (n = 31)
Values are reported as mean and standard deviation in millimeters.
* p = .04
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Discussion
Both prophylactic and urgent cerclage resulted in a statistically significant
increase in cervical length. Contrary to our expectations, the degree of cervical
lengthening after cerclage did not contribute to the success of the procedure.
Serial postoperative examinations showed that progressive shortening of the
cervix between 24 to 32 weeks resulted in an increased risk of premature birth
compared with subjects whose cervix remained a relatively constant length during
the course of the pregnancy. Nevertheless, our cohort of patients delivered on
average near term, when neonatal morbidity would be expected to be low.
The effects of cerclage in women believed to have incompetent cervices have been
difficult to prove because many studies were limited because subjects were used as
their own controls.6,12 It is likely that the historical difficulty in diagnosis of the
incompetent cervix makes it difficult to identify patients who might benefit from
cerclage. Retrospective studies of cervical cerclage showed that cerclage increased
obstetric intervention, as judged by admission to hospital, use of oral beta-mimet-
ic agents, induction of labor, and cesarean delivery.13 A cerclage has an important
beneficial effect in a minority of pregnant women.13,14 One randomized con-
trolled trial has shown modest benefit in one in 25 operations, with a large 95%
CI (one in 12 to one in 300 procedures).12 That study, likely the largest to date,
used clinical uncertainty about placing a cerclage as the major eligibility criterion,
reflecting the lack of standardized diagnosis.
Others have reported increased cervical length after cerclage. Funai et al,6
Althuisius et al,7 and Guzman et al8 agreed that a perioperative change in cervical
length was a result of cerclage application. All described a significant cervical
lengthening varying from 27 to 36 mm in 31 patients after prophylactic cerclage,6
from 21 to 34 mm in 34 patients after urgent cerclage,7 and from 2 to 27 mm in 29
patients after emergency cerclage.8
The differences in the various studies are mostly based on operative technique,
method of ultrasonographic surveillance, indication for cerclage, and gestational
age at cerclage placement. In our study, a difference was noted between the mean
gestational at placement of a prophylactic cerclage and an urgent cerclage (14.3 ±
2.8 weeks compared with 19.7 ± 3.1 weeks). Andersen et al4 commented that
perioperative cervical length measurements can be affected by the exact place-
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ment of the suture and can be increased falsely by a cerclage placed near the exter-
nal os. Because of those results, we chose to measure only the length of the endo-
cervical canal.
We studied the effect of cervical lengthening after the 72-hour postoperative peri-
od to predict birth outcome, as did Guzman et al.8 They showed that all patients
continued to have progressive shortening of the upper cervix on serial postopera-
tive examinations, with this measurement being less than 10 mm before 28 weeks’
gestation in all patients. In our study, serial postoperative examination results
were similar, albeit only through measurements of the endocervical canal. The
patients with continued cervical shortening after cerclage had an increased risk of
premature birth compared with patients in whom the cervical length remained
relatively constant during pregnancy.
Although it is not known whether the cervix is shorter in women with a multiple
compared with a singleton pregnancy, we realize that women with multiple gesta-
tions have an increased risk of premature birth in comparison with singleton
pregnancies. The 12 patients with a twin pregnancy and four with triplet gesta-
tion did not have cerclage placement because of multiple gestation. The indica-
tion was based on a history of cervical incompetence or was predicated on cervical
shortening starting with a relatively short preoperative cervical length. However,
when those patients were excluded from analysis, the results were not significant-
ly different.
In both prophylactic and urgent cerclage groups there was a steady decrease in
cervical length in patients who delivered at term and in those who delivered
preterm. However, patients who delivered at term retained the postoperative
increase in cervical length longer. They showed a more modest decrease in length
over time compared with patients who delivered preterm. Further, in the prophy-
lactic cerclage group, there was a statistically significant difference across gesta-
tional age (20-32 weeks) in mean cervical length in patients who delivered at term
compared with those delivered preterm. However, in the urgent cerclage group no
statistically significant difference was noted until 28 to 32 weeks. Although serial
assessment of cervical length is a valuable tool in assessing the risk of premature
delivery, it might not be as useful a marker in patients who have urgent cerclage
until much later in gestation.
Cervical shortening after cerclage
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It is not known whether patients with significant shortening of the cervix have
other risk factors that influence the length of the cervix. Dijkstra et al15 showed
that black women, women with severe stress and women who are skilled manual
laborers had significant shortening of the cervix in the same period of gestation,
between 24 and 32 weeks. Unfortunately, the sample of African-American patients
with sufficient cervical length measurements was too small to draw any conclu-
sions. Information about stress and profession was not known in the present
cohort of patients.
The relative risk of premature delivery increases as cervical length becomes short-
er, so it is reasonable to hypothesize that prophylactic cerclage might reduce risk
by restoring cervical anatomy, and this could be a greater barrier to ascending
infection. In the present study, it was clear that the response of the cervix to cer-
clage, as defined by change in the length of the endocervical canal, did not predict
pregnancy outcome. After cerclage, serial cervical length measurements with
transvaginal sonography might be indicated to predict preterm birth if a progres-
sive shortening of cervical length is noted in the late second or early third
trimester. This shortening could alert the clinician to consider increased surveil-
lance for signs and symptoms of preterm labor, utilization of fetal fibronectin test-
ing, and limitation of physical activity. Also, one might consider corticosteroids to
hasten fetal lung maturation. Although an increase in cervical length after cer-
clage was not predictive of outcome, progressive cervical shortening after cerclage
was predictive of preterm delivery. It is not known why progressive cervical short-
ening occurs earlier in patients who have a prophylactic cerclage than in patients
who have urgent cerclage.
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Abstract
Objective. To study the management and views regarding threatened preterm
birth among the three professions providing obstetrical care in the Netherlands.
Method. A questionnaire was sent to a random sample of 30% of midwives, gen-
eral practitioners and representatives of all Dutch obstertrical gynecological prac-
tices addressing management and views on threatened preterm birth, mutual co-
operation and the Obstetric Indication List (‘Verloskundige Indicatie Lijst’ (VIL))
Results. The response of the midwives was: 72% (100/139), general practitioners
56% (89/159) and obstetrician/gynecologists 73% (86/118). In general, there
seemed to be consensus on the management of preterm birth among the three
groups. There was less agreement regarding the management of women with
‘contractions’ at 25/30 weeks, ‘suspicion of cervical incompetence’ at 25/30 and 35
gestational weeks and a prior conization in history. Seventy-five percent of both
the obstetrican/gynecologists and midwives agreed that obstetrical care of a cur-
rent pregnancy by a obstetrician gynecologist was indicated, when a prior preterm
birth had taken place < 34 weeks of gestation, while general practitioners defined
the borderline at < 35 weeks. The three professional groups were positive regard-
ing mutual co-operation and the ‘VIL’.
Conclusion. There seems to be agreement in the Netherlands regarding the risk
selection of preterm birth among the three professional groups active in obstetrical
care. The problem of preterm birth moved from < 37 to < 35 weeks. At this
moment the ‘VIL’ is better accepted than 10 years ago.
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Introduction
Preterm birth is a leading cause of neonatal morbidity and mortality. It is one of
the most important threats of the developing child.1-4 Preterm birth, defined as a
delivery before 37 completed weeks of gestation, complicates 7% of all births in
the Netherlands.5 Internationally the preterm birth rate increases, and also in the
Netherlands the percentage of preterm newborns admitted on a neonatal inten-
sive care unit increased slightly.4,6 The ability to predict whether a woman is at
risk of preterm delivery has only value, if an intervention is available that is likely
to improve the outcome. It has been shown, that beta-mimetics prolong pregnan-
cy, for an average of several days, allowing the administration of corticosteroids.7
The opportunity to administer corticosteroids to the mother is an important inter-
vention associated with decreased neonatal morbidity and mortality. Another rea-
son to identify women at risk for early preterm birth (before 32 weeks of gestation)
is to allow appropriate maternal transport to a tertiary perinatal care center for the
women being managed at general hospitals without appropriate neonatal care. It
is also important to identify women at low risk for PTB in order to prevent the use
of unnecessary interventions.
The Dutch obstetrical care system is unique in comparison with other western
countries.8,9 Low risk pregnant women (80%) receive obstetrical care provided by
midwives (80%) and general practitioners (20%).9-11 Thirty percent of all preg-
nant women still deliver at home.5,9,10 First line obstetrical care providers have to
make a reliable assessment to transpose the delivery to the hospital under their
own care, or refer to the obstetrician/gynecologists (further mentioned as ‘gyne-
cologists’), if medical or obstetrical problems (before, during or after the delivery)
take place (40%). The Obstetric Indication List (‘Verloskundige Indicatie Lijst’
(VIL) contains guidelines which mark the border between the first and second
line. It is a good source for risk selection in the Dutch obstetrical care. The guide-
lines in the VIL regarding preterm birth are only briefly described.12
The impression exists that there are different strategies and views regarding diag-
nosing and treating threatened preterm birth among and between the three pro-
fessional groups respectively, active in the Dutch obstetrical care.13,14 This study
aimed to answer the following questions. (1) What are the management and
views regarding threatened preterm birth among the three professions providing
obstetrical care in the Netherlands. (2) What are the views about mutual co-oper-
Preterm birth management in Netherlands
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ation and the acceptation of the VIL among midwives, general practitioners (pro-
viding obstetrical care) and gynecologists, on behalf of future guidelines for con-
sultation between the first and second line 
Methods
Design. An observational study was performed.
Study population. A random sample of (a) 30% of independent resided midwives
practices, (b) 30% of general practitioners practices active in obstetrical care and
(c) all representatives of the 118 Dutch gynecologists practices.
Data collection. A questionnaire was sent by mail addressing the following vari-
ables:
1. Characteristics of the various obstetrical care providers (age, sex, type of prac-
tice, type of hospital, obstetric experience, frequency of regional obstetric meet-
ings and urbanization grade).
2. Management of threatened preterm birth was measured with six written cases
(vignettes)15 concerning symptoms of spontaneous preterm birth (SPB) at dif-
ferent gestational age periods (25, 30 en 35 weeks); (answer categories:1a. no
consequences management in first line; 1b. consequences management within
first line; 2. consultation gynecologist; 3. referral gynecologist).
3. Views concerning the division of responsibilities between the first and second
line obstetrical care providers (6 items); (answer/categories: 1. first line obstetri-
cal care providers; 2. combination of first line obstetrical care provider and
gynecologist; 3. gynecologist). Besides, we asked for the boundaries of gesta-
tional age of a prior SPB, after which the prenatal care in the next pregnancy
can be provided by the first line caregivers, or has to be provided by the gyne-
cologist (answer categories 1: 33 wk to 5: 37 wk).
4. The views of the Obstetric Indication List guidelines (‘Verloskundige Indicatie
Lijst’ (VIL)) regarding threatened preterm birth, the acceptation of the VIL in
general (5 items) and the satisfaction regarding mutual co-operation (3 items);
(answer categories on a five-point Likert-type scale ranging from 1. entirely
disagree to 5. entirely agree).
Data entry. This was performed with an ‘optical reading’ system (Teleform) and
the statistical analyses were performed with SPSS. Control of data entry took
place with unlogical codes and missing data.
Analyses. First, frequencies and means of the characteristics of the three profes-
sional groups were calculated (x¯; sd). The management and views were handled
108
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as rank order scales. Correlation between the personal characteristics of the pro-
fessionals and their views and management were analyzed with Spearman rang
correlation  coefficient (rs). Correlations ≥ .25 were considered relevant (ana-
logue of the Pearson r: expected variance ≥ 5%). The ratings on the Likert type
answer categories were described with means ± standard deviation (x¯; sd).
Differences between the means were analyzed with ANOVA, and p < .05 was
considered significant.
Results
Response. From the sample of 139 midwives practices a total of 100 completed
questionnaires were returned (response rate 72%); 89 completed questionnaires
were sent back from the sample of 159 general practitioners practices active in
obstetrical care (56%), and from the 118 gynecologists practices 86 (73%) ques-
tionnaires were returned.
The most striking differences within the three professional groups were the
‘amount of deliveries per care ‘, the ‘frequency of participating in obstetric meet-
ings’ and the ‘degree of urbanization’ (Table 1). A strong association was found
between the answers at 25 and 30 gestational weeks (rs varied from .76 en .93; not
in table). In further analyses, the answers of 30 weeks were used as an indicator
for both gestational ages (Table 2). Seventy to ninety percent of the three profes-
sional groups stated that ‘unspecific abdominal complaints’ at 25/30 en 35 weeks
and ‘contractions’ at 35 weeks gestation belong in the first line. The three profes-
sional groups did not agree on the management for ‘contractions’ at 25/30 weeks,
‘a patient with fear because of a prior preterm birth’ and ‘a suspicion of cervical
incompetence’ at 25/30 and 35 gestational weeks. The midwives wanted to keep
more patients under their own care, in comparison to general practitioners and
more than the gynecologists expect. Seventy to ninety percent of the three profes-
sional groups stated that women with ‘vaginal bleeding’ and ‘rupture of mem-
branes’ unrelated to gestational age need to get their obstetrical care from the
gynecologist. There was no association between the (personal) characteristics of
the three professional groups and their management.
The majority of all three professional groups agreed that ‘DES-daughters without
anomalies’ belong in the first line and ‘DES-daughters with anomalies’ in the sec-
ond line. Regarding ‘conization in history’ there was no alignment within the
Preterm birth management in Netherlands
109
hoofdstuk 07  07-05-2002  09:58  Pagina 109
three professional groups (Table 3). Seventy-five percent of the gynecologists and
midwives agreed that obstetrical care of a current pregnancy by a gynecologist was
indicated, when a prior preterm birth had taken place < 34 weeks of gestation,
and general practitioners defined the borderline at < 35 weeks (Figure 1).
Seventy-eight percent of the first line care providers and 74% of the gynecologist
stated that they accept the ‘VIL’ in total. However, 30% of the midwives and the
gynecologists did not agree upon the guidelines for threatened preterm birth in
110
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Practice Hospital
Solo 28 54 Gen. (without residency)   59
Duo 21 34 Gen. (with residency)        33
Group 51 12 University                             8
Sex
Male 3 84 74
Female 97 16 26
Age/years (x¯; sd) 40 (10.9) 47 (5.8) 48 (7.6)
Deliveries/year Self/direct     Indirect
0-29 - 77 38                 17
30-49 2 18 8                  12
50-100 24 5 14                 14
>100 74 - 40                 57
Grade of urbanization
Municipal area 41 4 75
Urban area 29 5 17
Rural area 30 91 8
Participation in district obstetrical meetings
≥ 1x / 6week 92 34 71
1x / 6month 8 18 26
≤ 1x / year/never - 48 3
Table 1. Characteristics of midwives, (mw; n=100), general practitioners (gp;
n=89)*) and gynecologists (gyn; n=86) in %.
mw gp gyn
*) With ‘gp’ in text and tables we mean a general practitioner practicing obstetrics. 
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the ‘VIL’. The first line care providers - the general practitioners more than the
midwives - were in general satisfied with the mutual co-operation with the gyne-
cologists (x(sd): 4.1(.9), respectively 3,7(1.0); p = .03) and vice versa: satisfaction of
gynecologists of co-operation with general practitioners practicing obstetrics and
with midwives (3.6(.8), respectively 3,9(.8); p = .03). The general practitioners
practicing obstetrics were more satisfied with the co-operation of midwives, than
the other way around (3.5 (1.1) and 2,8 (1.3) respectively; p = .02).
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DES-daughter without mw 80 16 4
uterus-abnormalities gp 66 28 6
gyn 75 18 7
Conization in history mw 34 37 29
(because of abnormal cervix cytology) gp 36 43 21
gyn 26 38 36
Preterm birth in history mw 30 30 40
(with ruptured membranes gp 19 62 19
at 28 weeks gestation) gyn 10 30 60
DES-daughter with mw 4 28 68
uterus-abnormalities gp 3 35 62
gyn 2 28 70
Table 3. Frequencies (in %) of the views of first line care providers (midwives and
general practitioners) and second line (gynecologist) regarding the division
of responsibilities between the first and second line. Who is responsible for
the prenatal/obstetric controls of the following pregnancy of a woman with
a complicated obstetrical or gynecological history? (mw, n=100; gp, n=89;
gyn, n=86).
First Co-operation Second 
line first and line
second line
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Conclusion
In general, there seemed to be consensus about the management of preterm birth
among the three professional groups. With symptoms of threatened preterm birth
at 35 weeks there are less referrals to the gynecologist than earlier in the pregnan-
cy. The three professional groups agree that the problem of preterm birth is not
longer at a gestational age of < 37 weeks but has moved to < 35 weeks.
Furthermore, the view of the three professional groups regarding the ‘VIL’ was
positive.
The response of midwives and gynecologiststo the questionnaire is satisfying The
response of the general practitioners was moderate. The respondents did not dif-
fer from the professional groups relating to age, sex and urbanization grade.16-19
The group of solo working midwives and general practitioners responded slightly
more often compared to their colleagues in group practices. The response of the
gynecologists from the residency hospitals was higher than from the total group of
general hospitals without residency programs. Until now, the management and
Preterm birth management in Netherlands
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Figure 1. Endorsement of the three professional groups with the statement that obstetri-
cal care of a current pregnancy by a gynecologist was indicated, when a prior
preterm birth had taken place from < 33 weeks till < 37 weeks (percentages)
(vk=midwive, n=70; ha=general practitioner, n=75; gyn, n=75).
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views regarding threatened preterm birth has not been researched before in the
Netherlands. Since it was the purpose of our study to describe strategies and pos-
sible dilemmas in this field, the vignettes method was appropriate. Although this
method does not present the actual behavior of the respondents accurately, it does
show differences among and between the three professional groups. Further
research on process and outcome of management of the three professional groups
requests prognostic data collection.
Early preterm birth at 25 and 30 weeks can have serious consequences. In general,
there seemed to be consensus among the three professional groups that at these
gestational ages women with symptoms of ‘contractions’, ‘vaginal bleeding’ and
‘rupture of membranes’ need to be under care of the gynecologist. Symptoms of
‘vaginal bleeding’ and ‘rupture of membranes’ at 35 weeks also belonged in the
second line. Late preterm birth that occur above 35 weeks of gestation, is not like-
ly to have major effect on perinatal outcome and treatment as tocolytics does not
take place anymore. There is a discussion within and between the three profes-
sional groups, which  have to be responsible for the care of women with ‘preterm
contractions’, symptoms with ‘a suspicion of cervical incompetence’ and women
with ‘fear because of a prior preterm birth’ at 25/30 gestational weeks. This is
probably caused by the sometimes unclear and less specific symptoms of threat-
ened preterm birth. Kragt et al. described the prognostic value of symptoms relat-
ing to SPB of all pregnant women, who consulted the gynecologist with symp-
toms of threatened preterm birth. Uncertainty of diagnosis occurred in 40% of the
cases of threatened preterm birth.14 Hopefully new predictive tests, as fetal
fibronectin, in cervico-vaginal secretions,20-22 bacterial vaginosis23 and ultrasono-
graphic assessment of the length of the cervix24 will have added value in predict-
ing and diagnosing preterm birth.25
About 75%  of responding gynecologists and midwives agreed that obstetrical care
of a current pregnancy was indicated by a gynecologist, when a prior preterm
birth had taken place < 34 weeks of gestation, and for the general practitioners it
was < 35 weeks. Several authors studied the recurrent risk of preterm delivery.26-
28 Especially for the early (20-31 weeks) prior preterm birth there is a higher risk
of a singleton preterm delivery in the following pregnancy. For women who deliv-
ered their first newborns at 32 to 36 weeks, the crude rate of recurrent preterm
delivery declined moderately.28
114
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In general, there seems to be agreement about the management among the three
professional groups. However, there are some differences between the first line
care providers. The general practitioners consult and refer to the gynecologist
more often than the midwives. In general the professional groups are satisfied
with the mutual co-operation. The co-operation between the general practitioners
and midwives seems less satisfying, which might be a result of the different posi-
tions of these professional groups and may be because of an insurance problem,
‘de primaatkwestie’. We expect the mutual co-operation will improve in the
future, since, the biggest differences in views between the midwives and general
practitioners are  behind us and the ‘primaatkwestie’ is abandoned since July
2001.  At this moment co-operations between midwives and general practitioners
are established to stand together to maintain the possibility of home delivery in
the Netherlands. Hopefully this will also lead to regular attendance of the general
practitioners at the district obstetrical meetings. At this moment the ‘VIL’ is better
accepted than 10 years ago, especially by the gynecologists (74% in comparison
with 37% in 1991).19 The three professional groups do not fully agree with the less
specified guidelines regarding threatened preterm birth in the ‘VIL’.
This study was conducted in a time period that there are still doubts about the
best diagnostics and treatment regarding threatened preterm birth. Guidelines
based on evidence are hardly available yet, but this is an ongoing process. In our
study there is agreement regarding the risk selection of women with symptoms of
threatened preterm birth. Our findings can hopefully be used for new guidelines
regarding threatened preterm birth in the Netherlands.25 The Dutch system of
obstetrical care is based on the continuous assessment of risk. Appropriate risk-
selection is important to maintain our unique system with the possibilities of
home deliveries, which is under pressure at the moment. The midwives already
got governmental aid of the ministry of Health (‘VWS’). Hopefully, the general
practitioners working in the rural areas will also be able to maintain this part of
their job in the future. This is also dependent on the investments in education
and logistics for the general practitioners that wants to practice obstetrics.
Preterm birth management in Netherlands
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Abstract
Objective. To describe how Dutch gynecologists implement ‘modern’ diagnostic
tests and treatments in cases of threatened preterm birth.
Method. A questionnaire was sent by mail to representatives from all Dutch gyne-
cological practices addressing diagnosis and treatment management of threatened
preterm birth. Correlation between personal characteristics of the gynecologists
their management, and their views were analyzed with the Spearman rang corre-
lationcoefficient (rs).
Results. The response rate was 72% (85/118), and showed variation in manage-
ment style; cervical length measurements as well as testing for bacterial vaginosis
were frequently done (50-80% of the gynecologists reported to do so) and treated
BV in cases of a positive result. Fetal fibronectin testing, however, was hardly
used. Tocolytics and corticosteroids were frequently given to women with preterm
membrane ruptures without labor, while antibiotics were rarely prescribed. There
was a correlation between working in hospitals with and without residency pro-
grams and different management approaches. Gynecologists working in hospitals
without residency programs administered tocolytics and repeated corticosteroid
treatment more frequently and prescribed less antibiotics to women with preterm
membrane ruptures than those working in hospitals with residency programs.
Conclusion. Standardized use of ‘modern’ diagnostic tests and treatment modali-
ties for threatened preterm birth is lacking among Dutch gynecologists.
120
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Introduction
Preterm birth is a leading cause of neonatal morbidity and mortality, and one of
the most important health threats to the developing child.1-4 Preterm birth,
defined as delivery before 37 completed weeks of gestation, complicates 10% of all
hospital births in the Netherlands.5-7 Internationally the preterm birth rate
increases, and also in the Netherlands the percentage of preterm newborns admit-
ted to a neonatal intensive care unit increased.1,5
Until now it is unclear which diagnostic and treatment methods for threatened
preterm birth are appropriate.1,8,9 This is probably caused by the less obvious
symptoms of threatened preterm birth. Kragt et al. described the prognostic value
of symptoms relating to spontaneous preterm birth (SPB) and of all pregnant
women, who consulted the gynecologist with symptoms of threatened preterm
birth.9 In 35% of the cases the SPB diagnosis was confirmed immediately (26%
actually delivered within 48 hours and 9 % had a short delay by tocolytics). In
25% of the patients there was no question of SPB and the women could safely
return home. Uncertainty of diagnosis occurred in 40 % of the cases of threatened
preterm birth.9 These patients were admitted to the hospital, and may have
received unnecessary tocolytic and/or corticosteroid treatment.
The principle objective of new diagnostic methods is to identify and treat the
women at high risk of SPB in time, it is also important to avoid unnecessary inter-
ventions. With this background, the guidelines regarding threatened preterm
birth are briefly described in the Obstetric Indication List (‘VIL’).10 The Dutch
College of Obstetrics and Gynecology (‘NVOG’) provided guidelines in 1997 for
using tocolytics and includes a few sentences on methods for predicting SPB.11
How these guidelines are implemented in clinical practice remain unclear. This
study aimed to answer three questions. (1) Do the Dutch obstetrician/gynecolo-
gists (further mentioned as ‘gynecologists’) use new diagnostic methods (fetal
fibronectin, bacterial vaginosis and ultrasonographic assessment of the cervical
length) to identify the women at high risk of SPB? (2) What are the gynecologists’
views regarding appropriate diagnostic methods and interventions for SPB? (3)
Are there differences in management approaches by gynecologists from hospitals
with residency programs compared to gynecologists from general hospitals with-
out residency programs?
Utility of dagnostic tests for Preterm Birth
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Methods
Design. An observational study was performed.
Study population. All representatives from the 118 Dutch gynecological practices.
Data collection. Representatives were sent a questionnaire that addressed the fol-
lowing variables:
1. Characteristics of the gynecologists: age, sex, hospital with residency program
(yes/no), obstetric experience (number of deliveries per year).
2. In three patient groups with high risk of SPB (‘prior preterm birth’ ‘conization
in history’ and ‘multiple gestation’), was asked which new diagnostic methods
were used (ultrasonographic assessment of cervical length, fetal fibronectin
testing in cervicovaginal secretions (FFN) and testing of bacterial vaginosis
(BV)). Response options were 1: often, 2: only at indication or 3: never. In addi-
tion, an open question about the treatment of bacterial vaginosis was asked.
3. In two cases (primigravid who works as a resident and a multigravid with a
complicated obstetrical history) with contractions varying in presentation the
use of ultrasonographic assessment of cervical length, fetal fibronectin testing
and the advise regards working (stop working or continue part-time) was asked.
4. In two cases questions were asked on the management and treatment (admis-
sion, tocolytic-, antibiotic- and corticosteroid use) regarding the clinical situa-
tions of ‘preterm rupture membranes (PROM) without contractions’ and
‘triplet pregnancy with some contractions’ both at 28 weeks gestation.
Data entry. Data entry was performed with an ‘optical reading’ system (Teleform)
and the statistical analyses were performed with SPSS. Control of data entry took
place with unlogical codes and missing data.
Analyses. Frequencies of the characteristics of the responding gynecologists were
calculated (x¯; sd). The views and management in the written cases were presented
according to the main characteristics of the cases (frequencies). The correlation
between the personal characteristics of the professionals, their views and manage-
ment approach were analyzed with the Spearman rang correlation coefficient (rs).
Correlations ≥ .25 (with a p-value < .05) were considered relevant (analogue of
the Pearson r: expected variance ≥ 5%).
Results
Response. From 118 gynecological practices, 85 (73%) questionnaires were
returned. More than half of the gynecologists work in a hospital without a resi-
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dency program. One out of four gynecologists were female. Other characteristics
are shown in Table 1. About 80% of the gynecologists used ultrasonographic
assessment of cervical length for women in all three patient groups at risk for SPB
(Table 2). About half of the gynecologists responded that they only used ultra-
sonography ‘at indication’. Fetal fibronectin (FFN) was used by 10% of the gyne-
cologists, but ‘only at indication’. They often tested for bacterial vaginosis (BV),
(50 to 80%, depending on the patient group), especially in patients with a prior
preterm birth. The use of a diagnostic method (cervical length measurements,
fetal fibronectin testing and bacterial vaginosis) in one patient group was correlat-
ed with the use of the same diagnostic method in the two other patient groups at
risk for SPB. (rs varied from .36 - .66). There was no correlation between the use
of these diagnostic methods and practicing in a hospital with or without a resi-
dency program.
When the gynecologists looked for vaginal infections, they diagnosed BV by gram
stain (63%), by microscopic examination (15%), by a combination of gram stain
and microscopic examination (18%), and by the Nugent score with or without
Utility of dagnostic tests for Preterm Birth
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Hospital
General (without residency) 59
General (with residency) 33
University (with residency) 8
Sex
Male 74
Female 26
Average age (sd) 48 (7.6)
Deliveries/year Self/direct     Indirect
0-29 39                 16
30-49 8                  12
50-100 14                 14
>100 39                 58
Table 1. Characteristics of gynecologists (n=85).
Gynecologists
(%)
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combination of microscopic examination (4%).12 Eighty percent of the gynecolo-
gists actually treated BV. First choice antibiotics were metronidazole (71%), clin-
damycin (13%) amoxicillin/clavulanic acid (9%), amoxicillin (3%), ampicillin
(2%), erythromycin (2%). Most respondents did not specify how the drug was
administered (oral or local). Treating or not treating BV was associated with the
type of hospital where the gynecologists work (rs = .26). Gynecologists practicing
in hospitals with a residency program treated BV more frequently than those
practicing in hospitals without a residency program. Cervical length measure-
ment was commonly used, however, FFN was rarely used in the two cases of
women with contractions (Table 3). For both indication groups (primigravid and
multigravid), the gynecologists advised the patients to stop working or go part-
time.
All gynecologists reported that they admit to hospital all women with ‘preterm
membrane ruptures without contractions’ and 81% admitted ‘triplet pregnancy
cases with some contractions’, both at 28 weeks gestation. The management var-
ied greatly after admission (Table 4). Forty percent reported to administer prophy-
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Prior preterm birth 48 33 19
Cervical length Conization in history 39 38 23
measurements Multiple gestation 24 53 23
Prior preterm birth - 12 88
Fetal fibronectin Conization in history - 8 92
testing Multiple gestation - 7 93
Prior preterm birth 41 41 18
Bacterial vaginosis Conization in history 4 46 50
testing Multiple gestation 15 46 39
Table 2. Frequencies (%) of utilizing modern diagnostic methods (on a regular
basis) for (1) pregnant women with an early prior preterm birth, (2) primi-
gravid with a conization in history (3) women with a multiple gestation
(n=85). 
Often Only at Never
indication
(%) (%) (%)
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lactic tocolytics in both above-mentioned cases and 26% routinely treated the first
case with antibiotics, but none did so in the latter case. In the case of ‘preterm
membrane ruptures without contractions’ almost all the gynecologists prescribed
corticosteroids to increase fetal lung maturity; 71% repeated this treatment after 1-
2 weeks if women had not yet delivered. They administered prophylactic and
repeated corticosteroids to a lesser degree (67% respectively 56%) in women with
‘triplet pregnancy with some contractions’.
There were correlations between the type of hospital in which gynecologists were
practicing and the management approach after admission. Gynecologists in hos-
pitals with residency programs gave less prophylactic tocolytics in comparison to
their colleagues in the general hospitals without residency programs (rs = .27), in
the first case. Gynecologists who reported to administer tocolytics, repeated corti-
Utility of dagnostic tests for Preterm Birth
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Contractions Contractions 
primigravid multigravid
(resident) (with cerclage)
yes 52 82
Cervical length measurements
no 48 18
yes 1 6
Fetal fibronectin testing
no 99 94
Advised to stop working yes part-time  61 part-time  16
or go part-time stop   26 stop    84
no 13 -
Table 3. Frequencies (in %) regarding the management of contractions varying in
presentation in (1) a primigravid working as an internal medicine resident
in your hospital (2) a multigravid with a complicated obstetrical history (2x
immature delivery) and a cerclage in this pregnancy (n=85). (EGA = esti-
mated gestational age.) 
EGA 29 wk EGA 24 wk
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costeroid treatment more frequently (rs = .25). Gynecologists in hospitals with
residency programs where less likely to repeat corticosteroid administration in
comparison to their colleagues in the general hospitals without residency pro-
grams (rs = .28). Corticosteroid administration was also repeated more frequently
in women with triplet gestation by gynecologists in general hospitals without resi-
dency programs (rs = .37). There was also an association between administering
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PROM Triplet pregnancy 
without with some
contractions contractions
Admission yes 100 81
no - 19
Prophylactic yes 40 38
tocolytics no 60 62
(n=29) until EGA (mean ± sd) 33.3 ± 1.5 33.5 ± 0.9
Routine yes 26 -
antibiotics no 74 100
(n=17) from EGA(mean ± sd) 26.6 ± 2.1 NA
until EGA (mean ± sd) 32.1 ± 2.6
Prophylactic yes 94 67
corticosteroids no 6 33
Repeated yes 71 56
corticosteroids no 29 44
(n=50) after 1wk 56 50
after 2 wks 44 50
(n=46) until EGA (mean ± sd) 32.9 ± 1.3 30.8 ± 1.1
Table 4. Frequencies (in %) regarding management of (1) a pregnant woman
(G3P2: prior preterm birth (32 weeks) and 1 term pregnancy) with preterm
rupture of membranes (PROM) without contractions at 28 weeks and (2) a
triplet pregnancy (G1P0) after IVF, with some contractions at 28 weeks.
(EGA = estimated gestational age; sd = standard deviation)
EGA 28 wk EGA 28 wk
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tocolytics and an initial (rs = .43) or repeat (rs = .38) treatment of corticosteroids.
Antibiotics were given more often by younger gynecologists (rs = .28) and by
gynecologists in hospitals with residency programs (rs = .29).
Conclusion
The study contains three key findings. Firstly, there is a variation in management
regarding preterm birth; cervical length and bacterial vaginosis were assessed
more often in contrast with the fetal fibronectin testing in cervicovaginal secre-
tions. Secondly, the treatment of BV, tocolytics and corticosteroids treatments were
used frequently, while only one of the four gynecologists gave antibiotics to
women with ‘preterm membrane ruptures without contractions’. Thirdly, a clear
difference exists in management approach between gynecologists working in hos-
pitals with or without residency programs. Gynecologists in general hospitals
without residents administer tocolytics frequently, repeated corticosteroid treat-
ment more often, and gave fewer antibiotics for BV or preterm membrane rup-
tures.
With this study we aim to give insight into the management approach of Dutch
gynecologists concerning the obstetrical problem of spontaneous preterm birth.
The response rate from the gynecologists on the questionnaire is satisfying. The
responding gynecologists did not differ from the Dutch gynecologists in areas of
age, sex, and deliveries per year. The number of responses from the gynecologists
of the residency hospitals was slightly higher than from the total group of general
hospitals without residency programs.13 We assume that our study accurately
reflects the current situation in the Netherlands.
The Dutch gynecologists frequently measure cervical length with transvaginal
ultrasonography. This is understandable since this method has extensively been
described in the literature. An inverse association between a short cervical length
and an increased risk of spontaneous delivery is shown - both in symptomatic and
asymptomatic patients - with singleton gestations.14-16 Uncertainty exists regard-
ing the therapeutic consequences of this diagnostic method. Currently, only in
women with a suspicion of cervical incompetence measurement of the cervical
length - and when indicated a cerclage - is considered useful.17 At this moment a
large randomized controlled trial is taking place on the possible therapeutic con-
sequences of a ‘accidentally found’ short cervix in an uncomplicated population.
Utility of dagnostic tests for Preterm Birth
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A positive contribution of the cervical length measurement to the pregnancy out-
come is until now not demonstrated in the indication fields of preterm contrac-
tions or multiple gestations. In several studies a cervical length of < 30 mm was
found to be the best cut-off for predicting a preterm delivery. For women with risk
factors of SPB, a cut-off of 25 mm was often employed. The presence of funneling
does not contribute to only measuring the length of the cervix in the prediction of
SPB.16
Screening of fetal fibronectin (FFN) in cervico-vaginal secretions is infrequent in
Dutch obstetrical practice. This is remarkable since the presence of cervico-vagi-
nal fetal fibronectin was found to predict SPB in women with preterm uterine
contractions and in asymptomatic patients.18-20 The high negative predictive
value in asymptomatic and symptomatic women is especially important in provid-
ing strong reassurance that delivery will not occur within 7 days in more than
99% of the cases and that these women will not give birth for 14 days in 95% of
the cases.20 Several investigators have shown that a negative fetal fibronectin test
when presenting with symptoms of threatened preterm birth is associated with a
reduction in preterm labor admissions, length of stay, prescriptions for tocolytic
agents, and consequently to an overall cost-reduction.21,22 The clinical utility of
this test is obvious: women who are seen for evaluation of possible preterm labor
(unspecific abdominal complaints, moderate contractions and a cervical dilata-
tion < 3 cm) may be screened by fetal fibronectin. Those testing positive are then
admitted for additional observation and treatment. Our data suggest that patients
with a negative test result can be safely observed in the outpatient setting for 7-14
days. A positive FFN-test and a short cervical length (< 25 mm) together seem to
be good predictors of SPB.23
Dutch gynecologists report high bacterial vaginosis testing and 80% of them start
treatment after a positive test result. The treatment of choice is metronidazole and
this was used by 7 of the 10 Dutch gynecologists. A standardized scoring system
for the diagnosis of BV, the so called Nugent-score is seldom used in the
Netherlands.12 Bacterial vaginosis is seen as a condition in which the normal
vaginal microflora and lactobacilli are replaced by a polymicrobial overgrowth of
anaerobes and gardnerella. BV is associated with an increased risk of preterm
membrane ruptures (odds ratio: 7.3),24,25 low birthweight,26 and spontaneous
preterm birth (odds ratios ranging from 1.8 to 2.8).27,28 In some studies, the use of
oral antibiotics (metronidazole or clindamycin) to treat women with BV who are
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at risk for SPB (e.g. prior PTB) has resulted in a reduction of the SPB rate and in
pregnancy-associated morbidity. This does not apply to local treatment.28-30
Prophylactic treatment in low-risk women or in high-risk women without BV is
not indicated because it may change the normal vaginal flora to an intermediate
type or to bacterial vaginosis which may increase the risk of preterm birth.14,30
From the literature, we conclude that, at this moment, it is only recommended to
treat women who have had a prior preterm birth with actual presence of BV with
oral antibiotics (e.g. metronidazole).
The Dutch gynecologists utilize treatment modalities for threatened preterm
birth differently. What was striking is that 40% of the gynecologists administered
prophylactic tocolytics in preterm membrane ruptures without contractions.
While prophylactic tocolytic use can cause desensitization of the uterus muscle.
The gynecologists frequently prescribe (single or repeat courses) corticosteroids to
increase fetal lung maturity.31 More frequently in the case of preterm membrane
ruptures than in the triplet pregnancy with some contractions. Another notable
point is 1 out of 4 gynecologists gave antibiotics to woman with rupture of mem-
branes. Furthermore, we found correlations between the type of hospital in which
the gynecologists practice and the management of the cases after admission.
Gynecologists in hospitals with residency programs gave less prophylactic tocolyt-
ics and repeated more corticosteroid treatment than their colleagues in the general
hospitals without residency programs, who gave more antibiotics for woman with
ruptured membranes.
The views regarding corticosteroid use in the Netherlands is quite similar to the
other 14 European countries.32 Antenatal corticosteroid treatment usually takes
place between 25 and 34 weeks of gestation. Eighty-seven percent of the
European gynecologists use more than one course of the drugs in cases of persist-
ing active labor. The current benefit and risk data are insufficient to support rou-
tine use or repeat courses of antenatal corticosteroid in clinical practice.32
Recently, a randomized trial was published on the use of erythromycin in women
with preterm rupture of membranes for prolonging the pregnancy, for reducing
maternal infection and for improving neonatal health with a probable reduction
in childhood disability.33 These results were not yet published while our study
took place. Although antibiotics for women with preterm rupture of membranes
have been used for many years and they seem to prolong the pregnancy and
decrease neonatal morbidity, the Cochrane review recommended not to use this
Utility of dagnostic tests for Preterm Birth
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treatment yet.34 The gynecologists from the hospitals with a residency program
led the way in comparison to the gynecologists in the general hospitals without
residency programs.
We conclude that the diagnostic methods and treatment modalities in threatened
preterm birth are only slightly standardized. We encourage the Dutch College of
Obstetrics and Gynecology (‘NVOG’) to create new guidelines regarding for pre-
dicting and treating threatened preterm birth.
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Preterm birth is a leading cause of neonatal morbidity and mortality. It is a major
goal in obstetrics to lower the incidence of spontaneous preterm birth (SPB) and
related neonatal morbidity and mortality. One of the principal objectives is to dis-
cover early markers that would allow us to identify subgroups of patients at high
risk of SPB and, secondly, to manage those patients with an appropriate and effec-
tive strategy.
This thesis consisted of two parts. The first part included the etiology and risk
assessment of SPB. The aims of the studies described in this part were to evaluate
which predictive tests are appropriate to use to identify women at risk for SPB and
what factors influence these tests, in particular related to the assessment of cervi-
cal length. In the second part we described the strategies which are used regarding
threatened SPB in Dutch obstetric care.
Part 1. Etiology and risk assessment of spontaneous preterm birth
In chapter 2 we present the mechanisms contributing to SPB, which - mainly -
have been identified during the past decade.1 SPB may result from one of the four
primary pathogenic mechanisms, or from a combination: (1) activation of the
maternal or fetal HPA axis; (2) inflammation (of ascending genital tract, systemic
or chorion/decidual); (3) decidual hemorrhage and (4) pathologic distention of
the uterus. Recent evidence suggests that the four pathways are active at different
gestational periods. The majority of very early (before 30 weeks of gestation)
spontaneous preterm births seems to be associated with ascending genital tract
infections.2,3 Later SPB can be caused either by the hormonal pathway, due to
decidual hemorrhage, or due to mechanical stretching of the myometrium caused
by increase in uterine size. However, SPB is often caused by a combination of fac-
tors. Each pathway has a distinct epidemiological profile and biochemical signa-
ture, but shares a common final pathway leading to myometrial contractions, rup-
ture of membranes, cervical change and finally to SPB. The observation that sev-
eral pathways are involved in its pathogenesis may explain why preterm delivery
has proven so difficult to predict and prevent. The elaboration of these pathogenic
mechanisms has led to the belief that biologic markers associated with the specific
pathways involved might be useful predictors of preterm birth. During the past
decade, there has been an explosion of research papers that examined the useful-
ness of mediators (cytokines, hormones, enzymes, proteases) of these diverse bio-
chemical pathways as new predictive tests for SPB.
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The review in the second part of chapter 2 describes the usefulness of new bio-
chemical fluid markers to identify women at risk for SPB and their preferred ges-
tational period of sampling. After looking attentively at various studies, we deter-
mined that the predictive value of all described biochemical fluid markers is rela-
tively close to - although often somewhat higher - than that of the ones used until
now. The low predictive value of these pathway-specific markers can be
explained, in large part, by the multi-factorial pathogenesis of SPB. Markers asso-
ciated with the common final pathways of SPB - uterine contractions monitoring,
fetal fibronectin (FFN) expression and cervical length assessment - have been
proposed as another approach to predict SPB. Some of these markers are already
used in clinical practice, while their predictive value is not yet established in clini-
cal practice. It is our objective to give recommendations for the clinical practice,
both for a general population and the population at risk for SPB. 
General population (without a prior history of SPB or other risk factors
for SPB):
* There are no current data to support the use of salivary estriol, home uter-
ine monitoring, or bacterial vaginosis (BV) screening as strategies to iden-
tify or prevent preterm birth.
* For other biochemical markers (e.g., corticotropin-releasing hormone
(CRH), maternal serum alpha-fetoprotein (MSAFP), interleukine-6 (Il-
6) and granulocyte colony-stimulating factor (G-CSF)) larger studies are
needed.
* In the general population no other risk factors than the obstetric history
has proven to be effective.
Summary and Discussion
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Population at risk (with risk factors for SPB or symptoms with threatened
SPB):
* Transvaginal ultrasonography (TVS) to determine cervical length and
FFN testing, or a combination of both is likely to be useful in determin-
ing women at high risk for preterm labor. However, their clinical useful-
ness may rest primarily with their high negative predictive value, thereby
avoiding unnecessary intervention.
* For other biochemical markers (for instance CRH, MSAFP, Il-6, G-CSF)
larger studies are needed.
* Only treatment with oral antibiotics (metronidazole with or without ery-
trhomycine) of women with BV and with a history of prior SPB might
result in a reduction of SPB. Prophylactic treatment in women at risk for
SPB, but without BV is not indicated.
Our recommendations are quite similar to the recently published guidelines by
the American College of Obstetrics and Gynecology (ACOG).5,6 It is important to
examine the diagnostic value of a test in the population (high risk versus low risk)
where the test is used for. In the review of the predictors of SPB, we choose to
show the sensitivity, specificity, positive and negative predictive values and when
available the likelihood ratio. A limitation of the studies is the use of predictive
values to compare studies and tests, because the prevalences can differ greatly
between populations. The likelihood ratio indicates by how much a given test
result will raise or lower the probability of having the event that the test is
designed to predict.7 We must point out that many authors erroneously conclude
that tests have a good diagnostic value. Khan et al. reviewed 14 prospective studies
about the prediction of SPB by FFN.4 They observed that authors’ conclusions
about the diagnostic value of FFN met the gold standard in only 26% of cases and
that 66% of the authors overestimated the diagnostic value of their test. Mainly,
because of an inadequate assessment of reliability and validity of new tests. It may
also arise from overenthusiastic recommendations by authors of diagnostic test
studies. It is not uncommon that new tests (for instance salivary estriol) are widely
introduced and then failed as a significant advance in health care.8
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New markers used in a general or selected population must be easy to test, inex-
pensive, and reproducible for physicians in daily practice. We recommend for
future research to develop a model to predict SPB in which the predictive value of
medical history, physical examination and additional diagnostic tests are incorpo-
rated. We suggest using various predictors for SPB separately, but also com-
bined.Future research and intervention trials are needed to evaluate which combi-
nation of tests through artificial neural networks will be most successful in pre-
dicting SPB. By using multiple pathway-specific biochemical markers, we may be
able to identify asymptomatic patients destined to deliver preterm, and to identify
the precise etiology accounting for their risk to better target therapy. Goldenberg
et al. found a small degree of overlap among predictive markers in women who
delivered preterm.9 This confirms our opinion that there are several pathways
that lead to spontaneous preterm birth. It suggests that the use of several biologic
markers together might be useful in the creation of a multiple-marker test.
Furthermore, to provide answers about the utility of new markers, evaluation of
the advantages and disadvantages of the use of the diagnostic tests in everyday
practice, is needed. The only way to convince practitioners that a new marker is
more effective than those they habitually use is to compare their diagnostic values
in a prospective study of the same patients. 
The usefulness of possible novel markers matrix metalloproteinase (MMP)-1 and
MMP-9 in the prediction of SPB was described in chapter 3. The final common
pathway shows that proteases, which are produced by chorion and decidua, play an
important role during cervical dilatation in human parturition. MMP1- and -9 have
been studied in various biologic fluids (serum, plasma, amniotic fluid, and urine).
We studied for the first time whether cervico-vaginal fluid MMP-1 and MMP-9 lev-
els were different during pregnancy compared with those at term or in preterm
labor. Unfortunately cervico-vaginal MMP-1 levels were low and did not change
during either preterm or term labor. In contrast, there might be a role for MMP-9 in
the mechanisms of labor and rupture of membranes. Indeed, MMP-9 levels
increased during term and preterm labor, with highest values in laboring patients
with ruptured membranes, but the levels prior to preterm delivery were not signifi-
cantly increased in comparison to MMP-9 throughout pregnancy. MMP-9 therefore
is not a useful predictor of preterm birth. Another research group has recently stud-
ied MMP-9 in fetal membranes and they confirmed our findings.10 We conclude
that MMP-9 plays an important role in membrane rupture in the final common
pathway model. It will be interesting to study the usefulness of MMP-9 as a confir-
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mation test for premature preterm rupture of membranes (PPROM) in the future.
As described in the above-mentioned recommendations, cervical length measure-
ments together with FFN are the most useful markers in the prediction of SPB.
The relationship between a short cervix and the risk of SPB is well established.
The shorter the cervix the higher the risk and vice versa.11 Transvaginal ultra-
sonography (TVS) is a useful diagnostic tool in the detection of changes in gross
morphology, but not in discrimination between the different underlying patholo-
gies causing preterm delivery. It is also a diagnostic method that has been used in
clinical practice, before the evidence for its usefulness and the adequate frequency
of measurements was clear in the prediction of SPB. The cervix is a dynamic
organ and that there is a lot of variability in cervical length. We sought to deter-
mine (in chapter 4 and 5) which methodological and socio-demographic factors
can cause this variability in cervical length measurements. We also aim to develop
nomograms. First, it is vital that the technique of measuring cervical length is
standardized. In our cervical length studies we used the standardized measure-
ment technique defined by Iams.11 Secondly, several authors stated that the pres-
ence or absence of funneling and fundal pressure needs to be addressed when
measuring cervical length.12-14 However in recent studies the role of funneling in
the prediction of SPB does not provide any significant contribution in addition to
the cervical length measurement itself.12,13 In our studies the presence or absence
of funneling did not contribute to the prediction of SPB.
In chapter 4 we assessed the association of sociodemographic factors on the
change of cervical length of 125 women with an uncomplicated singleton preg-
nancy, who delivered at term. The cervical length was sonographically measured
at 3 to 4 weeks interval between 20 and 32 weeks’ gestation. All women had a
slight decrease of cervical length across gestation. Women who were African-
American, under stress, or working as skilled manual laborers demonstrated sig-
nificant shortening of the cervix during gestation. Given that a shorter cervix pre-
disposes to preterm delivery, our findings may give new insights into the well-
described association of these psychosocial and sociodemographic factors with an
increased risk of preterm delivery.
Based on the results of  the previous chapter, we aimed to evaluate the racial vari-
ation on cervical length and its association with preterm birth (chapter 5) With a
prospective cohort among 856 women, we measured serial cervical length at three
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different intervals between 20 and 32 weeks’ of gestation (65.5% Hispanics, 11.6
% Asians 9.5 % Caucasians and 13.4 % African-Americans). Preterm rates did not
significantly differ by race, but African-Americans delivered on average earlier
(38.4 weeks) than the other race groups. All pregnancies displayed progressive
cervical shortening except Asians. African-American women had shorter cervices
across all 3 gestational age intervals even after controlling for preterm delivery.
African-American women who delivered preterm had shorter cervices at 20-24
weeks’ gestation than African-American women that delivered at term. This dif-
ference was not significant in the other racial-ethnic groups. At 25-28 weeks only
African-American and Hispanic women showed a significant difference of mean
cervical length between delivering preterm compared to term. At 29-32 weeks the
difference in cervical length between delivering preterm or term were significant
in all ethnic groups. It suggests that shortening of the cervix is particularly a risk
indicator for preterm birth in African-American women, since they already have
shorter cervices to begin with. Measuring cervical length before 25 weeks gesta-
tion might not be of substantial contribution to the prediction of preterm birth in
other ethnical groups. It is note worthy that thus far most studies on the impor-
tance of cervical length measurement have predominantly included African-
American women.
Several authors studied the recurrent risk of preterm delivery.15-17 Particularly the
early prior preterm deliveries give a higher risk of a singleton preterm delivery in
the following pregnancy. The African-American women in our study population
had a higher rate of prior preterm birth, but after controlling for it, we still con-
firm that ethnicity has an influence on cervical change across gestation. In our
study we report that the mean gestational age of African-American women is sig-
nificantly shorter (38.4 weeks) in comparison to the other ethnic groups (39.1
weeks). Several authors confirmed these findings that African-American women
deliver earlier than for instance Caucasian women.18,19 The reasons for this differ-
ence mentioned in the past were lower socio-economic status among African-
Americans; a short-pregnancy interval; a higher prevalence of known risk factors
such as hypertension, diabetes, anemia, higher risk of infection. However, in our
study, the statistically significant anatomic variation in cervical length, may con-
tribute to the higher rate of preterm births in the African-American population.
Our findings of a shorter cervix at 20-24 weeks and a significant shortening of the
cervix during gestation among African-Americans might give them a different
exposure to other risk factors in comparison with the other ethnic groups. In some
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cases shortened cervix becomes an ineffective barrier to ascending infection.14,20
This might predispose African-Americans to shorter gestations. The cervical
length measurements of the African-Americans in our study were not confounded
by the above-mentioned socio-economic risk factors.20,21 When measuring cervi-
cal length by transvaginal sonography to assess risk for preterm birth, considera-
tion should be given to racial-ethnic background when interpreting results. It
could well be that lower cut-off values in African-American women should be
used than in other ethnic groups, but future research needs to clarify this.
We did not focus on cut-off values and frequencies of cervical length measure-
ments needed for the prediction of SPB. However, from our review in chapter 2
we would like to draw a few conclusions for the clinic. The cervical length meas-
ured by transvaginal sonography is a tool that is non-invasive, easy and often used
in clinical practice. To date, it is unclear what a useful cut-off value is for the pre-
diction of SPB. For singleton pregnancies the international literature mostly sug-
gests to use the cut-off for cervical length of <30 mm to predict SPB in a general
population and <25 mm for the population at risk.11,22 The minimum interval
between cervical length measurements necessary to detect cervical shortening in
time mostly used in the literature is every 3 weeks. Based on our results we sug-
gest that the predictive value of screening for cervical length early in the pregnan-
cy might only be useful for the African-American population. Blacks have appar-
ently a shorter cervix with less reserve capacity than the other ethnic groups. We
recommend future research to determine new cut-off values for African-American
women and other ethnic groups. From a practical perspective, our study suggests
that the value of measuring cervical length may be limited prior to 25 weeks in
racial/ethnic groups other than African American women and before 29 weeks
among Caucasian and Asian women; It is questionable if early measurements are
cost-effective.
In chapter 6 we evaluated the role of transvaginal ultrasonographic cervical
length measurements for women with cervical incompetence. The study popula-
tion contained of eighty women at risk for cervical incompetence whose primary
physician determined that a prophylactic (n = 50) or urgent cerclage (n = 30)
was indicated. Cervical length measurements took place before and after the cer-
clage until 32 weeks’ gestation. We determined that there was an increase in cervi-
cal length after cerclage. However, the degree of lengthening after cerclage was
not predictive of term delivery. Our second research question of this study was
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whether serial follow-up measurements of cervical length after cerclage were use-
ful in the prediction of pregnancy outcome. We showed that serial cervical length
measurement in the late second or early third trimester predicted preterm birth. It
gave an earlier warning in women with a prophylactic cerclage than in women
with an urgent cerclage.
There remains discussion in the literature regarding the use of transvaginal ultra-
sonography for women with a cerclage and the frequency of follow-up after cer-
clage. We confirmed the usefulness of transvaginal ultrasonography with the
results from our study that women with progressive shortening of the cervix are at
higher risk to deliver preterm (not only < 37 weeks, but also < 35 weeks) in com-
parison to women whose cervices decrease slowly across gestation. We suggest
that in a woman with cervical incompetence ultrasound follow-up of the cervix
should start at the end of the first trimester and continue serially every 3 weeks till
30-32 weeks’ gestation.23-25 The cut-off values for cerclage placement described in
the international literature range from 15 to 25 mm.13,26 Althuisius et al. suggested
a (second) therapeutic cerclage and bedrest when a cervix is found < 25 mm
before 27-28 weeks’ gestation.27 This gestational period was chosen because the
advantages of prolonging pregnancy, outweigh the risk of the cerclage application
before the gestational age of about 27-28 weeks.27,28 In this randomized interven-
tion trial only a minority of the women  fulfilled the criteria for the traditional def-
inition of cervical incompetence.  60% of the women with a prophylactic cerclage
might not have needed it.27 Guzman et al. described that women with cervical
lengths of  ≤ 15 mm will benefit the most from cerclage placement. Larger ran-
domized intervention trials are needed in the future, which address the use of a
(therapeutic) cerclage versus restriction of physical activity for the short cervix and
the follow-up after cerclage by TVS.13
Part 2: Spontaneous preterm birth in Dutch obstetric care.
Since many studies regarding prediction of spontaneous preterm birth have been
published in the recent international literature, we are interested how these (new)
predictors of SPB are implemented in the Dutch obstetric care. Furthermore, the
impression exists that there are different strategies and views regarding diagnosing
and treating threatened preterm birth among and between midwives, general
practitioners (practicing obstetrics) and obstetrician/gynecologists (further men-
tioned as gynecologists). Dutch obstetrical care is based on a ‘unique’ system of
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risk selection with the option of home deliveries. First line obstetric care providers
are responsible for the obstetric care for low risk women. It is important to know
when a woman is at increased risk for SPB for the first line obstetric care
providers. So the patient can be referred to an gynecologist in time. Risk selection
as to SPB is important and is partly provided by the Obstetric Indication List
(‘VIL’). Firstly, it is relevant to know the risk factors, the symptoms and the avail-
able diagnostic tests to be able to assess the risk per patient on spontaneous SPB.
Secondly, it is important to be clear to patients with a prior SPB what the recur-
rence risk is and what the management will be in a next pregnancy. 
A written  questionnaire to study opinions and management regarding threatened
preterm birth, co-operation and the ‘VIL’ was sent to first line obstetrical practi-
tioners (midwives and general practitioners practicing obstetrics) and gynecolo-
gists (chapter 7). There appeared to be consensus among the three professional
groups about the way that risk selection takes place. The three professional groups
agreed that the problem of SPB has moved from < 37 gestational weeks to < 35
gestational weeks. In our study the three groups agreed that a preterm birth > 34
weeks carries only a small risk on an early SPB in the following pregnancy. In that
case prenatal care can be provided by the midwife or general practitioner. This
view is in accordance with the fact that reducing late preterm birth, the 50% that
occur at 35 and 36 weeks’ gestation, is not likely to have major effects on perinatal
outcome. Instead, the 1% to 2% infants born before 30 to 32 weeks’ gestation
account for the major part of the mortality and both short-and long-term neuro-
logic morbidity. The important time period for PTL management is from 24
weeks until 34-35 weeks of gestation.29 The three professional groups had a posi-
tive view on the general ‘VIL’ and to the mutual co-operation. To date, there are,
however, no clear guidelines in the Netherlands for the use of the various diag-
nostic tests for screening and/or prediction of early, moderate or late SPB in the
next pregnancy.
In chapter 8 we assessed the use of ‘modern’ diagnostic methods such as trans-
vaginal sonographic measurements of cervical length, examination of bacterial
vaginosis (BV) and fetal fibronectin (FFN) by Dutch gynecologists. Cervical
length measurements are used by most of the Dutch gynecologists, even as testing
and treating for BV. Fetal fibronectin testing - according to literature the best
marker available now - is seldomly been used. Gynecologists in general hospitals
without residency programs prescribe tocolytics and repeat corticosteroid treat-
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ment more often compared to the gynecologists in hospitals with residency pro-
grams. They prescribe less antibiotics for women with threatened preterm birth.
Apparently 40% of Dutch gynecologists ‘treat’ preterm premature rupture of
membranes (PPROM) with tocolytics while there are no contractions. With the
results from the ‘ORACLE’ trial the limited use of antibiotics by the Dutch gyne-
cologists in women with PPROM is striking.30,31 However, our questionaire was
held before the results of the ‘oracle’ study. Apparently, the management of gyne-
cologists from general hospitals is more traditional, while the gynecologists from
hospitals with residency programs seem to react more quickly to new develop-
ments. This regards especially the use of antibiotics for women with PPROM,
repeated corticosteroid treatment and the use of tocolytics. We discovered an inter-
esting discrepancy between the use of FFN and measuring cervical length with
ultrasound. The reason might be that the ‘ultrasound-equipment’ was already
available in the gynecologist’s practice, while for FFN a new system needs to be
installed. On some points the disciplines involved in obstetric care should adopt
their guidelines to use the evidence from the literature. Use of FFN in the Dutch
setting should be evaluated in the future.
Summary and Discussion
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Vroeggeboorte wordt door de Wereld  Gezondheidsorganisatie (WHO)
gedefinieerd als een bevalling voor 37 complete zwangerschapsweken.
Vroeggeboorte is een van de voornaamste oorzaken van neonatale sterfte en een
belangrijke oorzaak van lichamelijke en mentale beperkingen op de lange termijn.
Op dit moment is de incidentie van vroeggeboorte in de westerse samenleving 7
tot 11 % en dit percentage lijkt internationaal iets te stijgen. De belangrijkste rede-
nen hiervoor zijn (1) toename van meerlingzwangerschappen door fertiliteits-
bevorderende behandelingen en (2) hogere leeftijd waarop vrouwen kinderen kri-
jgen, (3) tendens tot eerder ingrijpen (d.m.v. inleiding of keizersnede) bij prob-
leem-zwangerschappen en (4) betere registratie van zowel de zwangerschapsduur
(door vroege echoscopie) als van extreme vroeggeboortes op de grens van levens-
vatbaarheid. 
In dit proefschrift concentreren wij ons op de spontane vroeggeboorte. Dit omvat
zowel premature (voortijdige) contracties als het voortijdig breken van de vliezen.
Het spreekt voor zich dat verlaging van de incidentie van vroeggeboorte door
middel van preventie en het op tijd diagnosticeren en behandelen van dreigende
vroeggeboorte een belangrijk doel is in de verloskunde. Verder is het van belang te
voorkomen dat patiënten onnodig behandeld worden. Internationaal wordt veel
onderzoek gedaan naar methoden die ons in staat stellen vrouwen met een ver-
hoogd risico op vroeggeboorte tijdig te identificeren en effectief te behandelen. 
In dit proefschrift worden de volgende onderzoeksvragen behandeld:
• Welke ontstaansmechanismen en voorspellende testen van spontane vroegge-
boorte zijn tot nu toe beschreven in de literatuur? En welke testen zijn zinvol
voor de klinische praktijk?
• In hoeverre kunnen de nieuwe markers matrix metalloproteinase -1 en -9 wor-
den gebruikt om spontane vroeggeboorte te voorspellen?
• Wat is het normale beloop van de cervix (baarmoedermond) lengte gedurende
de zwangerschap en welke (socio-demografische) factoren beïnvloeden deze
lengte bij een voldragen zwangerschap en bij vroeggeboorte? 
• Is het gebruik van cervixlengte metingen na een cerclage (bandje om baar-
moedermond) zinvol en wat is de voorspellende waarde hiervan voor spon-
tane vroeggeboorte?
• Wat is de werkwijze met betrekking tot het beleid bij dreigende vroeggeboorte
onder de Nederlandse verloskundige hulpverleners?
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Deel 1. Oorzaken van vroeggeboorte en  methoden om het te voorspellen. 
Het ontstaansmechanisme van vroeggeboorte wordt in hoofdstuk 2 beschreven.
Vroeggeboorte kan worden veroorzaakt door 4 primaire oorzaken, of een combi-
natie hiervan: (1) activatie van de hypothalamus-hypofyse-bijnier-as (HPA) door
stress van zowel moeder als kind; (2) ontsteking (opstijgende infectie vanuit vagina,
systemisch of op grens vliezen/placenta (moederkoek)); (3) vaginale bloeding
(vanuit placenta) en (4) forse uitzetting van de baarmoeder. De vier beschreven
ontstaansmechanismen zijn actief in verschillende perioden van de zwangerschap.
Het grootste deel van de extreme vroeggeboortes lijkt in verband te staan met opstij-
gende infecties vanuit de vagina. Een infectie of bloeding kan irritatie of beschadig-
ing veroorzaken op de overgang van vliezen en placenta. Als gevolg van ontstek-
ingsreakties komen stoffen vrij (enzymen, proteases en collagenases) waardoor
prostaglandine productie op gang komt. Dit kan leiden tot voortijdige ontsluiting,
contracties en het breken van de vliezen en uiteindelijk tot vroeggeboorte. 
Op het moment wordt veel onderzoek gedaan naar de vraag of de biologische stoffen
die geassocieerd zijn met de verschillende ontstaansmechanismen (ontstekingsmedi-
atoren, hormonen, enzymen), gebruikt kunnen worden als voorspellers voor
vroeggeboorte. In hoofdstuk 2 volgt een overzicht van de literatuur over het gebruik
van nieuwe biochemische markers als voorspellende testen voor vroeggeboorte.
Hierin staat ook aangegeven wat de beste zwangerschapsduur is waarop de verschil-
lende testen uitgevoerd dienen te worden om vrouwen met een verhoogd risico op
vroeggeboorte te identificeren. Uit dit overzicht blijkt dat de voorspellende waarde
van nieuwe biochemische markers gemiddeld gezien lager of gelijk is - soms iets
hoger - dan die van reeds in de kliniek gebruikte testen. De lage voorspellende
waarde van deze specifiek aan ontstaansmechanismen gerelateerde markers, kan
mogelijk verklaard worden door het multi-factoriële karakter van vroeggeboorte.
Methoden die reeds worden gebruikt om vroeggeboorte te voorspellen zijn: het
monitoren van contracties, het testen van een eiwit foetaal fibronectine en het beo-
ordelen van de cervixlengte. Zowel het bepalen van cervixlengte (met vaginale echo-
scopie) als foetaal fibronectine zijn van belang in de voorspelling van vroeggeboorte
in symptomatische en asymptomatische patiënten. De relatie tussen een korte cervix
en het risico van vroeggeboorte is bevestigd. Hoe korter de cervix hoe hoger het risico
en vice versa. Foetaal fibronectine heeft met name een hoge negatief voorspellende
waarde. Afwezigheid van foetaal fibronectine in vagina slijm voorspelt met een
betrouwbaarheid van 95% dat een bevalling niet binnen 2 weken plaatsvindt. 
Samenvatting en nabeschouwing
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Aanbevelingen die op grond van de literatuur gegeven kunnen worden, zijn: 
Algemene populatie (zonder risicofactoren voor vroeggeboorte en zonder eerdere
vroeggeboorte):
• Er zijn onvoldoende gegevens bekend om het hormoon estriol bepaald in
speeksel, (thuis) monitoren van contracties of het testen van bacteriële vagi-
nosis te gebruiken om vroeggeboorte te identificeren of te voorkomen. 
• Voor andere biochemische markers (bijv. corticotropine-vrijkomend hormoon
(CRH), moederlijk serum a-foetoprotein (MSAFP), interleukine-6 (Il-6) en
granulocyt colonie-stimulerende factor (G-CSF)) zijn grotere studies
geïndiceerd, alvorens conclusies kunnen worden getrokken omtrent hun func-
tie bij het voorspellen van vroeggeboorte. 
• In de algemene populatie zijn er behoudens, de verloskundige voorgeschiede-
nis, geen risicofactoren effectief gebleken bij het voorspellen van vroeggeboorte.
Populatie met verhoogde kans op vroeggeboorte (risicofactoren voor vroegge-
boorte, of symptomen van dreigende vroeggeboorte aanwezig):
• Om te bepalen welke vrouwen een hoog risico hebben op vroeggeboorte zijn
vaginale echoscopische meting van cervixlengte, foetaal fibronectine onder-
zoek, of een combinatie van beide testen zinvol gebleken. Met name de hoge
negatief voorspellende waarde van beide testen is voor de algemene praktijk
van belang om onnodige interventies te voorkomen.  
• Voor andere biochemische markers (bijvoorbeeld CRH, MSAFP, Il-6, G-CSF)
zijn grotere studies noodzakelijk, alvorens conclusies kunnen worden
getrokken omtrent hun functie bij het voorspellen van vroeggeboorte.
• Aanwezigheid van bacteriële vaginosis verhoogt de kans op vroeggeboorte. Er
heerst echter discussie of behandeling met orale antibiotica (metronidazol met
of zonder erytromycine) de kans op vroeggeboorte reduceert. Met de bewijsvo-
ering tot op heden, wordt alleen bij zwangeren met een vroeggeboorte in de
voorgeschiedenis behandeling geadviseerd. Profylactische behandeling van
vrouwen met een risico op vroeggeboorte, maar zonder bacteriële vaginosis, is
niet zinvol.
Onze aanbevelingen komen vrijwel overeen met de recent gepubliceerde richtlij-
nen van het Amerikaanse college voor verloskunde en gynaecologie (ACOG). 
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Hoofdstuk 3 beschrijft de resultaten van een onderzoek naar de voorspellende
waarde van de nieuwe markers matrix metalloproteinase (MMP)-1 en MMP-9.
Het bindweefsel (collageen) in de baarmoedermond zorgt ervoor dat deze tijdens
de zwangerschap gesloten blijft. Afbraak van dit bindweefsel leidt tot verkorting
en verweking van de cervix en kan tot (vroeg)geboorte leiden. Door de afbraak
van collageen, komen proteases (bijvoorbeeld matrix metalloproteinases) vrij. De
voorspellende waarde van MMP-1 en -9 voor vroeggeboorte zijn tot op heden
alleen bestudeerd in bloed, vruchtwater en urine. Wij hebben voor het eerst de
concentratie van MMP-1 en MMP-9 in cervix en vagina slijm bestudeerd bij 32
vrouwen die uiteindelijk preterm (te vroeg) en 80 vrouwen die a term (op tijd)
bevielen. MMP-1 en -9 werden gemeten tussen 20 en 32 weken, een week voor de
bevalling, en tijdens de (te vroeg of op tijd plaatsvindende) bevalling. Helaas
bleek de hoeveelheid MMP-1 in cervix en vagina slijm laag, en steeg de concen-
tratie niet voorafgaande of tijdens de bevalling. MMP-9 speelt mogelijk wel een
rol bij het ontstaan van contracties en breken van de vliezen. De concentratie is
namelijk significant hoger tijdens de bevalling dan daarvoor, dit geldt zowel voor
de preterme als op tijd komende bevalling. De hoogste waarden worden gevonden
bij vrouwen met gebroken vliezen. De concentratie van MMP-9 een week voor de
bevalling was niet significant hoger dan die tijdens de zwangerschap. Ook MMP-
9 kan daarom niet gebruikt worden als een voorspellende test voor vroeggeboorte.
Wel blijkt MMP-9 een belangrijke rol te spelen bij het breken van de vliezen.
Onderzoek naar het gebruik van MMP-9 ter bevestiging van het al dan niet
gebroken zijn van de vliezen is interessant voor de toekomst.   
In de hoofdstukken 4 en 5 hebben we de invloed van socio-demografische fac-
toren onderzocht op de lengte van de cervix. De cervix is een dynamisch orgaan
en uit de literatuur blijkt variabiliteit in cervixlengte. Bij het meten van
cervixlengte is standaardisatie van de techniek van groot belang. Wij hebben
gebruikt gemaakt van de standaardisatie van de meettechniek zoals gedefineerd
door Iams en anderen. Verscheidene auteurs hebben beschreven dat rekening
gehouden moet worden met de aan- of afwezigheid van funneling bij het meten
van de cervixlengte. Het al dan niet aanwezig zijn van funneling blijkt echter
geen toegevoegde waarde te hebben in de voorspelling van vroeggeboorte, als aan-
vulling op het meten van de lengte van de cervix zelf. 
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Hoofdstuk 4 beschrijft normaalwaarden van de cervixlengte en de invloed van
socio-demografische factoren hierop. De studiepopulatie bestond uit 125 vrouwen
met een ongecompliceerde eenlingzwangerschap, die rond de uitgerekende
datum bevielen. De lengte van de cervix werd elke 3 tot 4 weken met transvagi-
nale echografie bepaald tussen 20 en 32 weken zwangerschapsduur. Bij alle
vrouwen vond een geringe verkorting van de lengte van de cervix plaats in het
verloop van de zwangerschap. Een significante verkorting trad op bij de negroïde
vrouwen, bij vrouwen onder stress, cq vrouwen die zware lichamelijke arbeid ver-
richten. Het is bekend dat deze factoren predisponeren tot vroeggeboorte. De
verkorting van de cervix zou een verklaring kunnen zijn voor het verband tussen
bovengenoemde psychosociale en socio-demografische factoren en het verhoogde
risico op vroeggeboorte. 
In hoofdstuk 5 wordt de invloed van ethnische achtergronden op de cervixlengte
en op een eventuele associatie met vroeggeboorte onderzocht bij 856 vrouwen. In
een prospectieve cohort werd de cervixlengte gemeten in drie verschillende
tijdsperioden tussen 20 en 32 weken zwangerschapsduur. Twee derde van de
onderzoekspopulatie was Hispaans van origine, en verder was er een vrijwel
gelijke verdeling van Aziatische, blanke en negroïde vrouwen. Het percentage
vroeggeboorte verschilde niet significant per ras, hoewel de negroïde vrouwen
gemiddeld iets eerder bevielen (38.4 weken) dan de vrouwen met een andere eth-
nische achtergrond (39.1 weken). Met uitzondering van de Aziatische vrouwen
was bij alle groepen sprake van een progressieve verkorting van de cervix. De
negroïde vrouwen hadden in alle drie zwangerschapsperioden een kortere
cervixlengte dan de andere groepen, ook als gecontroleerd werd voor vroegge-
boorte. Negroïde vrouwen die prematuur bevielen hadden bij 20-24 weken een
significant kortere cervixlengte dan negroïde vrouwen die tijdens de uitgerekende
periode bevielen. Dit verschil bleef ook significant na uitsluiting van risico-
vrouwen met vroeggeboorte in de voorgeschiedenis. Bij de andere ethnische
groepen was dit verschil bij 20-24 weken niet significant. Bij 25-28 weken was de
gemiddelde cervixlengte zowel bij negroïde als bij Hispaanse vrouwen die te
vroeg bevielen significant korter en dit verschil was bij 29-32 weken significant bij
alle vier ethnische groepen. Negroïde vrouwen hebben dus blijkbaar een kortere
cervixlengte tussen 20 en 32 weken dan vrouwen met een andere ethnische
achtergrond. Verkorting van de cervixlengte blijkt bij hen dan ook eerder een
effect te hebben op het voorkómen van vroeggeboorte. Ons onderzoek suggereert
dat screening op verhoogde kans op vroeggeboorte bij negroïde vrouwen vanaf 20-
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24 weken zinvol is, terwijl dit voor vrouwen met een andere ethnische achter-
grond pas later een toegevoegde waarde heeft. Het is vermeldenswaard dat de
meeste onderzoekspopulaties waarin het belang van cervixlengte metingen voor
het voorspellen van vroeggeboorte werd bestudeerd voornamelijk bestonden uit
negroïde vrouwen. 
Onze bevinding dat de negroïde vrouwen gemiddeld iets eerder bevallen dan
andere ethnische groepen wordt bevestigd in de literatuur. De redenen die hier-
voor genoemd zijn, zijn een gemiddeld lagere sociaal-economische klasse; een
korter interval tussen de zwangerschappen; hogere prevalentie van bekende risi-
cofactoren als hoge bloeddruk, suikerziekte, bloedarmoede en een verhoogd risico
op infectie. Echter, de significant kortere cervix zou het hogere percentage
vroeggeboorte onder de negroïde populatie kunnen verklaren. Dit zou hen ook
kwetsbaarder kunnen maken voor andere risicofactoren. Zo biedt een kortere
cervix een minder effectieve bescherming tegen opstijgende infecties. Het is
vooralsnog onduidelijk of deze kortere cervix het gevolg is van aangeboren
anatomische verschillen, ontstaat door een ander hormonaal milieu tijdens de
zwangerschap, of op zich weer het gevolg is van andere risicofactoren (zoals
infectie). Concluderend is het bij het interpreteren van de echoscopisch gemeten
cervixlengte voor het voorspellen van vroeggeboorte van belang om rekening te
houden met de ethnische achtergrond van de patiënt. Enerzijds is de voorspel-
lende waarde voor het optreden van vroeggeboorte bij negroïde vrouwen al
vroeger aanwezig dan bij andere rassen. Anderzijds hebben negroïde vrouwen
überhaupt een kortere cervix en zijn mogelijk lagere normaalwaarden op zijn
plaats. We verwachten in de toekomst, met een uitbreiding van de studiepopu-
latie, hierover meer duidelijkheid te verkrijgen. 
Het meten van de cervix is een gemakkelijk en slechts beperkt invasief diagnos-
tisch hulpmiddel, dat inmiddels te pas (en te onpas) in de kliniek wordt gebruikt.
Vooral de hoge negatief voorspellende waarde is van belang bij onderzoek bij
risico-zwangerschappen. Nut voor de algemene populatie is nog niet aangetoond,
hoewel ons onderzoek suggereert dat vroege screening bij negroïde vrouwen zin-
vol zou kunnen zijn. Onderzoek bij risicopopulaties zou volgens de literatuur
met een tijdsinterval van circa 3 weken plaats dienen te vinden. De ondergrens
voor een toegenomen kans op vroeggeboorte is volgens enkelen 25 mm en volgens
anderen 30 mm. Het is vooralsnog de vraag of cervixlengte metingen (vroeg) in
het tweede trimester kosten-effectief zijn. Nader onderzoek in een grote populatie
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en onderscheid tussen de vrouwen met of zonder verhoogd risico op vroegge-
boorte is aangewezen. Dit om een adequaat en efficiënt beleid te kunnen for-
muleren ten aanzien van de toegevoegde waarde van cervixlengte metingen bij
diagnostiek en preventie van (dreigende) vroeggeboorte.
De voorspellende waarde van cervixlengte metingen voor het optreden van
vroeggeboorte bij vrouwen met een cerclage op basis van cervixinsufficiëntie
wordt in hoofdstuk 6 onderzocht. De onderzoeks  populatie bestond uit tachtig
vrouwen die in verband met een risico op cervixinsufficiëntie een cerclage hadden
gekregen (50 profylactisch en 30 therapeutisch). Vóór en na de cerclage werden
cervixlengte metingen verricht tot 32 zwangerschapsweken. De lengte van de
cervix werd langer direct na het plaatsen van de cerclage. Deze lengte bleek echter
niet voorspellend voor de uitkomst van de zwangerschap. Wel hadden de follow-
up metingen aan het einde van het tweede en het begin van het derde trimester
een voorspellende waarde voor het al dan niet optreden van  vroeggeboorte. 
Bij  vrouwen met een verhoogde kans op cervixinsufficiëntie wordt echoscopische
seriële follow-up van de cervix aanbevolen vanaf het einde van het eerste
trimester. Dit wordt bevestigd door Althuisius e.a. die in een prospectief geran-
domiseerd onderzoek aangetoond heeft dat echoscopische follow-up van de
cervixlengte - met een therapeutische cerclage bij een verkorting van de cervix tot
onder de 25 mm - een goed alternatief is voor de traditionele profylactische cer-
clage. Anderen vinden dat vrouwen met een cervixlengte van < 15 mm de meeste
baat hebben bij een cerclage.
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Deel 2. Spontane vroeggeboorte in de Nederlandse verloskundige zorg.
De Nederlandse verloskundige zorg is uniek in vergelijking met andere westerse
landen, aangezien zwangeren met een laag risico (80%) door eerstelijns ver-
loskundige hulpverleners (verloskundigen en verloskundig actieve huisartsen)
worden begeleid. Uitgangspunt daarbij is dat de eerstelijns verloskundige zorgver-
lener tijdig een betrouwbare inschatting kan maken om bij te verwachten medis-
che of verloskundige problemen, hetzij zelf de bevalling in het ziekenhuis te
begeleiden, hetzij de patiënt (voor, tijdens of na de bevalling) naar de gynaecoloog
te verwijzen. De Verloskundige Indicatie Lijst (‘VIL’) is een hulpmiddel voor risi-
coselectie in de verloskunde. De richtlijnen ten aanzien van vroeggeboorte zijn
echter summier beschreven. Verder bestaat de indruk dat er uiteenlopende menin-
gen zijn ten aanzien van diagnostiek en beleid bij dreigende vroeggeboorte tussen
en binnen de drie beroepsgroepen. Om in de toekomst nieuwe mogelijkheden voor
overleg op dit gebied tussen de eerste en tweede lijn te bieden, hebben we een vra-
genlijst ontwikkeld om de werkwijze, taakafbakening en opvattingen ten aanzien
van dreigende vroeggeboorte te inventariseren. Ook worden de opvattingen ten
aanzien van de onderlinge samenwerking tussen de eerstelijns verloskundige
hulpverleners en de gynaecologen en de acceptatie van de ‘VIL’ bestudeerd. 
In hoofdstuk 7 worden de resultaten van deze vragenlijst gepresenteerd. Er
bleek in grote lijnen overeenstemming te bestaan over het beleid bij dreigende
vroeggeboorte onder de drie beroepsgroepen. Bij symptomen van dreigende
vroeggeboorte bij > 35 weken werd minder naar de tweede lijn verwezen dan
eerder in de zwangerschap. Het beleid bij vrouwen met ‘contracties’, bij ‘ver-
denking op cervixinsufficiëntie’ en bij een ‘conisatie in de voorgeschiedenis’
bleek bij 25-30 zwangerschapsweken minder eenduidigheid. De meerderheid
van de drie beroepsgroepen was van mening dat de begeleiding van een vol-
gende zwangerschap niet in de tweede lijn hoefde plaats te vinden, indien een
eerdere vroeggeboorte tussen 34 en 37 zwangerschapsweken had plaatsgevon-
den. Er bleek overeenstemming over het feit dat het probleem van vroegge-
boorte een zwangerschapsduur van minder dan 35 weken betreft en niet meer
alle zwangerschappen < 37 weken. Deze bevindingen komen overeen met de
literatuur. Enerzijds blijkt dat het herhalingsrisico op vroeggeboorte veel lager is
indien de eerste vroeggeboorte na 32-34 weken heeft plaatsgevonden.
Anderzijds blijkt dat preventie van late vroeggeboorte tussen 35 en 37 weken -
in totaal 50 % van alle vroeggeboortes - nauwelijks effect heeft op de perinatale
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uitkomst. Vroeggeboorte, voorspelling en preventie, is vooral van belang vóór
34-35 weken.
Een goede risicoselectie is van belang voor de instandhouding van het
Nederlandse verloskundige systeem met de mogelijkheid van thuisbevallingen;
een systeem dat op dit moment onder druk staat. Uit ons onderzoek blijkt dat de
drie beroepsgroepen actief in de verloskundige zorg in Nederland de (gehele) ver-
loskundige indicatielijst positief waarderen en ook was men in grote lijnen tevre-
den over de onderlinge samenwerking. De acceptatie van de verloskundige indi-
catielijst is nu veel groter dan 10 jaar geleden. Het is een uitdaging voor ver-
loskundigen, verloskundig actieve huisartsen, gynaecologen en beleidsmakers om
het goede en unieke systeem van de Nederlandse verloskunde te behouden.
Op dit moment zijn er in Nederland nog geen specifieke richtlijnen voor het
gebruik van de verschillende diagnostische testen voor het voorspellen van
vroeggeboorte in de (volgende) zwangerschap. Na de vele studies die over het
voorspellen van vroeggeboorte in de internationale literatuur zijn verschenen, zijn
we geïnteresseerd hoe de (nieuwe) voorspellende testen voor vroeggeboorte in de
Nederlandse verloskundige zorg zijn geïmplementeerd. 
Het gebruik onder Nederlandse gynaecologen van ‘nieuwe’ diagnostische testen,
zoals echoscopische meting van de cervixlengte, onderzoek naar bacteriële vagi-
nosis en foetaal fibronectine, wordt in hoofdstuk 8 beschreven. Er bleek een grote
variatie in werkwijze te bestaan bij dreigende vroeggeboorte. Cervixlengte metin-
gen en onderzoek naar bacteriële vaginosis werden door 50-80% van de gynae-
cologen toegepast. Bacteriële vaginosis werd door 80% van de gynaecologen
behandeld. Foetaal fibronectine in vagina-of cervix slijm - volgens de literatuur
op dit moment de beste voorspeller voor vroeggeboorte - werd daarentegen
nauwelijks gebruikt. Weeënremming en corticosteroïden werden vaak gegeven bij
zwangeren met prematuur gebroken vliezen zonder weeënactiviteit, terwijl
antibiotica slechts bij 25% werd voorgeschreven. Gynaecologen werkzaam in per-
ifere ziekenhuizen gaven aan vaker weeënremming voor te schrijven en corticos-
teroïden behandeling te herhalen dan gynaecologen in opleidingsziekenhuizen.
Antibiotica werden daarentegen vaker voorgeschreven bij prematuur gebroken
vliezen door gynaecologen werkzaam in opleidingsziekenhuizen. Recent is
gebleken dat erythromycine bij preterm gebroken vliezen niet alleen de zwanger-
schapsduur significant verlengd, maar ook de neonatale morbiditeit significant
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verlaagt. Ten tijde van de enquête was bovengenoemde studie echter nog niet
gepubliceerd. Hoewel er al enkele jaren aanwijzingen zijn dat bij preterm gebro-
ken vliezen antibiotica de zwangerschapsduur verlengen en neonatale morbiditeit
verlagen, was het advies van de Cochrane Collaboration om deze behandeling
nog niet toe te passen. De opleidingsklinieken liepen dus blijkbaar vooruit op het
definitieve bewijs en algemene ziekenhuizen waren wat terughoudender. Al met
al, blijkt onder Nederlandse gynaecologen slechts in geringe mate sprake van
standaardisatie in het gebruik van ‘moderne’ diagnostische hulpmiddelen en
behandelingsmodaliteiten voor dreigende vroeggeboorte.
Voor referenties zie engelstalige samenvatting
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Abbrevations and Appendix
ACOG American College of Obstetricians and Gynecologists
ACTH Adrenocorticotropic hormone
AF Amniotic fluid
ANOVA Analysis of variance
BSA-TBS Bovine serum albumin in Tris buffer
BV Bacterial vaginosis
CI Confidence interval
CRH Corticotropin-releasing hormone
CV Coefficient of variability
CVS Cervicovaginal secretions
DES Diethylstilbestrol
DHEAS Dehydroepiandrosterone sulfate
E1-3 Estriol 1-3
ECM Extra cellular matrix
EGA Estimated gestational age 
ELISA Enzyme-linked immunosorbent assay
FBM Fetal breathing movements
FDA Food and Drug Administration
FFN Fetal fibronectin
G-CSF Granulocyte stimulating factor
HCG Human chorionic gonadotropin 
HPA Hypothalamic pituitary adrenal (axis)
HUAM Home uterine activity monitoring
IAI Intra amniotic infection
IL Interleukine
IUGR Intrauterine growth retardation
MOM Multiples of the median 
MMP Matrix metalloproteinase
MSAFP Maternal serum alpha-fetoprotein
NIH National Institute of Health
NPV Negative predictive value
PA Plasmin activator
PG Prostaglandin
PMSF Phenolmethylsulfonylfloride
PPROM Preterm premature rupture of membranes
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PPV Positive predictive value
PTB Preterm birth 
PTL Preterm labor
SD Standard deviation
SPB Spontaneous preterm birth (= PTL + PPROM)
TAT Thrombin-antithrombin III complex levels
TIMP Tissue inhibitor of metalloproteinases
TNF Tumor necrosis factor
TVS Transvaginal ultrasonography
VIL Verloskundige Indicatie Lijst (Obstetric Indication List)
VWS Volksgezondheid, welzijn en sport (Health and Sports)
Appendix
Since the questionnaires used for chapter 4 and 5 and the 2 Dutch questionnaires
used for the studies in chapter 7 and 8 are quite comprehensive, we choose not to
publish it in the thesis.
An English or Dutch version of these questionnaires are available by mailing to
the author. (karoliendijkstra@hotmail.com)
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1. Het is opvallend  dat 40% procent van de Nederlandse gynaecologen weeën-
remmers geeft bij te vroeg gebroken vliezen zonder weeën (dit proefschrift)
2. Het langer worden van de cervix na cerclage is niet voorspellend voor een
betere uitkomst van de zwangerschap (dit proefschrift)
3. De hogere incidentie van vroeggeboorte bij de negroïde populatie kan
mogelijk verklaard worden door een kortere cervixlengte (dit proefschrift)
4. Gynaecologen houden meer van mooie plaatjes dan van biochemische tests;
daarom wint de cervixlengte meting van de foetaal fibronectine bepaling (dit
proefschrift) en de nekplooi meting van de triple test 
5. Vroeg gemeenschap verhoogt de kans op vroeg ouderschap
6. Het consumeren van 1 keer per week vis beschermt vrouwen tegen vroegge-
boorte
7. Het aanmoedigen van de verloskundige vaardigheden voor startende huisart-
sen staat in schril contrast met het ontmoedigen van huisartsen om ver-
loskundig actief te blijven 
8. The world is too diverse and beautiful to see it only during your  holidays
9. De naam huisarts lijkt - in de 21e eeuw - de lading niet meer te dekken; een
naamswijziging naar ‘eerstelijns gezondheids coach voor allen’ is gewenst
10. Te vroeg is nooit te laat
11. Het vervangen van het woord ‘spreekuur’ in de ‘e-mailminuut’ is prematuur
zolang directe interactie tussen huisarts en patiënt nog gewenst is
12. Het onderscheid tussen luisteren en horen is een wereld van verschil
13. Gezien het feit dat velen New York beschouwen als hemel op aarde, zal
‘ground zero’ altijd een wolkenkrabber blijven
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